ࡱ> jlefghi ~bjbj 1`c`c*001?1???????8?< B?VvBE"EEEGZH1H$̲i?AHG"GAHAH1?1?EEQQQAH4 1?8E?EQAHQQb{4i?E~uQX2m&0VxQ"xn x? dQAHAHAHQAHAHAHVAHAHAHAHxAHAHAHAHAHAHAHAHAH0 =: HUMAN IMMUNODEFICIENCY VIRUS & ACQUIRED IMMUNODEFICIENCY SYNDROME Dana Bartlett, BSN, MSN, MA, CSPI Dana Bartlett is a professional nurse and author. His clinical experience includes 16 years of ICU and ER experience and over 20 years of as a poison control center information specialist. Dana has published numerous CE and journal articles, written NCLEX material, written textbook chapters, and done editing and reviewing for publishers such as Elsevier, Lippincott, and Thieme. He has written widely on the subject of toxicology and was recently named a contributing editor, toxicology section, for Critical Care Nurse journal. He is currently employed at the Connecticut Poison Control Center and is actively involved in lecturing and mentoring nurses, emergency medical residents and pharmacy students. ABSTRACT Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) have undergone significant research and recent improvements in disease outcomes and morbidity. Although it remains a chronic condition without a cure, new treatment guidelines and antiretroviral drugs have provided hope for individuals infected with HIV to live longer. Continuing education for health professionals caring for men, women and children with HIV/AIDS help to dispel myths and reduce stigma, enhance a fuller understanding of best practice trends, and improve prevention strategies to avoid transmission of the disease and complications associated with disease progression and/or treatment. Policy Statement This activity has been planned and implemented in accordance with the policies of NurseCe4Less.com and the continuing nursing education requirements of the American Nurses Credentialing Center's Commission on Accreditation for registered nurses. It is the policy of NurseCe4Less.com to ensure objectivity, transparency, and best practice in clinical education for all continuing nursing education (CNE) activities. Continuing Education Credit Designation This educational activity is credited for 1 hour. Nurses may only claim credit commensurate with the credit awarded for completion of this course activity. Statement of Learning Need Continuing education for health professionals in the rapidly evolving area of HIV/AIDS research and treatment is needed in order to provide optimal care and prevention of HIV transmission. Course Purpose To provide updated knowledge on HIV/AIDS to health clinicians working in various clinic and community settings. Target Audience Advanced Practice Registered Nurses, Registered Nurses, Licensed Practical Nurses and Nursing Associates Course Author & Director Disclosures Dana Bartlett, BSN, MSN, MA, CSPI, William S. Cook, PhD, Douglas Lawrence, MA, Susan DePasquale, MSN, FPMHNP-BC all have no disclosures. Acknowledgement of Commercial Support There is no commercial support for this course. Please take time to complete a self-assessment of knowledge, on page 4, sample questions before reading the article. Opportunity to complete a self-assessment of knowledge learned will be provided at the end of the course. During the acute sero-conversion phase of an HIV infection: a. Approximately 50% of those infected will be asymptomatic. b. Almost everyone who is infected will be symptomatic. c. Approximately 10% of those infected will be asymptomatic. d. Symptoms are very rare. Which of the following is measured to diagnose AIDS? a. Platelet count b. Neutrophil count c. CD4+ count d. Lymphocyte count HIV is transmitted by: a. Sexual contact or contact with HIV-infected blood b. Casual social contact c. Insect bites and contaminated water d. Blood transfusions and animal bites The great majority of people will have a detectable antibody response to HIV: a. Within three days of being infected with HIV. b. Within three years of being infected with HIV. c. Within three months of being infected with HIV. d. Within three weeks of being infected with HIV. HAART is considered to be: a. Curative for AIDS but ineffective for preventing transmission of HIV. b. Effective for preventing AIDS and transmission of HIV. c. Only effective at preventing AIDS in people age 15-64. d. Ineffective at preventing AIDS for someone with viral hepatitis. Introduction The human immunodeficiency virus (HIV) is a retrovirus that causes the acquired immune deficiency syndrome (AIDS). HIV can significantly depress immune system functioning and, prior to the development of anti-retroviral medications, essentially everyone infected with HIV developed AIDS and overwhelming opportunistic infections and/or neoplasms. Untreated, HIV has essentially been regarded as a death sentence. Current drug therapy in the form of highly active anti-retroviral therapy (HAART) has allowed many people to live decades after the initial infection. However, HIV and AIDS are still serious health problems. Although the number of deaths in the United States caused by AIDS peaked in the mid 1990s and has been declining since that time, an estimated 56,000 people are newly infected each year and the incidence of new cases has not changed in over a decade.1 In addition, HIV and AIDS disproportionately affects the African-American community, the lesbian, gay, bisexual and transgender (LGBT) community, and under-developed countries. There has definitely been progress in preventing the spread of HIV and the treatment of AIDS, but there is still no cure and no effective vaccine. Human Immunodeficiency Virus The human immunodeficiency virus is a retrovirus. HIV enters a cell and uses its RNA and the hosts DNA to produce copies of itself. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is most common in the United States, whereas, HIV-2 infections are seldom seen in this country. HIV-2 is less easily transmitted and infection with HIV-2 progresses more slowly than does an infection with HIV-1. An infection with HIV is a process of viral entry into the body, attachment of HIV to cells in the immune system, and entry of HIV into those cells and then replication. There are three phases of an HIV infection.1,2 The first phase is the acute sero-conversion phase. It typically begins 4-11 days after the virus enters the body. This phase lasts from a few weeks to a few months, and it is characterized by HIV entering the cells, rapid viral replication, and the establishment of viral reservoirs. During the acute sero-conversion phase approximately 50% of those infected will be asymptomatic and 50% will develop non-specific signs and symptoms such as fever, flu-like illnesses, and rashes. These signs and symptoms last for several weeks and then subside. The second phase is the asymptomatic HIV infection phase. During this phase the virus becomes established in cells of the immune system, particularly a sub-set of T lymphocytes called helper T cells (to be discussed in more detail later). The infected host is asymptomatic because her/his immune system at this point is capable of containing the virus to a degree sufficient to prevent the development of AIDS; however, because HIV has the ability to replicate and mutate very rapidly, elimination of the virus is not possible. In addition, the viral reservoirs cannot be eliminated. The asymptomatic phase lasts for a median of approximately 10 years. The third and final phase is AIDS. This phase is characterized by a very low level of the T-helper cells, severe damage to the immune system, and the development of opportunistic infections and neoplasms. The T-helper cells function (in part) by releasing cytokines, which are proteins that influence the anti-viral activity of other immune system cells. The T-helper cells are sometimes referred to as CD4+ cells because they have a glycoprotein on their surfaces called CD4+. CD4+ helps the T-helper cells recognize HIV, so if the CD4+ T-helper cells are infected with, and damaged by, HIV they cannot initiate and coordinate an immune response to the virus. If the CD4+ cell count is below 200/L and/or the patient has one of the diseases that are considered to be indicative of a severely compromised immune system, then the patient is diagnosed as having AIDS. The Center of Disease Control (CDC) divides HIV and AIDS into three categories, and those are divided into subcategories. Category A: Asymptomatic HIV infection without a history of symptoms or AIDS-defining conditions. Category B: HIV infection with symptoms that are directly attributable to HIV infection (or a defect in T-cellmediated immunity) or that are complicated by HIV infection. Category C: HIV infection with AIDS-defining opportunistic infections. These three categories are divided into subcategories which are based on the CD4+ T-cell count: CD4+ T-cell countSubcategories> 500/L A1, B1, C1200-400/L A2, B2, C2< 200/LA3, B3, C3 More than 90% of people who have AIDS and who do not receive treatment will die, and the average time to death after the onset of AIDS is two years. The severe damage to the immune system results in opportunistic infections and neoplasms, and HIV and AIDS and can cause diseases of essentially every organ system. HIV Transmission HIV is found in blood, semen, breast milk, and vaginal fluids, and the virus can be transmitted by contact with any of these fluids. Estimating the risk of transmitting HIV is quite complicated. For example, the risk of developing an HIV infection from sexual activity can be estimated for a single sexual encounter or for multiple sexual encounters over a period of time; and, estimating this risk must also consider factors such as condom use, viral load, the use or non-use of HAART, male circumcision, types and frequency of sexual activity, and the presence of sexually transmitted diseases (STDs). Sexual Transmission HIV infection is predominantly a sexually transmitted disease. However, determining the risk of HIV transmission from a particular sexual act is very difficult, and many factors determine if the virus will be transmitted. For example, ART greatly decreases the risk of sexual transmission of HIV as does a low level of HIV-1 in the plasma. Additionally, a sexually transmitted disease (especially a genital ulcer) or viral hepatitis increases the risk of sexual transmission of HIV. In men, heterosexual vaginal intercourse with an infected partner confers an approximate risk of 1:500; and, for women the approximate risk is 1:1000.3 Anal intercourse is riskier, most likely due to tearing of the anal mucosa, and cells in the tissues of that area that are susceptible to infection with HIV. The risk of HIV transmission for men and women during unprotected receptive anal intercourse has been estimated to be approximately 1:200, and the risk of insertive anal intercourse is approximately 1:1500.3 There have been case reports of HIV transmission from oral sex, both cunnilingus and fellatio, but the rate of transmission by this route is thought to be extremely low.3 Male circumcision does not appear to decrease the risk of male-to-female transmission of HIV4, but it can decrease the risk of female-to-male transmission by 50%-60%.5 Blood Transmission HIV is transmitted effectively by contact with infected blood, but the risk of transmission depends on many factors. People who use intravenous drugs and share needles are at high-risk for HIV infection, and intravenous, intramuscular, and subcutaneous drug injection exposure can all transmit HIV. The risk of HIV transmission by intravenous drug use has been estimated to be 0.65% or slightly less than 1 per 100 injections.6 The risk of HIV transmission by blood transfusion is very low, approximately 1 in every 2 million transfusions.7 Potential donors are screened for HIV infection, and donated blood is tested for HIV antibodies, HIV antigen, and HIV nucleic acid. Occupational Exposure An exposure that places a healthcare professional at risk for infection with HIV or other infectious diseases is defined as: ... a percutaneous injury (i.e., a needlestick or cut with a sharp object) or contact of mucous membrane or nonintact skin (i.e., exposed skin that is chapped, abraded, or afflicted with dermatitis) with blood, tissue, or other body fluids that are potentially infectious.8 Studies of healthcare workers have shown that the risk of transmission of HIV after a puncture wound from a needle or a sharp containing blood infected with HIV is 0.3%, or 1 of every 300 exposures.8 The risk of HIV transmission after mucous membrane exposure to blood infected with HIV is 0.09%, or 1 of every 1100 exposures.8 HIV transmission after a percutaneous injury or a mucous membrane splash has increased risk if the viral load is high, the amount of blood injected or splashed is high, or a large bore, hollow needle was involved.8 Amniotic fluid, cerebrospinal fluid, pericardial fluid, peritoneal fluid, and pleural fluid are considered infectious, but the risk of HIV transmission through contact with any of these fluids is not known.8 Feces, nasal secretions, saliva, sputum, sweat, tears, urine, and vomit are not considered to be infectious unless they are visibly bloody.8 Mother to Infant Transmission The American Academy of Pediatrics advises mothers who are HIV-positive not to breast feed.9 The risk of HIV transmission through breast milk has been estimated to be approximately 17%,10 but both higher and lower levels of transmission have been reported. Interestingly, the risk of HIV transmission through breast milk is higher if the infant is both breast-fed and given formula instead of exclusively breast-fed.10 The transmission of HIV from mother to infant depends on many factors. If the mother receives pre-natal treatment for her HIV infection, if the child is not breast-fed, and the child is given post-natal prophylaxis, the risk of an infant becoming infected with HIV has been estimated to be 0.1%.10 Other Causes of Transmission Men having sex with men, people who are bisexual, people with multiple sex partners and/or involved in prostitution, people with sexually transmitted diseases, and intravenous drug users have a relatively high risk of becoming infected with HIV. HIV is not transmitted by casual contact such as hugging, shaking hands, or touching objects that were touched by someone who is infected with the virus. HIV is not transmitted through air or water or by insect bites. Blood spills on environmental surfaces can pose a risk of transmission, but the virus cannot live outside the body for more than a few hours. Prevention Of HIV/AIDS The transmission of HIV can be prevented in many ways, such as through sexual abstinence, by not sharing drug injection equipment, and through contraception. Contraception The effectiveness of condoms in preventing the transmission of HIV, if they are used consistently and properly, has been estimated to be 80%-90%.11,12 Lambskin condoms are less effective in preventing HIV transmission than latex and polyurethane condoms. Oral contraceptives do not positively or negatively affect the rate of HIV transmission.13 Over-the-counter spermicidal jellies do not prevent the transmission of HIV,14,15 and douching can increase the risk of HIV transmission.16 A dental dam (a thin square of latex) or condoms can be used to help prevent transmission of HIV from oral sex. Anti-retroviral Therapy (ART) If couples are sero-discordant (i.e., one person is HIV positive, the other is not), then HAART can decrease the risk of transmission of HIV.17 Sterile Syringe Programs Providing intravenous drug users with sterile syringes reduces needle sharing and decreases the incidence of HIV infections. Pre-exposure Prophylaxis The CDC recommends pre-exposure prophylaxis (PrEP) with Truvada (emtricitabine and tenofovir) to prevent the transmission of HIV. The CDCs PrEP guidelines state that with the use of Truvada: Recent findings from several clinical trials have demonstrated safety and a substantial reduction in the rate of HIV acquisition for men who have sex with men (MSM), men and women in heterosexual HIV-discordant couples, and heterosexual men and women recruited as individuals. 18 Pre-exposure prophylaxis should be prescribed for: 18 Men who have sex with men, and have an HIV-positive sexual partner. recently had a bacterial STD. had a high number of sex partners. a history of inconsistent or no condom use. involvement in commercial sex work. Heterosexual women and men who have an HIV-positive partner. had a high number of sex partners. a history of inconsistent or no condom use. involvement in commercial sex work. IV drug users who have an HIV positive partner. share injection equipment. recently undergone drug treatment but are not currently injecting drugs. Other requirements for pre-exposure prophylaxis are: a documented negative HIV test. no signs or symptoms of an acute HIV infection. normal renal function. no use of medications that are contraindicated. hepatitis B vaccination. The complete document on pre-exposure prophylaxis can be viewed on the CDC website or at:  HYPERLINK "http://www.cdc.gov/hiv/pdf/PrEPguidelines2014.pdf" http://www.cdc.gov/hiv/pdf/PrEPguidelines2014.pdf. HIV Screening Screening for HIV should be done for all individuals:19,20 aged 13-64 years in all healthcare settings. who are women that are pregnant or may become pregnant. who are in a high-risk group. who seek treatment for an STD. who are starting treatment for tuberculosis. Screening is done by blood tests that look for antibodies to HIV and HIV antigen. In the great majority of people, an antibody response to HIV will be detected within three months of an infection with the virus. Alternatively, a person who tests negative but has been involved in high-risk behavior within three months of the test could have an HIV infection, which is the testing window often mentioned in discussions of HIV screening. The latest (2014) CDC guidelines to screen for HIV in adults and children 2 years of age and older are:21 A combination test that detects antibodies to HIV-1 and HIV-2 and p24Ag (an HIV antigen). The combination test detects HIV antigens, which can be seen 12-26 days after an infection, and antibodies formed against HIV-1 and HIV-2, which can first be detected 20-45 days after the infection. If the combination test is negative, there is no infection. If any part of the combination test is positive or indeterminate, than nucleic acid testing should be done. Nucleic acid testing checks for target sequences of specific HIV genes. If the nucleic acid testing is positive there is an HIV-1 infection. If the nucleic acid testing is negative there is no infection. ELISA and Western Blot Testing Two other commonly used diagnostic tests are the enzyme-linked immunosorbent assay (ELISA) test and the Western blot; both test for antibodies formed against HIV. Standard procedure is to do the ELISA first. If the ELISA is negative then HIV infection is unlikely and further testing is usually not needed. If the ELISA is positive or indeterminate it is typically repeated and, if the results are the same, the Western blot should be done for confirmation, as it is a more sensitive test than the ELISA. If the Western blot shows antibodies to all three major HIV genes, an HIV infection is present; and, if negative, there is no HIV infection. An indeterminate Western blot result should be repeated. Home Screening Tests The Food and Drug Administration (FDA) has approved two home screening tests used to detect HIV: OraQuick and Home Access HIV-1 Test System. OraQuick uses an oral swab and a test liquid and the results are ready in 20 minutes, and is accurate for 91.7% of people who are HIV positive and 99% accurate for people who are HIV negative, but a false negative is possible for high-risk behavior (i.e., needle sharing, high risk sexual behavior) occurring less than three months from the test date. A positive test result should be confirmed with clinical laboratory testing.22 The Home Access test requires the individual to use a lancet and place several drops of blood on a test card. The test card is mailed to a laboratory and the results are available seven days later; the test is 99.9% accurate. If the test is positive, a confirmatory test should be done.23 Neither OraQuick or the Home Access test can be used to test for HIV-2. Signs And Symptoms Of AIDS The clinical picture of AIDS is very complex and every organ system can be affected. The signs and symptoms of AIDS, such as anorexia, cough, diarrhea, fatigue, fever, and weight loss, are non-specific and AIDS can only be diagnosed through blood testing. The illnesses caused by AIDS can develop as a result of drug therapy, as a direct result of the infection, or from opportunistic infections such as Pneumocystis pneumonia and neoplasms, i.e., Kaposis sarcoma. Some of the systemic diseases caused by AIDS include those highlighted below.1 Cardiovascular Disease Coronary artery disease, cardiomyopathy, and myocardial infarction are more common in people who are HIV positive than in people who are not. The increased incidence in cardiovascular disease is a direct result of the infection that is independent of traditional risk factors and a consequence of HAART. Pulmonary Disease Pulmonary disease is a typical complication of AIDS. Sinus infections, bacterial and fungal pneumonias, and tuberculosis are common in people who have AIDS. Neurologic Disease Almost every patient with an HIV infection has some degree of neurologic impairment. Neurologic diseases are an especially serious cause of morbidity in people who have AIDS, and they are caused by: opportunistic infections such as toxoplasmosis. neoplasms such as Kaposis sarcoma. a direct result of the HIV infection, i.e., aseptic meningitis and AIDS dementia complex. Oral Lesions Fungal and viral infections of the mouth are a very common complication of AIDS. Liver Disease Hepatitis B and hepatitis C infections are common in people who are HIV-positive, and the majority of HIV-positive drug users are infected with hepatitis C. Hematologic Diseases Anemia, leucopenia, and thrombocytopenia are typical complications of AIDS. As with other diseases associated with AIDS, the hematologic disorders can be caused by drug therapy, a direct effect of HIV, or due to secondary infections and/or neoplasms that are characteristic of AIDS. Endocrine Diseases Dyslipidemias, i.e., elevated serum cholesterol and triglycerides are a complication of HAART, and hyperglycemia and insulin resistance are often seen in people with AIDS. Dermatologic Diseases Dermatologic problems occur in >90% of people who have AIDS: the most common are seborrheic dermatitis (an inflammatory skin disorder that affects the face, scalp, and torso), folliculitis (infection of the hair follicles), and opportunistic infections. Shingles and herpes simplex infections may also be seen. Neoplastic Diseases Kaposi's sarcoma, non-Hodgkin's lymphoma, and invasive cervical carcinoma are neoplasms considered to be AIDs-defining diseases. Genito-urinary Diseases Infections of the genito-urinary system are a common feature of AIDS. Infections and neoplasms that are considered to be AIDS-defining diseases include:2 Candidiasis of bronchi, esophagus, lungs, or trachea Cervical cancer Coccidioidomycosis Cryptococcosis Cryptosporidiosis Cytomegalovirus disease Cytomegalovirus retinitis with vision loss HIV-related encephalopathy Herpes simplex Histoplasmosis Isosporiasis, chronic intestinal Kaposi sarcoma Lymphomas Mycobacterium avium complex/Mycobacterium kansasii infection Tuberculosis infection, pulmonary or extrapulmonary Pneumocystis pneumonia Pneumonia, recurrent Progressive multifocal leukoencephalopathy Salmonella septicemia Toxoplasmosis of the brain Wasting syndrome due to HIV infection Treatment Of Aids Treatment of AIDS is focused on three goals: 1) managing the infection with HAART, 2) monitoring for and treating complications, and 3) preventing transmission. Highly active anti-retroviral therapy (HAART) has decreased the mortality rate of AIDS by approximately 50%, and it decreases the rate and risk of HIV transmission as well. In the U.S., HAART is usually initiated when the patient has an AIDS-defining illness or his/her CD4+ count is < 350/L. There are six classes of anti-retroviral drugs that can be used. Each class affects a specific stage of the HIV life cycle, and prescribing and monitoring the patient for side effects and effectiveness of therapy can be complicated. HAART Medications Chemokine receptor antagonist (CCR5 antagonist) Integrase inhibitor (II) Fusion inhibitor (FI) Nucleoside reverse transcriptase inhibitors (NRTIs) Nonnucleoside reverse transcriptase inhibitors (NNRTIs) Protease inhibitors (PIs)  Guidelines for HAART have been published by the U.S. Department of Health and Human Services (DHHS) Panel on Antiretroviral Guidelines for Adults and Adolescents.24 The specific HAART regimen that is used depends on patient factors, but treatment-nave patients will usually be prescribed at least three drugs - two NRTIs and an NNRTI, a PI, or an II. Four to six drugs may be needed if the patient develops drug resistance. Specific regimens that are recommended by DHHS are: Efavirenz/tenofovir/emtricitabine (NNRTI/NRTI/NRTI) Ritonavir-boosted atazanavir + tenofovir/emtricitabine (PI/NRTI/NRTI) Ritonavir-boosted darunavir + tenofovir/emtricitabine (PI/NRTI/NRTI) Raltegravir + tenofovir/emtricitabine (II/NRTI/NRTI) Dolutegravir + tenofovir/emtrictabine Other HAART regimens are used for children, pregnant women, people who have been previously treated with HAART, and people who have specific medical problems. Prior to beginning HAART the patients medical, psychological, and surgical history should be reviewed and the prescription, over-the-counter, and herbal/natural medications that the patient is taking should also be reviewed. If needed, the patient should receive vaccinations for influenza, hepatitis A, hepatitis B, pneumonia, and varicella. In addition, The Infectious Diseases Society of America recommends the following before initiation of HAART:25 CD4+ cell count Complete blood count with differential. Liver function tests. Total protein and albumin Serum electrolytes BUN and creatinine Fasting lipid profile Blood glucose and hemoglobin A1c Urinalysis Glucose 6-phopshate-dehydrogenase screen STD screening Screening for hepatitis B and hepatitis C Screening for latent tuberculosis Screening for varicella Screening for cytomegalovirus (CMV) Serologic Testing for Toxoplasma gondii HIV viral load HIV resistance testing Chest x-ray Trichomoniasis screening (Pregnant women) Pap smear During treatment with HAART periodic monitoring of laboratory studies is needed to evaluate the effectiveness of HAART and to monitor for drug side effects. The patient will also need close monitoring for, and possibly treatment of, the complications of AIDS. Aside from the systemic complications discussed previously, the side effects of HAART include anorexia, diarrhea, fatigue, low energy levels, skin rashes, sleep disturbances, and vomiting. Treatment with HAART is very effective, although failures do occur. With careful monitoring, good patient compliance, and adjustments to the medication regimen, many people on HAART can live for decades with HIV. However, the treatment itself can contribute to organ system complications, and patients on HAART are still at risk for non-AIDs associated diseases. HAART is not a cure. In the 2014 HAART guidelines, the DHHS notes: Eradication of HIV infection cannot be achieved with available antiretroviral (ARV) regimens even when new, potent drugs are added to a regimen that is already suppressing plasma viral load below the limits of detection of commercially available assays.24 Occupational Exposure The CDC and the U.S. Public Health Service recommend post-exposure prophylaxis for healthcare workers with exposure to HIV.25,26 The exposed individual and the source should be evaluated for the presence of HIV, hepatitis B, and hepatitis C. In the case of puncture to the skin, basic wound care should be performed and the exposed persons tetanus immunization status should be reviewed. There is no evidence that antiseptics, squeezing the wound, or applying bleach to the body area of exposure will decrease the risk of transmission.25 Post-exposure prophylaxis should be started as soon as possible, preferably within a few hours of the exposure.26 Post-exposure prophylaxis should be started preferably within a few hours of the exposure.26 The compete guidelines for HIV post-exposure prophylaxis are available on-line at the CDC website and through this link  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/23917901" http://www.ncbi.nlm.nih.gov/pubmed/23917901. Further assistance is available 24 hours a day at the National Clinicians Post-Exposure Prophylaxis Hotline, 1-888-448-4911. Summary Individuals infected with human immunodeficiency virus can experience significantly depressed immune system functioning, and develop the chronic condition of acquired immune deficiency syndrome. For many, prior to anti-retroviral medications, individuals with HIV and AIDS often encountered opportunistic infections and/or neoplasms, and their prognosis and chance for survival were grim. This course has offered an update on the current diagnosis, and of major improvements in the medical treatment and prognosis for individuals with HIV/AIDS. The CDC recommendations for prevention of HIV transmission and the existing guidelines on HAART drugs and post exposure prophylaxis for HIV exposure remain critical to health team knowledge and patient education, as well as to public health and safety. Please take time to help NurseCe4Less.com course planners evaluate the nursing knowledge needs met by completing the self-assessment of Knowledge Questions after reading the article, and providing feedback in the online course evaluation. Completing the study questions is optional and is NOT a course requirement. During the acute sero-conversion phase of an HIV infection: a. Approximately 50% of those infected will be asymptomatic. b. Almost everyone who is infected will be symptomatic. c. Approximately 10% of those infected will be asymptomatic. d. Symptoms are very rare. Which of the following is measured to diagnose AIDS? a. Platelet count. b. Neutrophil count. c. CD4+ count. d. Lymphocyte count. HIV is transmitted by a. Sexual contact or contact with HIV-infected blood. b. Casual social contact. c. Insect bites and contaminated water. d. Blood transfusions and animal bites. The great majority of people will have a detectable antibody response to HIV: a. Within three days of being infected with HIV. b. Within three years of being infected with HIV. c. Within three months of being infected with HIV. d. Within three weeks of being infected with HIV. HAART is considered to be: a. Curative for AIDS but ineffective for preventing transmission of HIV. b. Effective for preventing AIDS and transmission of HIV. c. Only effective at preventing AIDS in people age 15-64. d. Ineffective at preventing AIDS for someone with viral hepatitis. CORRECT ANSWERS: 1. During the acute sero-conversion phase of an HIV infection: a. Approximately 50% of those infected will be asymptomatic. There are three phases of an HIV infection. The first phase is the acute sero-conversion phase. It typically begins 4-11 days after the virus enters the body. This phase lasts from a few weeks to a few months, and it is characterized by HIV entering the cells, rapid viral replication, and the establishment of viral reservoirs. During the acute sero-conversion phase approximately 50% of those infected will be asymptomatic and 50% will develop non-specific signs and symptoms such as fever, flu-like illnesses, and rashes. These signs and symptoms last for several weeks and then subside. 2. Which of the following is measured to diagnose AIDS? c. CD4+ count  If the CD4+ cell count is below 200/L and/or the patient has one of the diseases that are considered to be indicative of a severely compromised immune system, then the patient is diagnosed as having AIDS. 3. HIV is transmitted by a. Sexual contact or contact with HIV-infected blood. HIV infection is predominantly a sexually transmitted disease... HIV is transmitted effectively by contact with infected blood, but the risk of transmission depends on many factors. People who use intravenous drugs and share needles are at high-risk for HIV infection 4. The great majority of people will have a detectable antibody response to HIV: c. Within three months of being infected with HIV. Screening is done by blood tests that look for antibodies to HIV and HIV antigen. In the great majority of people, an antibody response to HIV will be detected within three months of an infection with the virus. 5. HAART is considered to be: b. Effective for preventing AIDS and transmission of HIV. Highly active anti-retroviral therapy (HAART) has decreased the mortality rate of AIDS by approximately 50%, and it decreases the rate and risk of HIV transmission as well. References Section The References below include published works and in-text citations of published works that are intended as helpful material for your further reading. Fauci AS, Lane C. (2012). Human immunodeficiency virus disease: AIDS and related disorders. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, eds. Harrisons Principles of Internal Medicine, 18th ed. McGraw-Hill; New York, NY: 2012. Retrieved online at www. UCHC.edu. Bartlett, J. (2016). The natural history and clinical features of HIV infection in adults and adolescents. UpToDate. Obtained online at  HYPERLINK "https://www.uptodate.com/contents/the-natural-history-and-clinical-features-of-hiv-infection-in-adults-and-adolescents?source=search_result&search=HIV%20disease&selectedTitle=1~150" https://www.uptodate.com/contents/the-natural-history-and-clinical-features-of-hiv-infection-in-adults-and-adolescents?source=search_result&search=HIV%20disease&selectedTitle=1~150. Centers for Disease Control and Prevention (2012). HIV transmission risk. July, 2012. Centers for Disease Control and Prevention (2013). Male circumcision. April 15, 2013. Retrieved online at  HYPERLINK "http://www.cdc.gov/hiv/prevention/research/malecircumcision/index.html" http://www.cdc.gov/hiv/prevention/research/malecircumcision/index.html.  HYPERLINK "http://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Tobian%20AA%5BAuthor%5D&cauthor=true&cauthor_uid=24111891" Tobian AA,  HYPERLINK "http://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Kacker%20S%5BAuthor%5D&cauthor=true&cauthor_uid=24111891" Kacker S,  HYPERLINK "http://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Quinn%20TC%5BAuthor%5D&cauthor=true&cauthor_uid=24111891" Quinn TC (2014). Male circumcision: a globally relevant but under-utilized method for the prevention of HIV and other sexually transmitted infections. Annual Review of Medicine. 2014;65:293-306.  HYPERLINK "http://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Kaplan%20EH%5BAuthor%5D&cauthor=true&cauthor_uid=1403641" Kaplan EH,  HYPERLINK "http://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Heimer%20R%5BAuthor%5D&cauthor=true&cauthor_uid=1403641" Heimer R. (1992). A model-based estimate of HIV infectivity via needle sharing. Journal of Acquired Immune Deficiency Syndromes. 1992;5:1116-1118. The National Heart, Lung, and Blood Institute. What are the risks of a blood transfusion? Retrieved online at  HYPERLINK "http://www.nhlbi.nih.gov/health/health-topics/topics/bt/risks.html" http://www.nhlbi.nih.gov/health/health-topics/topics/bt/risks.html. Kuhar, D.T., Henderson, D.K., Struble, K.A., et al. (2013). Updated US Public Health Service Guidelines for the management of occupational exposure to human immunodeficiency virus and recommendations for post-exposure prophylaxis. Infection Control and Hospital Epidemiology. 2013;34: 875-892. Committee on Pediatric AIDS (2013). Policy Statement: Infant feeding and transmission of human immunodeficiency virus in the United States. Pediatrics. 2013;131:391-396. Levison J, Weber S, Cohan D. (2014). Breastfeeding and HIV-infected women in the United States: Harm reduction counseling studies. Clinical Infectious Diseases. 2014;59:304-309. Hearst N, Chen S. (2004). Condom promotion for AIDS prevention in the developing world: Is it working? Studies in Family Planning. 2004;35:39-47.  HYPERLINK "http://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Cayley%20WE%20Jr%5BAuthor%5D&cauthor=true&cauthor_uid=15508535" Cayley WE Jr. Effectiveness of condoms in reducing heterosexual transmission of HIV. American Family Physician. 2004;70:1268-1269. Polis CB, Curtis KM (2013). Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence. Lancet Infectious Diseases. 2013;13:789-808.  HYPERLINK "http://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Cottrell%20ML%5BAuthor%5D&cauthor=true&cauthor_uid=24664786" Cottrell ML,  HYPERLINK "http://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Kashuba%20AD%5BAuthor%5D&cauthor=true&cauthor_uid=24664786" Kashuba AD. (2014). Topical microbicides and HIV prevention in the female genital tract. Journal of Clinical Pharmacology. 2014;54:603-615.  HYPERLINK "http://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Gupta%20SK%5BAuthor%5D&cauthor=true&cauthor_uid=24174883" Gupta SK,  HYPERLINK "http://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Nutan%5BAuthor%5D&cauthor=true&cauthor_uid=24174883" Nutan (2013). Clinical use of vaginal or rectally applied microbicides in patients suffering from HIV/AIDS. HIV AIDS (Auckl). 2013;5:295-307.  HYPERLINK "http://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Bui%20TC%5BAuthor%5D&cauthor=true&cauthor_uid=24810219" Bui TC,  HYPERLINK "http://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Tran%20LT%5BAuthor%5D&cauthor=true&cauthor_uid=24810219" Tran LT,  HYPERLINK "http://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Ross%20MW%5BAuthor%5D&cauthor=true&cauthor_uid=24810219" Ross MW,  HYPERLINK "http://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Markham%20CM%5BAuthor%5D&cauthor=true&cauthor_uid=24810219" Markham CM (2014). Douching practices among female sex workers in Phnom Penh, Cambodia. International Journal of Sexually Transmitted Diseases & AIDS. 2014. May 8 [Epub ahed of print].  HYPERLINK "http://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Lasry%20A%5BAuthor%5D&cauthor=true&cauthor_uid=24804859" Lasry A,  HYPERLINK "http://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Sansom%20SL%5BAuthor%5D&cauthor=true&cauthor_uid=24804859" Sansom SL,  HYPERLINK "http://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Wolitski%20RJ%5BAuthor%5D&cauthor=true&cauthor_uid=24804859" Wolitski RJ, et al. (2014). HIV sexual transmission among sero-discordant couples: assessing the effects of combing risk strategies. AIDS. 2014;28:1521-1529. Centers for Disease Control and Prevention (2014). Pre-exposure prophylaxis for prevention of HIV. May 20, 2014. Retrieved online at  HYPERLINK "http://www.cdc.gov/hiv/pdf/PrEPguidelines2014.pdf" http://www.cdc.gov/hiv/pdf/PrEPguidelines2014.pdf. AIDS.gov. HIV testing frequency. Retrieved online at  HYPERLINK "http://aids.gov/hiv-aids-basics/prevention/hiv-testing/hiv-testing-frequency/" http://aids.gov/hiv-aids-basics/prevention/hiv-testing/hiv-testing-frequency/. Bartlett, J. and Sax, P. (2016). Screening and diagnostic testing for HIV infection. UpToDate. Retrieved online at  HYPERLINK "https://www.uptodate.com/contents/screening-and-diagnostic-testing-for-hiv-infection?source=search_result&search=HIV%20antibody%20test&selectedTitle=1~150" https://www.uptodate.com/contents/screening-and-diagnostic-testing-for-hiv-infection?source=search_result&search=HIV%20antibody%20test&selectedTitle=1~150. Centers for Disease Control and Prevention (2014). Laboratory testing for the diagnosis of HIV infection: Updated recommendations. June 27, 2014. Retrieved online at  HYPERLINK "http://www.cdc.gov/hiv/pdf/HIVtestingAlgorithmRecommendation-Final.pdf" http://www.cdc.gov/hiv/pdf/HIVtestingAlgorithmRecommendation-Final.pdf.  HYPERLINK "http://www.oraquick.com/" http://www.oraquick.com/.  HYPERLINK "http://www.homeaccess.com/HIV_Test.asp" http://www.homeaccess.com/HIV_Test.asp. Department of Health and Human Services: Panel on Antiretroviral Guidelines for Adults and Adolescents (2014).  HYPERLINK "http://www.aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv-guidelines/0/" \o "HTML Full Version" Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. May 1, 2014. Retrieved online at  HYPERLINK "http://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf" http://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf.  HYPERLINK "http://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Aberg%20JA%5BAuthor%5D&cauthor=true&cauthor_uid=24235263" Aberg JA,  HYPERLINK "http://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Gallant%20JE%5BAuthor%5D&cauthor=true&cauthor_uid=24235263" Gallant JE,  HYPERLINK "http://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Ghanem%20KG%5BAuthor%5D&cauthor=true&cauthor_uid=24235263" Ghanem KG,  HYPERLINK "http://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Emmanuel%20P%5BAuthor%5D&cauthor=true&cauthor_uid=24235263" Emmanuel P,  HYPERLINK "http://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Zingman%20BS%5BAuthor%5D&cauthor=true&cauthor_uid=24235263" Zingman BS,  HYPERLINK "http://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Horberg%20MA%5BAuthor%5D&cauthor=true&cauthor_uid=24235263" Horberg MA. (2013). Primary care guidelines for the management of persons infected with HIV: 2103 update by the HIV medicine association of the Infectious Diseases Society of America. Clinical Infectious Diseases. 2013;58:e1-e34. Bader, M.S., McKinsey, D.S. (2013). Post-exposure prophylaxis for common infectious diseases. American Family Physician. 2013;88:25-33. Bartlett, J. and Weber, D. (2016). Management of healthcare personnel exposed to HIV. UpToDate. Retrieved online at  HYPERLINK "https://www.uptodate.com/contents/management-of-healthcare-personnel-exposed-to-hiv?source=search_result&search=post%20exposure%20prophylaxis%20aids&selectedTitle=1~150" https://www.uptodate.com/contents/management-of-healthcare-personnel-exposed-to-hiv?source=search_result&search=post%20exposure%20prophylaxis%20aids&selectedTitle=1~150. The information presented in this course is intended solely for the use of healthcare professionals taking this course, for credit, from NurseCe4Less.com. The information is designed to assist healthcare professionals, including nurses, in addressing issues associated with healthcare. The information provided in this course is general in nature, and is not designed to address any specific situation. This publication in no way absolves facilities of their responsibility for the appropriate orientation of healthcare professionals. DFJekl . / 0 1 3 ͸ͯu\uKu?1hc{5B* OJQJphI}h:1h`V5OJQJ hc{h`VCJOJQJ^JaJ1hc{hWyB*CJOJQJ^JaJmH phsH 1hc{h`VB*CJOJQJ^JaJmH phsH hc{hM5OJQJh$|h95OJQJh5OJQJhc{5OJQJ(h mh$|5B* CJOJQJaJph6](h mh95B* CJOJQJaJph6]:jhc{5B* CJOJQJUaJmHnHph6]tH uDEFl0 1 2 3 =  d1$7$8$H$gdc{ dh1$7$8$H$gdc{d1$7$8$@&H$gdc{dh*$1$7$8$H$gdc{dgd`V $dha$gd`V$a$gd $da$gdc{$da$3 < = >     # + [ _ g r } fɷɷ~lZK@Kh khc{OJQJh khc{B*OJQJph...#h khc{5B* OJQJ\ph,K#h khc{5B* OJQJ\phI})hc{h2RB*OJQJ^JnH phtH #hTB*OJQJ^JnH phtH #h,B*OJQJ^JnH phtH #h2RB*OJQJ^JnH phtH )h2Rh2RB*OJQJ^JnH phtH  h*h`V5B* OJQJphI} h:1h`V5B* OJQJphI}_`anw|#789:;JKòÌug[L@h:1h`VOJQJ\hY15B* OJQJ\ph,KhY1h$|OJQJ\hTOJQJ^JnH tH hY1OJQJ^JnH tH hTOJQJ\hY1OJQJ\h`V5B* OJQJ\ph,Kh$|B*OJQJ^Jph...!h:1h`VB*OJQJ^Jph...#h:1h`V5B* OJQJ\ph,Khc{5B* OJQJ\ph,Kh0hc{B*OJQJph...hc{B*OJQJph...`a|9:;K89: 1$7$8$H$gd`V dh7$8$H$gd`V$d7$8$H$a$gdc{m$ d1$7$8$H$gd`V 1$7$8$H$gdY1dhgd`V dh1$7$8$H$gd`V d1$7$8$H$gdc{dh1$7$8$H$gd (Kksw789:;apsy}~ǸraSaEaSahB*OJQJ\ph...hc{B*OJQJ\ph... h:1h`VB*OJQJ\ph...#h:1hc{5B* OJQJ\ph,Kh`V5B* OJQJ\ph,Kh`VOJQJh:1h`VOJQJ#h:1h`V5B* OJQJ\ph,Khc{5B* OJQJ\ph,Kh6?5B* OJQJ\ph,KhY15B* OJQJ\ph,Khc{OJQJhY1OJQJh`Vh`VOJQJ:;a Fvwxyz{|}~^_`a 1$7$8$H$gdc{ $1$7$8$H$a$gdc{ 1$7$8$H$gd$|dh1$7$8$H$gd`V d1$7$8$H$gdc{ 1$7$8$H$gd`V EFuv}~򴢐{rfXGX<hc{5OJQJ\ h*hc{56>*OJQJ\h*hc{5OJQJ\h:1hc{OJQJ\hc{OJQJ\h`VOJQJ\h:1h`VOJQJ\#h:1h`V5B*OJQJ\ph...#h:1h`V5B* OJQJ\ph,K h:1hc{B*OJQJ\ph...hY1B*OJQJ\ph...hc{B*OJQJ\ph... h:1h`VB*OJQJ\ph...h`VB*OJQJ\ph...]ab#$'4_`fgjr̾zzmzmzmzcXh6?5OJQJ^Jh6?OJQJ^Jh`VhV~OJQJ^JhV~OJQJ^Jh`Vh`VOJQJ^Jhc{OJQJ^Jh`VOJQJ^Jh`Vhc{5OJQJ^Jh`V5OJQJ^Jh`Vh`V5OJQJ^JhOChc{5OJQJ\hc{5OJQJ\h*hc{5OJQJ\h_hc{OJQJ\"abb0k45k & Fdhgdc{gdc{^gdc{ & Fgdc{ $1$7$8$H$a$gdc{./0458>opsy˷˩˟憷yyyyoh~xOJQJ^Jh`VhV~OJQJ^Jhc{hc{5OJQJ^Jh6?5OJQJ^Jh6?OJQJ^Jh`Vh`VH*OJQJ^Jh`VOJQJ^Jhc{OJQJ^Jh`Vh`VOJQJ^Jh`Vhc{5OJQJ^Jh`V5OJQJ^Jh`Vh`V5OJQJ^J(123459:=Cnosy,-/7?~#&'Eڅ{h6?OJQJ^Jhc{h`V5OJQJ^Jh`VOJQJ^Jh`Vh5zNOJQJ^Jhc{OJQJ^Jh`Vh`VOJQJ^Jh`Vhc{5OJQJ^Jhc{5OJQJ^Jh`V5OJQJ^Jh`Vh`V5OJQJ^Jh`Vh6?OJQJ^J.k/~FGHIJKLMNO\]-$a$gdiDfdhgd`V$a$gd`V & Fdhgdc{gdc{EFGOP[\]   9DEF[dgtvwƻ||tlh,OJQJh>AOJQJh`VhyOJQJh`VhNaOJQJh`VhM+OJQJh`VhfOJQJhiDfOJQJh`VhOJQJh`VhP*OJQJh`VOJQJh`Vh5OJQJh`Vh%5OJQJhc{5OJQJh (5OJQJh%OJQJ*!FO#+N"JNO ,-OױwkbYkhc{5OJQJhiDf5OJQJh`Vh%5OJQJh`VhrH*OJQJmH sH h`VhM+OJQJmH sH h`VhNaOJQJmH sH hiDfOJQJmH sH h`Vh%OJQJmH sH hiDfhNa6OJQJh`VhNaOJQJh`VhfOJQJh`VhyOJQJhiDfOJQJh`VhsOJQJ-.e f ""H%I%&\)^)**+*8****<+>+K++ *$^gd% dh*$^gd & F dh*$gd*$gd%dh[$\$gd`VdhgdiDfdhgd`V  / N R W b d f Z!b!""""i#j##4$T$U$]$z$}$$%H%I%f%l%T&ϴôϤϔυϔvjjjjvjjhOJQJmH sH h`VhM+OJQJmH sH h`VhNaOJQJmH sH h`Vh%6OJQJmH sH h`VhrH*OJQJmH sH h`Vh)p[OJQJmH sH hiDfOJQJmH sH h`Vh%OJQJmH sH h`Vh%OJQJhiDfOJQJh`VhrOJQJmH sH )T&^&g&u&&&&&%'&'+'-'b'd'''''''(((\)^)h))**+*6*7*嵧p]$h`Vh%OJQJmH nH sH tH $hh%OJQJmH nH sH tH !h5OJQJmH nH sH tH h`Vh%OJQJhOJQJhY1OJQJ^JmH sH h`Vh%OJQJ^JmH sH h`Vh%H*OJQJmH sH h`Vh)p[OJQJmH sH h`Vh%OJQJmH sH hOJQJmH sH 7*8*****:+<+=+>+J+K+++++++++++++++ʷݧʷݗ݃pX/h%h5CJOJQJaJmH nH sH tH $h`Vh%OJQJmH nH sH tH 'h`Vh%H*OJQJmH nH sH tH hs1TOJQJmH nH sH tH h%OJQJmH nH sH tH $hhOJQJmH nH sH tH $hh%OJQJmH nH sH tH $h`Vh%OJQJmH nH sH tH hOJQJmH nH sH tH +++++ , ,=kd$$Ifl0#:* 064 lapytC$dh$*$Ifa$gd%$dh$*$If^a$gd% dh*$gd`V++++ , ,,,,, ,+,,,6,7,8,@,A,K,L,M,N,O,B-M-ιΩzΩzΩzΩg[LAh`Vh%OJQJh`Vh%OJQJmH sH h%OJQJmH sH $h`Vh%OJQJmH nH sH tH ,h%hCJOJQJaJmH nH sH tH /h%h%5CJOJQJaJmH nH sH tH hOJQJmH nH sH tH )hc{5CJOJQJaJmH nH sH tH /h%h5CJOJQJaJmH nH sH tH 2h%h5CJH*OJQJaJmH nH sH tH  ,,, ,,,7,rxkd$$Ifl^0#:*064 layt%$dh$*$If^a$gd%7,8,A,L,rr$dh$*$If^a$gd%xkd]$$Ifl0#:*064 layt%L,M,N,---//0~og\gTLdgdCHdhgdCH $da$gdCHdhgd`Vdh[$\$gd`V dh*$gdxkd$$IflU0#:*064 layt%M-N-R-\-----------!....///|///////000ȼ~r~j~j~~_~jSShCHhCH5OJQJh`VhP*OJQJhCHOJQJh`VhF6OJQJh`VhFOJQJh`VhnOJQJh`VhMOJQJh`VhsOJQJhc{5OJQJhCH5OJQJh`Vh%5OJQJh`Vh%OJQJmH sH h`Vh%OJQJh`VhrOJQJh>AOJQJh`Vh)p[OJQJ0,0K0M0W0000000E1o1Y2^222222(3)33333344455>5־֮񓟃sdTdh`VhBHPH*OJQJmH sH h`VhOJQJmH sH h`Vh aH*OJQJmH sH h`Vh bH*OJQJmH sH hg}OJQJmH sH h`Vh bOJQJmH sH h`Vh1RH*OJQJmH sH h>AOJQJmH sH hCHOJQJmH sH h`Vh1ROJQJmH sH hY1OJQJmH sH h`VhMOJQJmH sH 0)3M5N5b57788889;;2=3=R=S=>>#@'@(@dgdodhgd`Vgd=KAdhgd=KA dh^gdcBdgdg}dhgdg}dhgdCH>5?5B5I5J5K5L5M5N5S5T5U5`5a5b555555626L6R6ƴ唇zj[L=[[==h`Vh+QyOJQJmH sH h`Vh)p[OJQJmH sH h`VhMOJQJmH sH hg}hM5OJQJmH sH hc{5OJQJmH sH hg}5OJQJmH sH hg}hg}5OJQJmH sH h`VhM5OJQJmH sH "h`Vh5H*OJQJmH sH h`VhBHPH*OJQJmH sH h`VhOJQJmH sH hg}OJQJmH sH h`VhBHPOJQJmH sH R6^6_6n6w666666666 7 7 777]77777888ֻqqeqZJhg}hg}5OJQJmH sH h`VhMOJQJhhOJQJmH sH h`VhR1dOJQJmH sH h`Vh-4OJQJmH sH h`Vh )H*OJQJmH sH h`Vhy5OJQJmH sH h>AOJQJmH sH h`VhyOJQJmH sH hY1OJQJmH sH h`Vh7=D=E=R=S=t=u==񺮺ɟِɺɺqdqdqٺٺhc{5OJQJmH sH h=KAh=KA5OJQJmH sH hhhR1dOJQJmH sH h`Vh aOJQJmH sH h`Vh}jOJQJmH sH hhOJQJmH sH h`Vh OJQJmH sH h`Vh )H*OJQJmH sH h=KAOJQJmH sH hcBOJQJmH sH h`VhR1dOJQJmH sH &======= >>>>3>S>a>b>>>>>>??@!@"@#@&@'@(@peXhh5OJQJmH sH h`VhzOJQJh`VhzH*OJQJmH sH h`VhnOJQJmH sH hhOJQJmH sH h`Vh OJQJh`Vh )OJQJmH sH h=KAOJQJmH sH h`VhzOJQJmH sH h`Vh )H*OJQJmH sH h`Vh OJQJmH sH h`Vh 6OJQJmH sH (@.@/@8@9@D@E@I@O@^@m@t@u@w@~@@@@@@@@@@AAABA÷ërÁrffWh`VhFOJQJmH sH hoOJQJmH sH h`VhaZgOJQJmH sH h`VhbOJQJmH sH h`Vh)p[OJQJmH sH h,OJQJmH sH h~xOJQJmH sH hhOJQJmH sH h`VhnOJQJmH sH hoh=KA5OJQJmH sH hc{5OJQJmH sH hoho5OJQJmH sH (@E@BBBB^C_CnCEEEEvFwFFGG)GGGI dh^gd>dgd>dhgd>dhgdogd, $dha$gdodhgd`VdgdoBAEAArB~BBBBBBBBC C CC'C,C\C]C^C_ClCmCnCѶ~vnv~vnv~bvVJVhohaZg5OJQJhoho5OJQJhohP*5OJQJh3OJQJhoOJQJh`VhP*OJQJho5OJQJhc{5OJQJh`VhaZg5OJQJh`VhoOJQJmH sH hR1dOJQJmH sH h`VhNaOJQJmH sH h`VhrY$OJQJmH sH h`VhbOJQJmH sH hohb6OJQJmH sH nCCDDDDDDHDKDMDmDDDDDDDEEEEQERESETE`EyEEEEEEEEݩݩݩ{{ҿrf]fhc{5OJQJh>h>5OJQJhh5OJQJh`Vh&EOJQJh`VhumH*OJQJh`VhumOJQJh`Vh*}bH*OJQJh`VhOOJQJh`VheOJQJh>OJQJh`VhP*OJQJh`VhaZgOJQJh`Vh )H*OJQJh`Vh~H*OJQJh`Vhw*OJQJ"EEEEFF=F>F?FAFrFtFvFwFFFFFFFFFFFFFFGGGG)GTGZG`GӼӴӨӠޗޗދހuuޗހj_h`VhNaOJQJh`Vh OJQJh`VhP*OJQJh`VhOJQJh>h5OJQJhc{5OJQJh>OJQJh`VhH*OJQJh~xOJQJh`Vh OJQJhc{hO6OJQJh`VhOOJQJh>h>5OJQJh>5OJQJh>hO5OJQJ"`GhGiGGGGGGGGGGIIIIII I;II?I@IAIZI\I_IeIIIIIIIIIIIIʺҢҚҚݚ{ݚ{pp{pehah OJQJhahOJQJhc{OJQJhaha6OJQJh`VhhOJQJhaOJQJh`VhH*OJQJhhh]"6OJQJh5zNOJQJh>AOJQJh>OJQJh`Vh OJQJh`VhOJQJh`Vh]"OJQJ^Jh`Vh]"OJQJ'I I@IAIeIIIIIJJ?JXJ|JJJJJKKfK & F dhgd & F dhgd Zdh^Zgd`V & F dhgddhgdh & F dhgd & F dhgddhgd>IIJJJJ4J9J?JWJXJZJyJzJ{J|JJJJJJJJJJJJJJJKKK\K]KfKgKzKKKKKKKKKKKKKKKhLh]"OJQJh`Vh OJQJhLOJQJh`Vh]"OJQJhahNaOJQJhah OJQJhahaOJQJh`VhOJQJhahhOJQJhahOJQJhaOJQJhc{OJQJ3fKgKKKKL7LQLRL#M$M2M3MnMMMMNANOObP & Fdhgd3 & Fdhgd & Fdhgdc{$a$gdLdhgdL & Fdhgddhgd`VKKLLLLL4L5L6L7LPLRLhLLLLLLLLLM M!M"M#M$M(M)M1M2M3Mϼqe\eSehc{5OJQJhL5OJQJh`Vhc5OJQJh`Vh^)OJQJmH sH ,hc{h^)0Ju>*B*OJQJmH phsH +jhc{h^)OJQJUmH sH hc{h^)OJQJmH sH %jhc{h^)OJQJUmH sH hLh^)OJQJhLOJQJhc{OJQJhLh]"OJQJhLh&EOJQJ 3MSMTMWMgMhMmMnM~MMMMMMMMMMMMM NNNN@NANbNfNNNNNNO$O3O6OOOOOOOȽȽȽ圑呆{o{hh6OJQJh`Vh)p[OJQJh`VhveHOJQJh`VhkOJQJh`VhsOJQJh3h,OJQJhc{hMOJQJhc{h*[OJQJhc{OJQJhc{hMH*OJQJhc{H*OJQJhOJQJhMOJQJh`Vh*[OJQJ+OOPPPP"P#P^P_P`PaPbPcPPPPPPQQQQQQQ.RwRxRyRRRRRRRSS¹폮|q|qeh{h5OJQJh`VhcOJQJh%;OJQJh`Vh%;OJQJh%OJQJh`VhNa6OJQJh`VhNaOJQJh`VhOJQJh%H*OJQJh`Vh=bH*OJQJh`VhvH*OJQJh`VhiOJQJhOJQJh`Vh%OJQJhOJQJ%bPcPQQQQxRyRRSSUUU5X6XYYYYZZ[gdH# $dha$gdH#dgd{dhgd dh^gd & Fdhgddhgd`VSSS S SSSSSSSSSSSSTT'TQTTTTTTTTTTTTUUUYUZU|U}UUUUUUUUUUUUU·ʷ····¬¬~h`Vh%OJQJh>AOJQJhWyOJQJh (OJQJh`VhOJQJh`Vhb)OJQJh`VhxnOJQJh BfOJQJh`Vh!~OJQJhc{5OJQJh{h{5OJQJh{h5OJQJh5OJQJ1UUUUUUUUUUVVV V)V-VVV^V_VcVdVVVVVVVVVVWWJWgWjWkWpWWŽввujЂjjjЂjh`Vh~WOJQJh`Vh>OJQJ^Jh`Vh>OJQJh`VhNaOJQJh{hNa6OJQJ^Jh{h_s6OJQJh`Vh_sOJQJh{OJQJh`VhcOJQJh BfOJQJhs5OJQJhc{5OJQJh{5OJQJh`Vhr5OJQJ%WWWWWWWWWWW1X3X4X6XXXYTYVYWYgYhYYYYYYYYYYYչձզwnwbWh`VhOJQJh`Vh_s5OJQJhc{5OJQJh`Vhc5OJQJh`Vh_sOJQJh`VhuVOJQJh`Vh=OJQJ^Jh`Vh=OJQJhH#OJQJh5zNOJQJh`Vh=bH*OJQJh BfOJQJh`Vh~WOJQJh`Vh>OJQJh{OJQJhs1Th{6OJQJ YYYZZ1Z2Z;ZEZ_ZfZuZvZZZZZT[`[k[z[}[~[[[[[[[Թߧ̌̄ufZJh`Vh=bH*OJQJmH sH hc{OJQJmH sH h`Vh=bOJQJmH sH h`Vh&&OJQJmH sH hc{OJQJhc{hH#6OJQJh`VhOJQJmH sH "h`Vh6OJQJ]mH sH h5zNOJQJh`Vh)p[OJQJhH#OJQJh`Vh!OJQJh`VhOJQJh`Vh&&OJQJh`VhE5OJQJ[[[[[[[[[\#]%])]*]+],]6]7]=]>]?]]]]]]]]]H^ںvjjbZvjOh`VhOJQJhAOJQJhH#OJQJhH#hE56OJQJh`VhH#OJQJhAOJQJmH sH h`VhAOJQJmH sH h~xOJQJh`VhE5OJQJh`VhAOJQJh`Vh` OJQJhH#h` 6OJQJhc{6OJQJhH#hH#6OJQJh`VhrOJQJh`Vh_sOJQJmH sH [[[+],]?]]]]^^_k_l_z____y`{` dh^gd Bfdhgdy"vdgdy"vdhgdH# & Fdhgdy"v dh^gdH#dhgdc{dgdc{h^hgdH#H^^^^^^^ ___6_9_:_;_<_a_j_k_l_q_r_x_y_z_____________,`?`x`y`z`{``ƻڏ΄xmگh`VhveHOJQJhH#h/p6OJQJh`Vh5zNOJQJh`Vh/pOJQJhH#h6OJQJhy"v6OJQJhH#hH#6OJQJh`VhH#OJQJhAOJQJhy"vhH#6OJQJh`VhOJQJhy"vOJQJhH#OJQJh`VhWFOJQJ*`````````$a*aaaaaaaaaaaabbmbnbob|b}bbbbbbbӻӯӤzznbZhy"vOJQJhYhH#6OJQJhYh>66OJQJhYhY6OJQJh`VhH#OJQJh>6OJQJh`VhNaOJQJh`Vh>6OJQJhy"vhH#6OJQJh>AOJQJhH#OJQJh~xOJQJh`Vh/pOJQJhH#h/p6OJQJhH#hH#6OJQJhy"v6OJQJ"{``aaanbobbccccVdWdpd eAeQedeseeee & Fdhgddhgd5zN dh^gdY dh^gdH#dhgdy"vdgdy"vbcccccccccUdVdWdfdgdndodpddde e e e6OJQJmH sH hYhY5OJQJh`Vh>6OJQJhy"v6OJQJhYh>66OJQJhs1T6OJQJhYOJQJh/pOJQJmH sH h`Vh>6OJQJmH sH eeef#f2fAOJQJh`VhcOJQJkkkklalblllllllmmк|gYK:+h`Vh6VOJQJmH sH h`Vh6VOJQJ^JmH sH hy"vOJQJ^JmH sH hg(OJQJ^JmH sH (hy"vh6VCJOJQJ^JaJmH sH +hy"vhA^5CJOJQJ^JaJmH sH +h*hA^5CJOJQJ^JaJmH sH "h*hA^5CJOJQJ\aJ+hy"vh6V5CJOJQJ^JaJmH sH h`Vhy"vOJQJ^JmH sH h6VOJQJ^JmH sH h`VhoOJQJ^JmH sH ll3lLlbllllllllldddhgd`Vtkd$$Iflv F$$$$  064 lap ytf9$dh$Ifa$gdg($dh$Ifa$gdA^ llnnoFoooooppQrRrbrrrrrrrs#sMs[s$ & Fdh*$gd & Fdd*$[$\$gddhgd`Vgdy"vmm m!mJmQmmmmmn"n%n=n?nFnInMnnnnnnn7oEo|ooooo娜֐n[n[n[n[n$h`VhpOJQJmH nH sH tH $h`Vh<OJQJmH nH sH tH h`Vh (OJQJmH sH h<OJQJmH sH hg(OJQJmH sH h`VhIOJQJmH sH h`VhcOJQJmH sH h`Vhv?H*OJQJmH sH h`Vh<OJQJmH sH h`Vh6VOJQJmH sH hy"vOJQJmH sH ooooppppp8q=qYq^qtquqqLrMrOrPrQrRrUr;̈́thYE'h`Vh<5CJOJQJaJmH sH hQh (OJQJmH sH h<OJQJmH sH h`VhNaH*OJQJmH sH hOJQJmH sH hOJQJh`Vh/OJQJh`Vh/OJQJmH sH hg(OJQJmH sH h`VhcOJQJmH sH h`Vh<OJQJmH sH $h`VhZ~ OJQJmH nH sH tH  h`VhZ~ OJQJ^JnH tH UrWrarbrs t>tgthtrtsttttt@uAuYuxu5v9v:v`vvvvvvvvww[w_www֯֟֟֔vnc[c[c[c[hf OJQJh`VhFpOJQJh\ OJQJh`VhyOJQJhOJQJh`Vh/OJQJh`Vh<OJQJh`Vh<5CJOJQJaJ+h`Vh<0Jy5CJOJQJaJmH sH !h5CJOJQJaJmH sH 'h`Vh<5CJOJQJaJmH sH *h`Vh<5CJH*OJQJaJmH sH "[sssss tt2t>thtsttt9v:vwxxy{{P}dh[$\$gd`V $da$gdf dhgdy"v dh^gdf dhgd`V$ & Fdh*$gdwwwwwwwwxxxxxxxyyһ|kWF2&h`Vhf 0Jy56OJQJmH sH hy"v0Jy56OJQJmH sH &h`VhNa0Jy56OJQJmH sH hf h\ 0JyOJQJmH sH hf H*OJPJQJh`VhNaH*OJPJQJh`VhZ~ OJPJQJ0h\ hZ~ 6B*OJPJQJ^JnH phtH -h`VhZ~ B*OJPJQJ^JnH phtH h\ OJQJh`VhNaOJQJhf OJQJh`VhFpOJQJhy"vOJQJyyyyyjywyyyyyyzzz{{{{o{q{z{{{~{{{{{{{{t`t`O h (0Jy56OJQJmH sH &h`Vh%0Jy6H*OJQJmH sH &h`Vh%0Jy56OJQJmH sH #h`Vh%0Jy6OJQJmH sH h%0Jy6OJQJmH sH #h`VhM0Jy6OJQJmH sH &h`VhM0Jy6H*OJQJmH sH h\ 0Jy6OJQJmH sH hy"v0Jy6OJQJmH sH #h`Vh6}0Jy6OJQJmH sH {{{{{{{ ||(|W|X|b|g|h|||||q_Gq0,hy"vhM0Ju>*B*OJQJmH phsH .jhy"vhMOJQJU]mH sH #hy"vhM0Jy6OJQJmH sH ,jhy"vhM0Jy6OJQJUmH sH #h (hM0Jy6OJQJmH sH h~x0Jy6OJQJmH sH #h\ hM0Jy6OJQJmH sH h (0Jy6OJQJmH sH &h`VhM0Jy6H*OJQJmH sH h#[0Jy6OJQJmH sH #h`VhM0Jy6OJQJmH sH |||||O}P}Q}R}Y}Z}[}u}}}}}}}}ųtgZME:E:E2:2hRrOJQJh`Vh5zNOJQJh5zNOJQJh, k5OJQJ\^Jh`V5OJQJ\^Jhy"v5OJQJ\^Jh#[5OJQJ\^Jh`Vh (5OJQJ^J#h\ h+0Jy6OJQJmH sH #h`Vh90Jy6OJQJmH sH #h`VhM0Jy6OJQJmH sH #h\ hM0Jy6OJQJmH sH #hy"vhM0Jy6OJQJmH sH ,jhy"vhM0Jy6OJQJUmH sH P}Q}Z}[}~~|}~yzd^gdy"vgdy"vdhgd`Vdhgd\ $a$gd, k $dha$gd#[dgdy"v}}~(~N~_~c~f~l~}~~~~~~~~F^s!$1;PQR]{|ǼDZǼǦǼǛǦǼǼǍqhy"v56OJQJ\^Jh (56OJQJ\^Jh\ h#[OJQJ\^Jh~xOJQJ\^Jh, kOJQJ\^Jh,OJQJ\^JhRrOJQJ\^Jh\ OJQJ\^Jh5zNOJQJ\^Jh,OJQJhRrOJQJh5zNOJQJh`Vh5zNOJQJ+xyŁƁǁȁ NRV\Ԃ؂܂ɸ|r|eXereXereXereXeNhOJQJ^Jh`Vh^TOJQJ^Jh`VhOJQJ^Jhy"vOJQJ^Jh#[OJQJ^Jh#[hy"v5OJQJ^Jh5OJQJ^Jh#[5OJQJ^Jh#[h5OJQJ^J!h#[hy"v56OJQJ\^Jh (56OJQJ\^Jh56OJQJ\^JhChy"vOJQJhChy"v5OJQJ\^JzƁǁȁKт,-He|EvwƄDŽ^gdy"v & Fgdy"vdhgd`Vgdy"v+,-04KOehlmsu%HMQVhuvw̫̿|nh#[hveH5OJQJ^Jh~xOJQJ^Jh`Vh^TOJQJ^Jh) OJQJ^Jh`Vh) H*OJQJ^Jh#[OJQJ^Jhy"vOJQJ^Jh`Vh) OJQJ^Jh#[hy"v5OJQJ^Jh) 5OJQJ^Jh#[h) 5OJQJ^Jh`Vh, kOJQJ^J+ÄĄńƄDŽʄ˄τՄ 4789<Bpru{…ÅȅɅ̅ԅ%W[ͿzohveH5OJQJ^Jh`Vh, kOJQJ^JhveHOJQJ^Jh#[OJQJ^Jh`Vh^TOJQJ^Jhy"vOJQJ^Jh`VhveHOJQJ^Jh#[hy"v5OJQJ^Jhk5OJQJ^Jh#[5OJQJ^Jh#[hveH5OJQJ^Jh#[h)p[5OJQJ^J+DŽ4l…ÅS=>׉^gds1Tgds1Tdhgd`V^gdy"v & Fgdy"vgdy"v[_cĆņ;=>FȻ󰥗ssi\iPhs1TOJQJmH sH h`Vhs1TOJQJ^Jhs1TOJQJ^Jh#[hs1T5OJQJ^Jhs1T5OJQJ^Jh5OJQJ^Jh`Vh5OJQJ^Jh#[5OJQJ^Jhy"v5OJQJ^Jh`Vh, kOJQJ^Jh, kOJQJ^Jhy"vOJQJ^Jh#[OJQJ^Jh`Vh^TOJQJ^Jh`VhveHOJQJ^JӉԉՉ׉؉ى܉"$&6BFPZdfz~ּ~vfTfB#hh6OJQJ^JmH sH "hh6H*OJQJmH sH hh6OJQJmH sH hs1TOJQJh`Vhs1TH*OJQJ^Jh`Vhs1TOJQJ^Jhs1TOJQJ^Jh#[hs1T5OJQJ^Jhs1T5OJQJ^Jh5OJQJ^Jh`Vhs1TOJQJmH sH hs1TOJQJmH sH hs1T6OJQJmH sH hs1Ths1T6OJQJmH sH ׉؉$&Rd[euvwxyz{|}^gdgddhgd`V[$\$^gd^gds1Tgds1Tdh[$\$gds1T$^fqtuv}эҍӍԍՍڍȺȺwh\RȺȺȺȣh*OJQJ^JhOJQJmH sH hhOJQJmH sH h`VhOJQJmH sH h6OJQJmH sH hh6OJQJmH sH h`VhOJQJ^JhOJQJ^Jh#[h5OJQJ^Jh5OJQJ^Jh`Vhs1T5OJQJ^JhOJQJ^JmH sH h`VhOJQJ^JmH sH ԍՍ  MW ^gdrgdrdhgd`V^gd*gd QVWX+}tkbUIhDlhr5OJQJhr5CJOJQJaJh5OJQJh`V5OJQJhM+5OJQJh`VhrOJQJhrhr6OJQJhrOJQJhrOJQJ^Jh`VhrOJQJ^Jh#[hr5OJQJ^Jhr5OJQJ^Jh) OJQJ^JhOJQJ^Jh*OJQJh`Vh*OJQJh*h*6OJQJ+Đ?IDKqϜbl'Ƞ^ & Fgd?Jq˼wh\hPA\APAhrhBHPOJQJmH sH hrOJQJmH sH hOJQJmH sH hrh1ROJQJmH sH hrhrOJQJmH sH hOJQJmH sH ,hh0Ju>*B*OJQJmH phsH %jhhOJQJUmH sH hhOJQJmH sH hhrOJQJmH sH #hhOJQJ\^JnH tH &hh6OJQJ\^JnH tH FGHIJɕʕӕԕ֕וUV^_aby$%./12ØϘИ$%/0坆hrh )6OJQJhrhM+OJQJhrhBHP6OJQJhOJQJhrhBHPOJQJmH sH $hrhBHP0Ju>*B*OJQJph#jhrhBHPOJQJUhrhBHPOJQJjhrhBHPOJQJU20DGHJK2_pq|}ʝ钅{m`QEhOJQJmH sH hrhM+OJQJmH sH h*B*OJQJmH phsH +jhrh aOJQJUmH sH %jhrh aOJQJUmH sH hrOJQJmH sH hrh aOJQJmH sH hrOJQJ9AΜϜ4PabcwhhXhI>Ihrh{9xOJQJjhrh{9xOJQJUhrh{9x6OJQJmH sH hrh{9xOJQJmH sH hrhNa6OJQJmH sH hrh~6OJQJmH sH hOJQJmH sH hrh~OJQJmH sH hWkl%&'(9:DEGOǠȠɠGHӼxexxexxYxxhrhum6OJQJ$hrhum0Ju>*B*OJQJphhrhumOJQJjhrhumOJQJUhrh=OJQJhrh*}b6OJQJhrh*}bOJQJhOJQJh*B*OJQJph"HPQST͡Ρӡԡܡ;M]^_ۢܢcdklnoxyҤ+345=>G$hh0Ju>*B*OJQJphhhOJQJjhhOJQJUhh*B*OJQJmH phsH hh*B*OJQJphhhOJQJjhhOJQJUGHIJkfgݡpYY?Y4hrhvOJQJ3hh0Ju>*B*OJQJ\^JnH phtH ,jhhOJQJU\^JnH tH &hh6OJQJ\^JnH tH #hhOJQJ\^JnH tH hhOJQJh*B*OJQJmH phsH +j hrhvOJQJUmH sH hrhvOJQJmH sH %jhrhvOJQJUmH sH 7CDSTdewxHIKLMstuƬ퐁vdQvv$hrh=b0Ju>*B*OJQJph#j hrh=bOJQJUhrh=bOJQJjhrh=bOJQJUh*B*OJQJph#j hrhvOJQJUjhrhvOJQJUh*B*OJQJphhh*B*OJQJphjhrh=bOJQJU#jy hrh=bOJQJU ()3467±ñűƱFGQRT\./KSввввввŪŞߑhOJQJ^JhrhXOJQJ^Jhrhv?6OJQJhOJQJ$hrhv?0Ju>*B*OJQJphhrhv?OJQJjhrhv?OJQJUh*B*OJQJ\^JnH phtH ,jhhOJQJU\^JnH tH &hh6OJQJ\^JnH tH #hhOJQJ\^JnH tH hhOJQJ^JhOJQJ^Jh'yk[e1 $}UAíOJ&ϙM sAM*ah{bfds;fUb[cT-#b.c2v =T CaLA\`Dp53 oNfv.bldb @O3 fVF?66N+r7Q5s욹XdlG+V/NF&fŜ<3=EEJOLOʙ5I7@?K55v5L\0?ז3a?{7[貱]Eomaei3+ K?F< F6Pd$fo`oxO _?N^)h jȅ ?w?!@<7߿Ol;9E!@v //%[TXtMp`gFǿll.'% l$'34m1d[q2%KvHM8o`L Hg9u]Nr2vzrBCv1KD~..')r~t[8Z_l䖢]E;/Cvy1iG׳~"eh$1$lC1QC_ -!A=g'~@ܧEi;AJZ3pXf*oŏ`u(y;=Q+bK>:#7ҷ9H魻F`&6?9wtw)(ܧķw<#0;Ғ N,N}ICCaeYI߮.sx)w EHo@8>8/ "OFNz΂3f=y| g86Ehͷ xOu.|~".VW 1a sgUԖrH @EM){f%@5"`c ǣM~%-B`<.Y2$MV+>(=w .Dz3|C؝WyBMy{r_ MhblE$"r$X>fJx ^ /q`I$k{"+$,F5sN·rƟij{օnC閽3TЎ@SH( Q#rxbL\ӄ߹ 2AV}Ib!#~S9@~bc C h''%96(=dvwƩa='o]P>P`PK@p)p`8U4DL@Vtru;s/sݝI!/q!H.-rD1Cd]N6'%ۊK(BSwUǟ//=>vj.?ilRw)6Xܷ{}XgBO52Pn|w^0Ѷ]B7=Jޱ8D $7=Iч_ ٘cvؗ}{A/ ?sRC%,XT.^\Vg1 A߯qv*UX>ʑގo7֙:v w$MÐN@6/Lxٸ#xF!+.v&NȊْX 1U鎂l !aCc"aBL i|^H^[~1J/j@,\C240!/K捏C@`-I'>j6}Zemn8o8am63Y~uvY׺mB++Њ.ХSxz^M\*Q>zD~*Hڇfe 9gcQ_!t=5g/FUWԄ$Yoh`ab۹c"x]`__`f[_GK旯)+,g'J?(~7+B-^*!^b? JжCTi4FGcZB>BMkMN]QgI|TS!!e-$Ysˌvgԗ:,5zh(czWҞ<}?㪜_)?1c+?ד5tox^¸=t,J/fkv{}\*K#lD= yӥ}ȩMcB+DgED2aXѓɏ#yWcAq8U8M - )ٍ1Y]h?S1 ]7.ڷeV1QX:2mm+njm<"H_"zD?B;CE0i@Y滅6c"GbɭƯz: suY]"-Jx^zFa( G sp%5ʑx"]BEE"ld7ϖ^#?SI (v dF_ࡣS8Y1x8~=ܺav̵z z0Ehm i<"L0RΕ aQPnm<Sʗ^1[x598QhB*Ed#]Pi(W_^ /EOwO$FP6횳.leJfCɸUʓ1 {W`kčW& ̀\ؙFDfiӋzFtP&Β]6=ɋQf %@OPS#<ȍxF &.IDtr_ ܤ0Z*'xJ7JgT7 {nKz:t !yP)ҝE%.>:)W|c wrvf_ 7.̟֤0~SgsLJ|QN /R^` 뺹)r-BB0hb`K] ̦#-g9i`$7UE1CқudGG69kFEpzwƋbCU,}S&^) 2|m1a 6'w{_L.m&_cfQ_oӿZc{y:^ =T~G|s*cOӡ6,Cz{< \@ 8J@&PbO%icM4S i/l?:<Myd;Y2NLַ7 |XF*,y8:dAt@z }٠)٠mӨyOBn|=m[ԧnʼn#EZ*UJ AS|%Dܗ/*n!TO-EMJɈn?7S5H%!i0JvZ v@]tv͌3ɁVLG3"mKمlOܑ،_k/3 }+޹2<|VlPpw Kw3/p=,a{{MWZQ,{SRHiAQeHgNYIi6Ni`hdt+U_NO[gN@E GnK1D`D h=x_]nFX,[C6 V<ՕļJ:g%cdYL,f?`nYϰ7^l%:Fgk^|h[N~%SFKFk1Hyag|=)y =.~vta`G"ԋ"%F:mCGss4WFqP e^J2(/0egbˏ/|:ky iH)G4#Ȉ+oe8kKd;W ,%1#Fm]="{ e@sx.őh*VR|LxZhp5o}>xR3ang&e N]n+(? M=Y~b[b=̪rj3I3K`A)eHg"oPȠf|Nt 5nx')qDxK_l E_ոK[>tHl: **+-OոsWcrDTT4-}Z>Pq!yVL.qp Nʏva P(7 rohѩL|$V9; `A;F:WDSN^y--'M^M?*jiea@iix^PR=!JQuLSY1vy/Ԁ8$vpG+w']۟YM4?g}.b3 Lox+8epHsY![لO4-1 8.СVC/8qME1z>pwe@,.Hxd$)'=J^B;ah8qu$!J6V9tį:az8Ng")G~N5[,IHo31A1 )o}j%u> Jð$ kj"aS:LKi":Mͽ jXNMw{7#G ]YJ(cIf?5HR 9.(V:(8tQ8ob#0R_sUM+K|{^o[vcG8?S8͵g/G`Rt* y4Aezװow#-izyU兀EM-NOn>b=SJa7D f Gb_p{D _ {-u1YӋKN >oА`*u6db6fz`4(+| sQcvaCGlf-"& FԵaڗb8c*YttiJ-\g$~_Aڷ4EMlmj:P:s.w_>(oyUPqeO$("C#" 2_dװa7^a{b>r DJ uX@1yf b@3JcdBUʐRPHsNQzefُt̸)ڒ-8_p' 6 M?ö$bxvNR HŚYy[zYGyN!A;Tn!8Bg`~7lfb]m<ҼNOh)jAk7ـB ړ%]l/G*S8T ,e .WHP)⊻Ҡے U2.V IӂcUG[g911E6ZX;#L!!yHlp4י]wr_ ՜.6 &cS%E>/dI2>W,|,=+ڟ*37s}fe50· pl]h-W hਥZz_Ӫ+3ڷfiO"51%iFMF}"M<%ؠTY-մfQ9?/Yx[qw>7 ;̇>ta \Y~M;Usm5$0_;~+!obgv`J5-m-"DuD˰HEĕ: }FhTW ىL1tI2&9: @N +kk^'AZ/t+-;b-Q_qs6ô32RґbMO%t+]UgKߣge ^kp6~" *Q1שtaS Ƈ#RsSj* qXl":V3bDk-O0,/]h9We:H-\mcNB}P (e㊖1_Q/v暑{>e @p>ym~Nhi}qê W ';&L hxtf%O(mi(l_vTݿۖ}'A%ߦUŞB4@#Fbzo<*L[('.5 ~Ъi=4J!= qHָE1[Ciβ>]P̵w*D~z4Bn9 D>6n6E3U ‰~RD~O0![p5f~`Ħ]$l%Fω>uo> ;`C͑ D%\8XVC@P|ZW"Nx}`@%D֔e#?դ6I" x,YQh2W-“7bY:Yf@v5Ŧ0.cFS>ZΚ-?ƚKNOC<+XTj~A*},jdFJRkyPHQ1a eɏ%Ga:PfW4nT& ARhbui_ײ+?Sc=t:j#b/!tgG'̰s G=G$ Lm4{ =[ .GhNL Ŷ`JP7_}#ďb `z(dy\ Ai2;Jc<%TkDT/KղG*"L| l=Zhp.Mw@7`C?|t #Zs{,iE3\BDRW`Xe>>"^C/<ܚ)g%֭d1 xWh"`ͦ!O7QW/62Y${qz`C;v zPa#A){"}C9&uKNJ"t -Ɛ]`ֺE۟g{SZ[fv_ 5A0b;1|ڵ59urǬp$PVb;Xr`6i⟛R+)=(YJi)@c@_oߦ&F5?PQÌ>4P[Фm^83'9kv?R-((a{{(bv+ 3Ԣ"W4U/'` JZ׋_2 `Dj,-[B dMFV,kW>"uL@`P>o7#}u6hA~ w'Nl=Ԅ 9pR9;(b5[Ps~@Ks]ѽt{ &yǧЁTuk-d1}\x2 ]qT!$j20㼷lH.V1#5}N=uG!,Kv t-~u]:mہ8jKꇼ(^[_0k<#=}ͭ<ٿ8E2oimBŪIh锵IGË<9#O.}U,luń(A,If5+{7EpNVdCa3S-eޡ&1G)Ĵ6Ň"70*djyZgLA_XY=*|YmIj}\hղ)j$-CVB7@b==>ӮEy#x2%A%ր8O]a!zji}$AЀ>f 58DM5rJHn7ׄ vi;l\nyNGl^-X;^="TixzM:}|I}6w%$vED91Eڙ|:R[([CL{ݶcҵ{l)vU E1?jk9X ?x(UZR$ܟkzƫ|&`0"E˹ $Qq.J1/ww?׫0l۟tUO$o1k-KlN們2}|/kFH[bx52һ#N)"xg3Nia[$Z.zWx}'p隩YZ.$Df/U?L?mb=h]8|]C̷Y[RB kO ޫUrX{a9cLBuL?ICY7:.o/.Ǹx?/.ȌT]")dtDf 3F}wZ&)|r.s>k &P,?3yLyuO]m-nde iE_\,Z1jER sӭcުAֽDίw,Hu~{L-E?(;֑^ZVc|CS䩭q\E^8lv*hHky|*WSvUg#s砠~LpV>1_AO=]Ð qNe8_#}uD{ d23SEBg1 &SrXߣIh\ #N!2: S#(RHgHlMl.OJr&IrWk|V.P+َQ&LdNaGfzlH$PS:Ao)ЅVQ.|o\8޷?y?vHմL[W_)ݒlL>Ke޵s@#nfrl $jjg^H"FܚC.C=&>bQbq %V÷r:“yzʘ{!T_C Q/3 ]h7ggjeY,Wλ~0pkJpWp[~2wAq3Ec 꼜)[--?殃TS M+] `~|–T+檳>ݽ<';R %t`T@dI0udEn^pCN0oO% mnOJN@ȧ,pe[rh╍FH{+[Ss' u:k"hC۽&{(֐aVCHik+?Hf!D6z]~Xu ! ӺRh CZ(8>vήK?l#ipکt"ا)sL!R4~6@h"!:rz=L &eU|q8ї =ju>ssj"~FV"!ѿQǔ9&*Q! >D]:Cʅ YKi?Yz`m$'-aK@C:>QgA" /Ch/hgp/ٽN쫻/DQd7MĎEvx^fGՉ7{@5^ zQR(k9Mu MByu6$>NƩ35<0Xbw#촭-ڈ~|aQ5AMm͇Ղ 2 0^IF=X&Fk^),~a^`kJE[o3 IH=v]eQC=.[Mj'&_Xdf~; ΕgCRa!XѤv5+=`SBr+Gf}pADe ͰSȾs4+uޓ \#mB/?<EBm.D4t4h"Xq #/wȅ+51q5 R/, e; `#\ZfmrWՁCKQ)=@v ZDF4^:xL戠P2 ;4wL7$2<6X ءѴG,A| {LZd<#59H7`~ڮStcigkŠwjZ3GZ_D=MuCk8hVs"\%9ϵ Ip ;l(0R<ޤ$$soBZ0S>QHR{M[8µ鸊fNI- J mRc* qF~͗&3Vygc='`'2'+UG%>eg`g&)vk y^cZ' vZa2fAiD23~[DD}"z\ e:0e01T>і`{F?PXڵݔZlx C~CP<+R> C}gXPs '0*"@}e]BLV ܂ ί ȦM4ˤAǧӴꄀ/gwӶ}t>J9,/F7&q*М<ہ(}-ÿ{MiںTQ쫉ke ֝1k?]!nU^sht^4owg=mtGߑiU8]"W%q&ԣUC"pp: Mnd42? {ŢEʴ)3B)}/=e5y"4FB4|QJuC";Ԧ)o0jn>$~8s'Z M큺> ( h~`Û. r -+N}x`sN 9E]аA$BJke Q.n4J5(.r= &fx%x3f̛l:_b[@`@e)w7(U, 2l^@kpP+#1IkrpmP|$߾lo-}K?H6~pZ=ݡ&:±)+ĵ͈j0HrzƯDb_I%p-"o$l,GL hn8IL(L)[lOxG{z@`}H,D(EҸ3:u(8l3c &;"SQ$1kK@c@7XkI=)3ϜNfe_DڊUl&hL9:+@0êDZ\j~Ǫ>r ]~ڃ@ԩO@XM~{3׷*CEGAwvf]$_& +B驁Vq&w+|ϖ-+ﹰVg# nG;בf[]6?dH"廈Ɇq=+6n rm ʷt9ޱWHN)%Qa7IAgNU);JBaiY3Ju~+9"&$ Ğ1<'%d̑{K>ٸ<z^D>x|RJ_amdqߚm{[Fi[ghBɨǺg`T䀻;ABfc߯éZfu{P/UMaY>{'8I~>SͲ:_<F &jVb3R9A#Mc6@w8/_ #s7=h^3‹;Kϛ ?_cmR7Cq4pRxMإҫTcyD:3f}"+xՌA:1>5n*)z.;n)*A:4:uKU[  B|kK,p$Gr/  J9.~p *|j 0﯈ZP<@)>@XdX2|_0f& F*RQWi&vMJokMUS;l>t]x(ZM낰`Yk5i~D|g>4)hſf4 ӸM"-\5͠D,*8+1A #$$-} y̰Ys<b 05k]ű{ڴ˒a. )ɿeESLúubI\H*&Z]c\e'KV!ƄkU;,<:*l5SMLӧ`wnW|D-.e`+B/"~;E*&ݴ~X&oʑP)b0p7D ϚQ>}8Tئ%sދ}dg PV B7Ds-H.'>4 F#gY[{%m0QDI6a۰9 읇!89 E2FyOΜ! A`1!(A̢&朵JKUU5==33wfݻZ{˩rj[߷#ӳ sAn֥׮Qap3U*]Rm# Q|sr $ )Ks*p,r*V0'2&ŀ$&h dfL4cf-AiB&)D0<[IDbT:5L 7 f,m4u01!HA>&Xp`Esqe~0c ζ\y7MJrK:B#Bñ fDlzjrSK~GeFo7~Qb 'AvS6 yCT9 &׍G/ 7l׮{ h*ʰ3.AsÊO3ZZ!0$ҡ@?6 @a7A%//jBwL0cEpc!rNG9 },Aq$G(j99BeѺ P TP`dZm`"!B7@xGI;&Ή?J\2\qPyYpž蒾bO)&\*[p8Ӣ9b1A1L.N۴iq%ݖglϮZ?0 ziV>]~{A<Hۊ"\Aq(&mW`a[r)tm;lgѫAGNnW̿a#s[;CQK6re'y %V߳ʟ;t:泺U= Ӷqz@vX|sYS>BKHD,+)~2%K84h"|74MM55pY @L5q@jf-!-ip G#Qn}< @!0A#hFE412(B(t`Ǘ4, dAR5bP/6Lv4 lF. w*.)AiaYCnhsѨ7KBaKnZcruhV.#C̶onki=o]{!V4VT84{x-uP)..X5[veͷ#C{ώ@Hd#$Uܨ,n9xKM^|f&bİE}0lS:̢lu 0 $S[~}PpxI=e1_ݢ֧->Z'T>2vzS>=N4}r6 "Ô1qqun1MT]ݛ2V1f'0oiZ_c)1^\MNO#`2?Z}<Bo XGB 0z'71ˁk/#zXNat6^NOJqeZeqj=cc馹nܶJ" /Fw4K<JXt-ƣ_7>9 m5Cc#{8y7Ng)3 t\v&Fm_w{ 0Ha]8% CB1q@ߪI$ Y=VAuF|8qNM\|Gn^kVu޸G䩫ش J.* ѐR)EK֧uBݔCl7qg Y翶4Oy\ AU;V#|gg~ !d:4hBw pl[)FB"Hu8ifw CDw!4D&3# -I❏w6OZ HN4S 1F~gqiB71*~6c'3ebD)uDt1Ltʰ"%a7| e'<6O|%>8^[Rq*o^K6x6  ;]_ˮZM / T_6j5q2|:9Swj٭/ý~xD{~'qpeإ+&EŠ f#<U޿nn]fW-P>tm"3 Y¤샊 VA22Um^oI7s'';SX|]F~!}Vl|6j{ }T>5]8.9-#}Zzjx1J&Y/_w=sz$}%4$ZB,Sc<%Z#$M1ЬfP1@F鋴eT"JI_9X@Cb&]kW/|:0^1!^JO( `1@S& á0'3x,.`f|-dۨ{~9 ̸ k6^Shsa4aoX<sYqO۽#įN:^^zKPw0m>D:izIlxpI٫]}կK*!6&_$O}|۝9zc ۃ\@VΔVX;#Uw}M0VyuTs#}O/ν\+v'z B>\h08d{wQsM b,>wx2iM*zWwh]%s`LtqJn6`PjހDS3H5Ua A„Z"1K!rTa-} itZ ޹Bk {xZJL(=lȉ $׏"Bt߲庴:.|`Ή"&p[!J7eWb66_ߎϑdmOҴ..c g?Qo}Ɲ{&+a;7,3ci-y9!e'L1]:oS EiW|. dWBn(ޭtI=^e#(ҟ. wJz>̍ʣLk6؟^nVrbL^Ն \.>Q^pC$7 \x9(\4+jˎc^}T)lHI. ?G\M18} ŵE@NX> v0f?bҪ1W(4Z$vB5|>h `; &дt(o݊B%(Dt"։2!!3EE!|a&^CF5@[9^X^2 B|J8 i[ŔЕBPfr`ź1!p)T @cba00 NI%f] N%7W\B+vxygԊ'W ?O«DMXX{>=A{IvU߂_?iݟvGQ!Ug`yпAǮ!"3ㄲa!!?Օ6o k}va LY[VdMi>Lܴ|[!]w3m֭WlȒ@wWDY| |wU#zCƓv jR"´[JY}9ze61ӡ!-=#ɵ̙ .8nGC+G%m+ÆQmk'ܢwj]8 UnWSϔ|nP)?s'^/3TL  k _@ `v  EHY͐糱˹:!z1KuOAFC^`_;RSS'rM_}|Z@lU\v!GC0Ki]>dkς{A4o-?ly۰~rp١談#LC{eԉVB*ǬOC(} MhּɸE<Y[tsm w-ihv 7߯8ƾS%/Sa9?nAx @ ;~ËIMH594\)Ih#1\SAKt፲o8Rr,!%yBY9ZY )O\ V23PlbSQfta印vУ ʚ(Q]wPxlltvH;yV\sSM۸;==^7 Z[+dx,>4Ż( 5&mef6h%ѭ+< 3J ĥ 4Z\KeXl\vFu{YcWLlRrqMEa0=Xl}ܵTca,hɁ}sS7 >E'P,"#(bHQH t I,9)LX똪 { 1_$,ʐI( H"K"1؋ $&M)!{D]`hv O3K 9ZlFbd,Y9e b2gJ@abK`X# [ϱا3]mFM#Av/ZOn_$[s! bWVʸ2j5ww hTӼ +p9[G!os339}@("ǦlmbR{W8g;l<nL[ eBA dx!p{P 9qoA^H>lvC.8)l0x-h89`(Oǯ'×)VȤTXZǶ/ %\E=ur~T*WSх`c9j XwxPyǡw`> N46/'jG,꡿/d9 Ac@@ $б4/sH`J{52mH6o5Y{JpI9NbK `1bC*᧴3(:\ם 1" ."H3=+(.>Kj I-{.i$J.ο(i@'ZR-RF9lpjAa H HZ@Z&⒲r, #}Z/Rd+޶H0-د2!hj^c1jM78X|WtΘzw>)G!`VG%ҳ9p/DΞ4(oR׹h;$n >m8_~si)&2%q I';\%k_ KVCU_ANﳕPt܅>ݹ{y,OדvVa ^ eJl*N6r=ѣtyhGM`"sf>Grl@S#jR`R_E=(Tsd"|L9ĉ CS=[ c1-aaBcI9A(1PiK3ȁA{ SYbMZM J9;|Z,6]P{%  ZsL+ \s+k<,x7&tՄ2Ԡz!YI%],NFmE(SQ V/7?N$Y`@ҎZPODcá7=ң\E}Z|?zP* г$̕3otz8iPҩAô)`(_W~5EʋAMAC9v _!;;d ,:b/s q= ҍS5ҭAmK-f(yz~wԌ )g\uw;Cā]dfk0(If.,+,wZar2O)GIl*_"%٩\lz ׍B4a(9"n5Oizanس :eUVP$Nhd ZGƅq\yk k^ʮRTcXـF;HčKS" @egw7(N& 8t"$Lf!qERy%'k+g‡JK7e% K A$H*(irsH=f:FP!  qpY(b9AC.w`a,J,v$Zu!XBNǞ(YCPgjF{SWrDՈaKRSR-Bn6}vؒƚW!7`k[ r>}=vnl5su[|w@c KxЦ;Ո;,gЄ9-X|^_ΊcphqWUy$gNHrwqsikڷLf}xRkCB"g, /2o5\/ZonoVƿ &r'qP*\>_l\7޹%jp/gOJܱU0K3{+K4)DF(אqIK %PeǕL6k3Qsշ`a` qTJ5q+|~:l&E8/EU8+" hva-xe >; mdrC~!%+EX2 %IaO(z?/. HPFZڰT áo!׷#P"RHVC2ţ!54WrkHu"<8g#fLr/(t^$j$_ƫߍu)՛׊F71ZO2 =8g#"g:DV:+8 hEy|G*gPIn}k/](Mtu>^{׶Bx/YqO!?[R8 cw2NWJ4[>RRslU1+84N^:k{9zgD`; zl`Ħ,!qgH"p/߂mMN7>>o~t`50<˼OQw݇ΖݏnYW-nl Z?}yX,>ƆIm~X|vZYڎ>RmQu3Ր41 Lhlʹ<nX^pCK{2 ,B0/a{VR^EdbکI[aA~ZD%G[g0)oPQ-5HGRvƙZ#B. L yL$jjyQxVfq&mQ w1>PTc5j >IJ BXQ@RVZ.CaGQq C#F$ <֘Na13:N0l@b~;-) vO XpE2 iԨW=hz5o;>g;?09~sf|Zҳ *ag.u!IK֠cr~D{]8?oRGQ?~7۷ XP5G(CGڿ˝O ڬ+9迹.ݴv‘szG {͹6ƃ6՛XK7Zgnnox;š@*ES Z@a7ɛt)N"kWϬ,4܀EژegPh?ޠ= > DG tAE8< g+n-p)P >bZVSFz8:fI)7%l#xQK\]@ڀn!c7ՊSU7l=+ΖmZsACD  ?bZ-P/ bGhXACi4zGDYUoXiTO&+a'7&imK6-Ou P8jɠzв\ȊSb{hrHlwM*>r@<"\XH;iUZ,9 yӐX9KNv]/,֬OYP:!s0mx~gNɏ7CѝW:1dl ; X*8G«V؛ִf02 *!J㊎2α4g-KYV!mOKIǓ7 ܀o[CRH.`S(63(N@ao}Xo c=7_r*^ ,Gx? E!.*@|Fִ?~  hɧsaٔ!Nir[&(Ih3^T4iu>[Lp!;X^dcr0&|6msiSbg,pJ0q mundRۛռ^RⲣufmH 0d_aj;̭A!J:3Wqcq3.0/BU⚦ܐG_)cF_+{F ^?Qyl+e 6d\LTƧª; Ou7[OWu(71_tHxFu2]^t>/N ɻV"eM?R02g1˽z˴UuTJegFY;}i۾b戢/ oWU&<p5jV#%)uMa`/uSFEbͥLa]f?r ʌQAdijK81f?g? ^/-|Z{uYq-8|V/<{4w5lƍk4@Aiu!uZYH!. 91]IطrQp^ᅫ>cO+ov~ ,4C&n5"(&u%M)UBI"ȈLS<0F)J2B~ RBihA[JC-XV-x`,)`ј,@Lխ-JDڡ =] d bk5+7Q/t?0t0 7=ۚGnߐ*kw aG*#,ÜPu yPfF?/ZǏ7e!dtY=ÍvVoO?,أy71.x%~>`Sҝ+E,c*Ѯf@f \k~: n‰ۆȖdr䯠3_wRh_OB\N.qJ(NvjCYv1k؄ӏCvyMwK8XdCKFZ3O{L9,GY'B$A@2a[C(|zo~ hXRK` -WL4 &ReA"T]4#oL͂M)L`"]H[<`9pCvNlӤDX6@$^O#AP s |kԸ&$tLݥ˸_q;Q]Tt^OWR.9$jӬ4Bh2O"nfG8  /3˓ c|DhN쯙F3OTL/Qi o4wrQS;_CCh5tt}wu{z{ !x&<7&adfoe;Ғ f_6:BEJ5= ǻ;w> YpjNH}JՈc=yv?zx||3Ĕ]B/ 3 K͙'BWPt,S: Uw`ƗEew eP a)! Z0$VA>n杷.I[Q׼>~EqY1ù)M |^Ɂ%i4G2z,/ߜ|8Ka"EPR2JOBy/oTol +:`M칺eA$ΐɸ+SЕhͳHm"mHQ\kASE5'҄ uyknҸ&mP(1(Cr+Aj AL5*A[0yG ~oJB&S9m8\8RpHZk9,iFרu,X bgfs^K%A+EǙ3QۊWC[yz nyo>]#L:V4p`%#:tk1RP;JI'Adʨp|(q+?yG~YqLrVW=k `*\X۹![\=T6sZAu9Kjb jq BuBq 5.Y @)O\>R)qkeJL&ia8&N*vS?V|hX|ns4x9ħrTI onr<ӎ{o|p+|߼#RQ@z%v1TМMx5`ɞ qusS d#A9s|LW t@X5٪~I.fe ELJR;JpQ@Ŷ@ $>L"P7TʒtGJFZ.c*샬)uX>a5΋5T(EGit-ctE:QpW/Pe; P!_G!m1| ȚSvHv5Y6xqvxjv,'̀D! .j[Պo@I`Jl8Klt|0ű0Eݤ>1h.'xo!Ra0uPvA/Jl~uJөǤP,RTI ;Kr/A/{Gr#(̑U_Tb÷w}hz)bT8Y_ X\8c)m<bq2Ơ0L,'8{hPƁ6HL m`Kae髶μILyV&m7i(8k]`I`$CT $ 0+B CCa8H^qo2)SM :٩g@;f,|`#"׃}魹s.d#_II*z^D9K6U[Zmm4~4V_Kĝ/3lA;s7T\pFRAc-4KƖ |M*Li[ i#dԵ_w|g5usxo S}VǨG\c聵!TD4+Jh{yܶrQbε'/7T6=9ygeR Hq&hc)l){seO~kDMKP[v-gq*K_k^Cy9].4, ,8 >t%o-75" 75ׯ TRl1W+:bX}Nk86RUa$`ChG|9 ւ h43h!I#+`f33m\ؽ뀥wp:H慦E^=$CVmQ;9؋A6] v\|NtcLCl3]y G9 DL/`.!{uq@CɆbi^BbeԾ:@n~dz+.jRlvKQ.zw NIt)y T…Ps7-Os.=09~$8H1  0Z¸;|SI=(AYWگ*͈D&o@@{^Q_$@@x'V TOi ^ 'i79yI` q)3,傟eḅIY\$+i]\B1~]y/3*<-YŢۦXQGls8_BY`6Q=' ⼶. AdJ0R#o+kO@D]Շq c֞S50yvrG6]V.>ïsP>n'xbH`Px?d'4m'zLz2k3Zp#WК4U)2n*C͖Z6Y&hrG٪7OD-AD1]q \NLkO¦:p6ol EVȖXc\gsUƭv Y AI͐lQ r\9o!!]HSrKQ;N0m"*Rªb4q-PgkMY޳+ KO"*nSoDa `]]B@C)E"i(](kǕjM"OΆ_t\9BR5FjSN~iJ9r\R\ RƆ cY+prQ ?q:46d]le2s@JQ+P-pqTr#aMH%ǣ UZ)ygp$:@SF`<@쒧l 85#PSH;ͿH=ݴAtɠHt zo"o ?ԲRֲn2vZ@5i2lmedpܫyt6\ԟ\0lUu0^Dg+vx{U?jQ(49=h0] O/N/ZzȤe~\RlcYtr6g>veV>86ÎlqǺ5|Ahurʱ{1-{ɢZżiW"Iw վg@@3e,j-?߿XA2  kՄl惋 DC8u,xnh%㉊vNQ4ScvDLC5TTxTjhJG">rbR13M+NS q\sV "w]x j!lxV*8{aNxѺIn42z0AJ?ney)TXqrM^P.hC xmr1}]{*\A \#]%KHմe!O++є! e/w2JvHU^"_\>NΝ;yL*Iem'kF̾)m͚CjYNaӋq]fOdq6̗6:e-70S`~YvX dV *!Pf=E嗝N~Z-RWP ݴ7k+rځN@PtK%ٵm5lML0.`|/(!BNAwJ4Dck4!B@.U0ޕJU(RK4U3ers|DCJo _U b d ڄQHr $+Alս!Ԕ@Rz):C`]U",|e):LmT0I _dT8YC`vQ"}BӤ pX ؔb_P2.Ww{|ap}ZN9{rj3ѱ =bzXn v Sh('94tࢱ->闅]~Wz;߉COI_vG-JU_t mKkw W]Lޘ5q>ʿq3* 0Y 2^>ֱxYVIh ´h|2 ͥIFB;'0![!hfhFJƹK|7 =%;4?| |ӂFF[CרC-!Dd: '_{KGQKM*,( .ңj?qVэP{U'Up&-j^1gsmKhakݼi 80hj֝/Wy_n>|Pb&ۿHvwƻr8;%hplW+ Xߥbqy!Hk& UTR^Do.Ks$ !S I&ShZ-|K<65*bg(mۅ^DwKQȢƳ4C'-QdBA" ΰSZ Ǎםb.v&. |wԢFlÆ5 CX3h4PL bC5&g@<+BʿYq!AJuV;2]cpϣnߗ_Bp3ݟ^g1"TIxhI ܥPZW!e[K(稝c1 Kqc #S})zBYڸ=!ȧT5 7pݦQJ?pΫXxx2yy?FiĽN8 bĦD't=I20.苂mXQ`C LZ>RR9GEJ4 28їMҚ-qŴ x!A Gߌx!w S` 9e-m+$QuƂې{~ïDl~$k'!zB[ pj6=6 s$*)!~"đ2ۖs!+˔X̫Ԍ; ;]=*{.܇~ҳU3-k늤mtǎ{9i"qI5+ҭX9lW.$4 61NP?Cn6t0jVˁ<^fN*nd|I6T' W 7+P y~sˑ1B>5#Oi^hh̸vN@Ew1 '8rt-`t1rs#b@?M{΃ k܁]k*+:qտ՝Q8OpN]J-HpC[Gr|U)/ {EKv>a}1@nH&TZ_@ZaZIGkJ}rɧzZ~-f#XQH=`Q< V@Nʵw7L׀@DSgL pL\xFGc=&OAgRErҪwtݝ*߫񱀊ǚx7mQQ*)-?MwWW>x?$Zz3h p8E'BNHh魓 .WjjCȮ֮3=vH.RU]+!eQ6S2AauQY4O@8]?pާuy1έqx\'Q uuBN~nb8Thxu7;~`rNU챀!03~x`̬4+EEZJ/y.i蒦2ؼ'B3|,u'NSkkh9FZ)!38 G|eq̘r>s)i{E>&@ gdK]?5R%˃[!q#' ٓ#wM7-Q&.4E*kblQ_S ng<~FY@Mb3sҹth(#uQw% ǎf^zBļ:RoŠ%sO X%ˋ;O_oo:wBѰ?$MچX.u+bCy>Y(n+*!Ys]<{gv\WwS:7=oF\S$sUwJ\['sG^kW9?k_w)FZ5jQX4%Mi'fׄp%bA?\qLa&w@3lY> ~F,$*B2l S!TT (0lo7DΒM+lkTOr!bcԽe(iMQNϹ/g *}:`+}!]g;XwBY=E'D$TO)9iqfz=9gÆ/n6w}uDYf`En  xDG^Ic'%%By5Ok[ wC&6n]G]~ۀ.mUv HĬ C(nQ~f#^qpfg~so*&±6'ai+cZJX,07=kBMteiuM ن %E N!ܪɿ%/)%OЛ'mPGwu'T?igE/LfJڀz fbjfoj'pcaV{w?~R 0E_R`Njәf4U,GٻHh>P[uTrgJTMCeNCG\ BzPxdЦ|e u)ׄ7PP4{CĘ2dkS̵vݰvsM1!Gv%F].O%oaٷuP[|5 "WNN_0}yÎ40Ej6܃2OX%1l>}*xYǸ @t\kNk>JA0(5GQBg &1 :D5(9B=@\-Oooᦷ`]?YhӪehe ʥOu,Qf=v⃊SΕc;NFi6ݝx:hi7R/7HQR,܍()Rsv6(Gn qIɝo>C?L 5v >͝:О*N Փ疐/*Fe%>oG򙭢]Kc6"W_1 NR]agxpTyEU|MnKJ^ۧ oݕpC}yT?,,h`+I]h/8YD?ac!^%H]HCaX@jbx+WJlr82.C' DJkAárkzHPMCO2mRW+;acjn+bOC@ P"xA< 1%$~@5ӡ(|;`1)afm+.;p1 O܅tS{l(m/^{S _XDk1_tBUSFMh|WvsY>dQ,Q x.oNJߟ:3?/k~qþw`lAi}|傥Pd;ɗa [Ɂ:^5oRFyM#'PkQ5oF'APۚ-c[ꖵEj I\K: UO u=X|-%ĝ-Eų6f]tU[r5׵W/ZUN ' Zk'c/9Gx1k3i Xf4:}HTqt%%.8Bƙ5VoQC!0S&O6hW8GiBsAeJ#u6;ʘmCYD3,H2ns.!Cxq ̉Xܷ609+ք%C.I眀 -0-=;X*' .F𳗟U|l/覲 6DvfHU>ѾZSt画bWc=g'9blT4~dwLOEՃwuX_LHR-Mw:S<Ft[y"q@Gm[j47ԬOTgvnʃE¢(9ӣq]coS'eՀQEh3Rz99$$S-Dd#rS!ϔ]ŔSddr~ c7V2 G_Vk?hW kDS"2jl,/FFد \)5ۧ8bt 5_7_ MmKaVIXCw͆5}jZjMwP-ո;|{Ѽ#S.D\<9eb.ΏV66qүKrd1gAuuѶ"{H hIkP^ԯ,5pP"hPLR/TFSضEBmXJ0&15R7?B4t]xlNP;ߒYkn .~u*Ur|8BOgTh0NQ0rඐ]Wv_F iޡ9`OiZ|{QjqZ,dTSM\ m0AĨ o=0E/4yD3B`bN]=gO}K{2ee'4)VV(wlIsX$⡆ +%3i_$+Zpt>OZ\ MZ57_}U$/q.8{ KEgu1pZͰaPא4m%PZ)b sn I3|Jįr+Lx"2w$ |?9`ib#X]%8@%I;{m (!}Iq*I-̬P3@@dD/%?ίȾe=2ɪG~Be_V60?e%Y3W7__t?nk9Bލ:HC:˼BA8bvEY/涉kFd%i{˝y"bK,9'׆[% .t7L:\Ͼo}ApK qxZTz#RbNMm\dU,Щ^Ex.f!r{C/>naIx (G"ʦF v%Mblm{notGKv qTIQzR;Ÿx~3~=pH>HjK!iuT86JD^BD·2(FIJuj70xYq'@å|{B/pA<88jP FTljd"5ke>|Ut5Qa _NsaX_%,dBfin/09hY2,+ڭw )oR8 j`^)3pdş=lq@ yQ W~Ve.S©!Μ6RGnh^Ca8> EVd3ps'JmY&UΨ7NE[sQEш*}@|3nUY6{L:fB[X^;?_QõzlA?P_`7b;eRF( NNqlL{?!g7_泀s_@h7†8Y׹(.]P0B(abO;Jз(r-#ltl$MCl]nԑkA]e2"(/If4CضC$4idKhCq.?dʀK% ]_WYN" )T` / ;i˾uڄXֵ͐8್O |93ZXaY"/{E##>))*/7BHOv]1<\s|}&]=MM59N-^EdlȇLkOu/MNBlrŒQ>mD[,m0k@, (@N^*L\}Bs4!ݘӂ}L~aQm2l`HД=bJ5T^;zvh{}{URbǍ.> >QG5zͻ5z<3p~ڠr5) L"# :mm"tpVv7pwg(H8fq@/ 7yv^T={s?vEIJ1И0zXg̫^:VD$7Snљeݠ3Pңs@hQ`\- e1y'Z'"]7p=m8lFvǦ߃oX?{(껷}KzcDt}0wݕdoӭgnmB"m`gB}/^`)0h.뇹C͖&+kyA%`vRyGr΄]ZggyMW E`h@1h׸J)RA_&*"EWDBH|csEuĬq1mD0!l(]79؁}DLVsocGUA|\PShy%0gGDF--A94s^H9R0 聘D7ݳ/%*!*P)D8rc-EE[EFQ>7|j^tFRA`kA sj WϹU+]dny)^OΪC|/w>K^&T _\}8ϴG5X;gkvDSeEVGj}A]ٙ)Zyɱ+~Mrxe0Yyt2ƻMSlҦs]IXlv? :LK-Iw/]_'Z"1`)USAu'g#OsiUXkb=N)rult/.媑({,61ށӪ~ nOCp e›wb[|G\jx '] D46μdlllr;x#mv &]7T}EcS}gw4/jy6?{2(`Je\sdjb#xҲiT5KJ4SD%pj}uܰ{ t~Nw!‚_P:Y3<'=v ^Ykս˶?Yfח^_ +菡һŇV@}!< ]C$'+wma6иI%s@R7`հ ބS)fk}ٞqb;9:['^]^0LTx>ˎ4^y. s]_|:ɔ@㿰%ⲟڸfJ\Ro7KN龜wu(@I͈hNju Ѣ|PH@ ]. 0aZ\DJâ f;y[57KP(|; SjK03EQtqN4Ge.Dթa¶Ӱ,uFbFBY9uD60<te͉74!i#-T=5M;6>t)blm!UQFTWdg[:Jŵ_C?K;b sj=4;l\o-ʁ+pO!l4*r0ߤXkY[H?>kt\ DnSWn37joMQD4e _UsۏD:[ G𼟒` Ò4!0f;2f^?ߐg߀zh}陂;]+5ܲ8RSe"ʳuӚlۖ\H [=Gl?ųT^vo 1~Kx?ˎ?t_hʰ0H]Ui=T 8Es'm9Af%dImgzKD-qCG}p _tx rd+ۻ|[Axu,˻:FG6*^Y$"!x$[r9bbXsYlntN~{5큈R>K)ȱUGKUE`u0yD]؂d#ᓆ~=ʳVZ{ D AzB7? ("%H>R&[~cGlڕ:npRih%x^I)}ER\J+ GT_1wmR@:!HEaФfy]( jvbPˉ \=1LP 7(VӅY% (w˜2h4&1)aOOMAW^_Y?Sy OEuDٜ{"kkh~>\Y*25p]4Z P6sZ4QvVfM/plyIN@(qO.l8xj;i<=z)j[qZQC+apQv,W ݁?.,hc2:a8,j *pv#KJ}:2CDf+\(ݥHleRwFW~>7#KT^s^[ >)I=sC4G͚6U73x0N%% E$ W- 0o>aF4s Jx~ԾfIwAxYr GY{ Ă.&4 d-1u."&9cSW%S.9ggyn@#eI{ OU_+Xwoe{_ ]W*lu8s.5e3^j yt}^.E1: LdֿK8JE ;e i'g//tr aSj5lgvrlלs!lXCH>?MukL'`0/vgg?? g]ݑ03 iSi|,6 th@@QJf$Q_RE]]h]=mEۿZ7䟿n1_ZU:,iz,:l|S'%iQ+4*lR>ObJ|2! [aN5`3*Z~V{ !Y6DAA3DH;/'`>KcӒO.Bg*<pT"PVxb :3%p&˚njMD'C2&JA#n,c\e67^RxFPqCe܁\Ho#ǝe$P'`Pc`=ayB {^Fv'Rn HXe~c%]9yB ]rH ,y _Ae‹|~5MB h#~z+5_&( DY{-,,ņ޻lym;+fƥk::qd.1{z*#4>l%ԳǫO=O'kasrg71yT󛋪-sb< BZ[* ]P;\:~Wg/|y3`qڙj%h޵:/5RRȌm,z'v{c۠h@PsXԌ>SFM̕+)L! jzg6C1g;8ƢB$QF_M_ yo*OQg I29pR=I4s=Q/NQTn5D_b/Cy.Sm;|{@ͬKw<.čJSG4O_r7-6n)z涄?6׉k(kXQCUĐ:e~+HnGUWYh 9% 3o\,{O_iaC oUhJ 8+DvlWSg+_٩{ NN*o%yɲP=ےcD{B< 1߼fP b_H_v.jRށͣK;/ue` n;ԓ Zzyq{磌g=sFAщ&SŤVT?`OMk>ҵ"za:%Zzw A^k.qi*4NG^ߒ ]Z[V ۾P~ ]c\1[ RIC\)1%<Jƨ|hI*q\%px9LiUҟ@igcaM҄4,#*֩mAr'TnGzj;s,%tӮ%{렪WOZ [ G$*IcnZi Mф1=R.Ap2@:DžǍ8!BhuںugP t0MW, ,phFcp­ƭ&&gEQ=yuprvΖ+K}ǯtfSXnÖʽ`%5VӾׇ+G'se҂BOUǬ.4Av[,CW T6 )+/>XD tBesk-4>q7IkHGndt;kZ{OÞlw/llnKbĒIr-ywC)k R.AW̎Q"uF@ 8U9] y$d3}['7ШHGE]822MFw99 䤂TPPPI"1a9,CjÄ3q? {C_Z3߬oMw, lyp冓6V#k s~$9;.톀KX k;KB>>Lrmgr{6]*_YDp: ?Mѧ~RٶDVtෂ M r[Ӝ:%^/{6`{4ҸVY ڋO9_r=pް]XTֆɦ\!yC`Md5&MZ iͨ3nu!ts/!ݛdIZ3Jߤ[x[{]F'C{7k"( @LPSeآ1}&sS}X `} j9/1IUf/ d \7pn 5[R˦b&+!h8 ޥ媌Uj+N"z,::ȌU1 Q>tIo&OUcukW]G[;n0+Dz oNU/ /u91U@}`l0!d86':<\P jtkA0jB}gSyAƲ&lL ILԫ49A?}pbʒ<ͩ"RLDj&'Ad|AM?zPMy`Y,)/<"MiN]^j|W6tf.U⫎`=M499kRQ\q2~7zу6gBc;h BXʤޭl䘻[1ٱ{9OwhTr][HM3,(Jmbi]D^L~-gm U,1N,;Pen)XѶDMJ\QOKXn}6ֻqJ;WӷmO\=*]$xisyhPs}c1L}Jzq6ncǁO-)=R- $ZS?ϠdT"Zip碋4^Fz '75)jrG齐t J.C0teM[cp)&܋RrG3=w.qut̨*)2('xɟ$(4O2RiO-Q:@Pz{q;sb"QYP3)y%hJ@^/a+;~.2 $ wU(r$<`2i]&hP3q)BGc# ELԫnUuKIV^:=ecIUxg]y5)jab_HU2[qr#=5OMCZI<(g׽~FTyeh>VȧTT[|>xHSbL6m?97>ѮL{pfzx~" l\X ǻX5͆1BG^>Oҷ!- 'ivs 0)\ @I06rIU&) “et`SYzY6(]IhV"׭ ĄTn ,h94U_5$c5* pڹhcjA]!dOҟ㏢M `r<7\6ܒQ!,-UP־r CKvM nKU|Rum_o̱ T2/%gٍzlP`c[|@dTaf2|fL2cZ_H8Q9cp(s߻q҆U8DZA` P̗35sZeb UJjMР@^Hh-S s¥q۪/ نO-lڹ1g+ VpLIxq P<@xl"Hq}cm3(ydQR%jPR^8AU6y\U~QHj-.8h#IDtaK)SK Ď)le2$pOFwWF0Bȋ6P8{PJ$\( 'bA^|v!͹`PCnHdݣl3fyoBYMlZh6XuPՃ0'tY?z0Y\Wk/ԫ.n m\ %ۯ-LOy:QO-[Mg^턯FR ^'TQpˌwṇq弮t{]+]gj:ݶ??YI{] $a9c@#XP iZ(ѿhz(L\ΔM]ӷ_co3[?w/_Gpg¿vn;Ϭ6?`FJ!x]sXY" 4L)Y('>6d4zJpi YJ\.cz4>v8McѥD+7q:X vMU&}Gn!⨐vڧE(j91C[ BHCbskN2=LtupI\%X!} QI!y P^$_YTk 0"/vCgm|G7|}"}˨oq>5g^ɮ+hд$w8>>~x(}]Z RJ#ceg!2gpK˕㻬o /7㦠x}{ק=<@q}zәefmb ]d!*s=$[OP^EIRȗH? f@W,  N 8Q\B!XRnHDQ `}A"U8Q\-www"T v7/.Y QTVe\cL5XcҩsV+ XL>!#nѣJLA>XQVC$J(CuH0ڊr|F%丹 H7<?0^{Un~z/49w?*{Ĩ& ^khBTMG&ܓjuupH/yh=Y HXpͬP>@Y-0fQ@`$$k{dANN':pf $bԬҗP,`# TY1 Vtb8yrcUBEU8Kӎvz!dtJln> iSeOOnO]w(?Dm'ZUUjH)b}_,tʠSG]Ұ.2|7L͛_Vޕ%?vLBH})H%~8. JKfQje_Q8{fٷ3 3Tfbw(pJI C`D1}7lNYVL(()ԧR`;{)O;]֭WU/gSM"c\D=n>,e AEenzGn{yC|T$vrOTk>O;B!dNI1{̧ lN=S"%甭O'_~v冡| ^:eB2!:~K{3SR<5H*|_"woo!-j0lĶTBGaei6>9/| /Fmu]v z l?m:⻟dC^GG`z-|5{([bb% RZطno~ oV³*7C(eW_5l\5B^6ކB[xJ-sl3xl m!e%\k5)X\J}§U[!G0 -_BSg7[ʛ֪RA6$*bqk:@<Ƙs^zB+JUCw>q¼OJ$h=6} )(FZ6"Q*N^olyaK3UwMwԍs1D0[˻ސC4dw1bqnEXvjo* Ƨ`乴2'ww;ᷱR.F\8nͤY $Q*D5k){F5$ u`2D"M.ƑWڥs L`{൉&\E҂TT{IhN ;{=;]e5^H M*2 ~{ Emfԥ9P f(y>smU[*Q~huW;g?nt6ז (M>s9뭠b F $0Wb $:·˂w .hO/ JkDl~?|(ה2f1Y]a9:Z;aح36}fhxϤ}Ri:fB,DJq__~ ^_BSѪ_圿|R]7Wx_ )dЂo2|swḿO4n*4.jERj om V$k[-8zo(Z_m_|z @ڤ\d]૏AuXyg6I<{ѺTvt˴nJr <2QJ&K4/D9Y B&A̮6@%Lsڤ;au٬rdЎ""Tm@Z5薀|1I &F+ 4fst)KFãp'h aW:l/+%j4Dg)ЪHpAF { R'uNJ J'9`VGQW wG{W{h0 rIԈes5!s%Sk,+8ه9Ӱ((>c;~WA/֯}/lW^sY-)ϊO^}ER;ǭpCI|K9y= ]ߵ)bkcXFzUXQ묫oHoB+ kL_p}6 Ozt.x5 "c˰,=.LY;Ccp< ;꫆7?N=$@~p>flvsDyοNlE /. Vy d ]:]4EX"I_Q;Gb=mLǎ̴gV.9$9GOXNR2mǦ69'1R˔"wDo|%M~+]-x͇&CjndʻjY}pf<яȠe#,Un&]Z/͖8+)3Ķ<,&_؈U^ řGɺᜲySt}'/*/f|Zqj>~(-j-55O}7Qz #T7 5y[)rRQBpj;ӷ46!m/{$ I.tt7kP' 1[Թt:,}慇 ;4!6Mb6H.EAox)u{"7g3y/pPf n+&}Z&ۀTRa_|AH ȼd40x&4}yXHta%>&>0GV'. Zı3T Rn'I(S$GCيƏ䁼E}G=qG+%&_-v Vw]CP"D#qcv iLvbnֿT\Tnx#r:[UkvGP} Veoi;Tҳ ӱ*ΘF:3z`ʀ u\ڳJ -~_ ;Dh:X-]k[-U8db7YcY,#)}Aaψ)>ŽM~VQZ[$[t}[i'  z/*F"wѨU@TI/aǒ qQ;P&0$ %Jڞ |p";iG3͋?|iE8ePb7>'RFǍ λYc9V]7Nzxp z~Գˎv(Ps\s>ܜ (ydOwV-_AX޺.é9*=ij7i~&{xRB"KQ,8I%cvK.m:h_}ki)mĊIg_XW/[ r3E&-m~>rUT BPgheWozعu%ǐ&U\v<]Pr' |SRzWOVo`Rk6$@#ךJPmg(tƁt)Wn} ( $rL%$bR%+u2U[U7 W}s8₻.KF90)KxHI܄'LKTTw(x;\ڷ|K}'ڕ/b90sZ,P2l7dߠ3:׷:В Ђ̔rOYxO'B_k:(7-}Y~͘(wQB,?yŌC-MgSb9sϽS%f.ܞI GlǮ7L&G'KQބ=}0GYYn +:TFE $OK P&n#vٌqX񐭾mAJS jaʀvv#x~֒gDXrӑv6J!0 %PBC{b:0a7Wß*pϮ0P+ݢ1Ei$"{(]d'PXDJa]Mbe~Ut0X.2:cCy0 8yИz '`mHz9jbt ?@#> sW*T][07˚&zȏ@78Øy^UtNxCƔ iBIj~8|&^'^S,EH\?OWң(Jɹd!dH"˪W(\2fZp _MSqsݏm{kN*3Scv~z:܊}D%vO SPieU{%ɃG҆L!($bCv-W ߼?OcR+c (!&5eqLr UR뷱_?Mpa+3y/Xc?x#8ETT3D ǂk-*M_DGT q !ڄ9gWr &By֯%HAP"ٜ/ -#os7&*Nز|.IsoKj5g i& V#Zr!zTzouȠGqsŦ6(ѮHD6g+FpP1I*#%e˯Psm[6v\אq˺KiMͮaGn+>P{ ZO{}s վ{k2}uF|I'J N"ԠɇZ*h-5c7tnֳ^a\LC/Duoc>_5+᫯ Owe$$a%l`HrgF_R9NήW5qO?}z'_Ah:Ǒ)XfLƩA f 34^<ۥbTd8E(cWMw\[J5,Y8:]͖7I٣DRޖmiwҾ}EKt5~G-(,קD*D*Mdo<4cx?)GrK/`bUe( wZ OV<ثlNJ8LdT}_|b$ݰfRD#޻IkI`g(;ݖԝsK_׼KJ}ڤUC%cS}W{Ϸq=L:=4Z T4!c6k6), FEJ >+(K)ք=?-y>H]Secac'6; ?N!2!6ى& A,`V'`a 372*7YZ,1@{,bI&@nиl ~-R6](;O>+D[e0VhPqZg1 I16VG,s֥ce|9;HL8o_O\C]v7)?$Iov1:n ˜g%d). 87dr| y-[}{TʓIKZi'TئJ ڈeC 8 ϵmUj&*?LAj.t΅U?֮E8Ɯkz2x t@~;Ñ/+^C h?K\Kfy\Z.Q>E zVU (^t@bBz!WS+'ص/5_k$\3@p?df873T<1Ox7^w}C8-d2~zZa}Uź)` DULȠt'h5?&ɂ" (8dBVK9sֻ꓌2 ~Tq8@^lǝh6BjWa XS\0_2Ἕ'Aj%M ?VaYh+ eCH%& H;04(ynIi-#_ڗid\8y(0. )z,5}UU΢k°$iȼ褶jJ&%eKAqr͸E%ɡQ[AI\'HqG/IahfmT'JڠNC#Qޯ7'}x3ZZO.~]{1Q;Z|'o%?Im]?K\$̢Bşs ¿ D "'\qiRԖӦ!_3ځ Itހ85tsav#(2!kR ёˍE=:ÚjFwԯoBA;RC%H -ȹ 1TLɒUd  q B@T:.o.Encw/Li2r,(b NsƸ au<' 5`#X= =7]4q{\wG؄ Ů*K# T%޻/^~sٗ_:L4CX?2 ٚu뜴zЍ)dJW?|, gO#/ rBVB<~e3_?2~j݊c!_ם0rB9~ZtNjןQ =H$@ȐJҥ?HQq&uqf_/E#Zθ1GbCE)y.|Ie9<!M NF9gL A9`VXIj : yQt@0ń\"oruL}uB{}ŦܮCwP~y ULʫ2.NF9QIe42}%`ȷ\^8-Sx6R?(9)&T=Z1t|X̧ f9 Nim˞R}[>H-\V=o~CWŠQ|x8J~qBueх9BY[}mpv;=wy~EDn \un $͓wݣ!.{9QbHI'U$a1"LCE~:@J-A^'3+F4v(+UwiE`H,ˁYt)#z .,e)d1c.]jքoT |q.xv^ٍL\ƭl{)$6!o  -PFA.teΞ;w&yY(KbC`%Xg ֥N"Z,ݮ[~HqS~]4 YCu6U3ma8i[n};kz?*8كi')% ?{߼Jߍ` jv%:بDP)bFV6opr2+x{)|e\;{_@|X\rJ\yD;|T}~Dݻ;xʽ8O@S'δJK^w;@2~ XAZK1vq.! Eȋ U^J(IK 9FJbJ/`zRpQ_J7&c#+ Ɓ2~tmq}: GԷL͢3%B`=n8$U4m7шYS%P2 #]k5 @(4*ףxw.SM,zWvppr| M?Gx}70_?g$D qEYVj DӉ\ي?1=)]mOY8).~K9;iXqesnGȮw,> U@Oo7>h#“cW4-cʦѣkbWlx\.`-ť)g ׅFN`,3sֵ_f="UcU11FbMT u\2̞͌ [׭If+ghz'7ܺ}I"lUW+d4Fhuɟu@եk. -:hZR̙C2X{ +k*jX?f^SrS^| 2wC0*c2NGiǴ{Uc0x9!\g\yG<;qx!7g 37;W;;,#.w(i[6ᬄcUXǠ!)sqXKa &䚦c"dԟ?jePa[25sa0 N54Mol4e,r :4 c̣0fu2E e>uoI3Fi(: M׵=-%2_ʒ cҲcP{JKfl`jȔ9KFjB *SU倕,tq eKվ0}ip{d[ȱ;wDE!niAt]| . sΉ9gEbಾ#]C6 &>6_o9xYOOخ .x;n_ׄ[wx .?{,%cq9Z]{uǣm]Wuk=@yVj}]L&;E H,Ry]wn$f|@Y 5ocY.WRYb%})J4XD jҐbΠ\B%|BѫL;M--bmw\Mh{]r(YL;sC_.9{X8*[SptaHuژa0x"OFpq.=#pcTѺ$E'-+'8/OhȂ}TX ,@dP Ka邝P69g1uȝ׽>7n?{$x:F?+Q7'<[ufn_{Q0zhkleʈ#!MO5 /]s<;>q59{2GOJXϓʐ%9 ? ,UHJ:w]o` YfW,cI=rQQE00c9hP1R Wl\Qz$cˬkԎ^^ѱWbv- ݊| HUa"&]OR]Ⱦٶ`=w/"Y+Wag塱2[d\b,jypOyՙ ]yA(ڑU5cyUۛ\enIՊ%JK)TZ+P<SO<0NmH?h+.X(Q`—* T0?`JXj+ K[.;7K6~'35ŏ}6uIZlhkM/nfgRY0+bѕ|뻇]CzzӪ'(m4u H_["NlE:[Gs\7ȂسS-0% "`0@&4w4QjWO Zq[L~i}wAȶ'ϔ zU2-RiW{0}?ҍU .X*8TB~Ww}˹/FK廌\t(GSk_jP" XeB۶3zɵr٦+gZOz*g4>'QP`l8^.v{H̫q\3k`1FMP1[}r2sN=mf[$nۯ'mg«۶~ol-cQFₙ6 :5R --NJ>~Mc-i\ʫw6mWia>K=Xl 6c>5V &)`z a%( 37U(HlgYQ<| M -%cž~ z1N-Ff26Y"T@+jeUVevHYvԞzE{v}ԙ-rMDj[e(P#זªʶ]FqVkx>ɋb@ iq'HeDIq X3ځF,-IM{l)DW )Za3$jPm)sQ>x̜{֏Kj:&y Lf(]w~kEG>E&B:ί1..5 mVgw=MavC7Gߌlʉه/߭l-yʞx&*K/ꂘ*6獣SD(&ڤ8]Ӱ!#:.`19r5CHYJDe8Q~Dƣ(Pp SUƴA)r,ld_^w9ƵRSֺ5QjBV 4Sԕ8Ӕ1ARqKnGMfqNY.. P­ҚRVr:leaDea1PP1#drR9$;a΁& V5Ty)-m:R+Ԛ|[62NS#tlؤ GFW.~xGo{5rr-NY7+mA޳3cF} rcC,Te,.\(By$6F6 8i| $ġ`3ц!٩RS0EgH & I&w:`9C0 %zn![vcxiYو6kwvkyg AKLM=y{[OYu-ZR]{58Za->SF{Yv ,Sꀛ2CcpJT*ܢT2N)d"M:掦` aer\ᑪC {|~u-\5h\`ټ0U\Mfwx6jJCrs)Np÷ۯOzC,h |jS &ɭRG@v$5fJJlЗwb@RϘCͶ@Ù 7۷a#YCA-+w;N Txԯ\w7nxzއ8~;|Tʷup_Srώ#Jo}ǁM"LrQMQC,P=2' TVB!S P9P ^t0+P\:H䲴V/!0eUŖ B#Uy*!Q1GP Ӑpч8t@0F&F)V 3"cdzuP'?ӯz/襲ʅfG ;q/;ieVjHrk 43tFQ~yI߲umOg4k-%؂,^CS󴋵c`^|纥 XaC Q$&TJi\fYY2H馬P!VXE.5u80 8SH  ˨ G4=~ַ PB2i֋a cDXp XMFKd莪uVl ;lRRQȚX5]7N J]WpFkmr%3GT o[?4~"М 'v[Zk{ኑh <^>mKUChPZL6.W ףެp ג_Ϟr'uJݓ?աߟ+ԟ;c#]zʜpn4Uo\=T X ׹n05@$QԘy\_n#3mu^(m'H IdDzFG%07Iʍ6P1@$ ݐLu2w;N-; O0֥cFDH@Isp2Hc*kÍN׋dU-KQ\**zW9kep6ŻZw]ђ]p0<|<9WckWm~9%vε.ķv=aX<5h-Xj̍{f-[-}l(ҤC;kv[u-ԵU׼$ީ}ݚkowN?<^ӵ?=x^NrۧG`$T7D'?ypAp a+&&0@ TH&YZ(ӆ0һLz²q씺v) ;`_HY6Jc:8b9HEАScdZ'I>C"tcT"qVfE`V<=201X&QBQXy$g J;uZ#PS&`Q~>o/O5֤'U+TPT|{6DU ңK$,ښlYձlzǹem$׮|%4xbxt_nξ]ܦ-ގf݊7_xl/5RG??Rn I#|m0?y`̄`& .1Ix ~N3ฐd@$oUƥaҹObխMH! kʡr"U7.(t݌x F䔬” 2!a ! jRW?(r6" :Mqմ8JD#hQXAQ툂$(ȯ<cf~1{^SPߑ˞F/v׭8^`VB^iiGy/{Nfv:]={:XŖk'Fdf;n|!@CGKx}/-W?no\ѕ\K5_ͦ~~2#^aMU#<)O Bѣ CyhpP+E8LIZ*Ijn &"-TQw1"唩r;4r#02`qPKLrmqfͺr+KI⨚ Fx B$K .*ge)2BBQa0"IN^+ѺYRsxЁ@p҆hh]6pfժշʗ bZrlؒm1gVat3E!E .Ι;'.e]ozЦэ;Tm|~Vi9ټ:߱:ֿvcwxP}=0b_\G:5խֿ>uHmS:L` }#_SIJA1\v V&آaz8Uwpi$*R As81a̸i`7b6! ]lq$, ]DD9}.'ƪ3 ]`JDT`ySIrGau>d%E;1:@1JxD0kR1B(YYa I*5Z6m;Zqy~d҄~@$IJa%5f/;޲cCclK mu٘['ai[˂'\N^{a{H~K ~v"񡾟\奟E| ] N ) {x(x(xXgE tHh Ah(|z`;Lx9xj{Ye2b. +3Rfqy#(LK(HI U`%t4 G.0$3ʂd優gCԉPx,5prhт0@)2SosIc@0f$S ߒF$Xc~$)Υ][k^9W/f_;0yoKڠH܊H¿\o^IA D`ț,A&ZDnꂠ̵c'wu>$sꕺԞ}ZճUwUw$њ/k<$#jBOS GL51"X<oi?Ϗ1-8!lA-7*Q:B&)b*BjVP ^ޢd\P("nF^DP'" _6) ͷ ,ް@6^_(AdpL.8YTFJ]we$2f@1,`_FL1L< 'W$V37ab`ƣgZoo(,4f>ňbbj(daj)T={ &( ~C7؂)[(%C3 g^Ϥg{ 5%"4Ö=:8ƠXXO3+dG|_𪻡-?D"cˈQ#IPbbcGd7E,Ő a6x`tu*r/&!}lέ4V[z[צWMzu`t`y.d&A FQuQb苇p+`_7])=k( pA"He]:=Ѻoޓj߻Ձ3C&I8E7"5< 1p~O - Ū -o}~ Im_xm2 tQp=zg6a(Wz1|㬖32ro4ʳWQMM! rVW2bȏG6ۡc#>*ܣ:V:^5ѻsC|'gF] f`~bCzFF9t Yc()_Try=D\ΗlƘͩ0̇ EEwB@-B;u\G]ut-F]m`)mp@(iBUOj# ouBۗ~ogMUl-A 2ONbUy=tTa1M YVbw v.*cY:xx?>aqnj7mWTN//A0NSAW-~:"`7ȇo >1ty  qC{9e.E@; a!dIdR<jC5"tRp{Ngaug o8Wo ɀ[ 2Z,hAl/?/N ~ Wֻ󍧃CL#XFATq:Zk.؎ʀKQSFPҩʌc#Ena_xtFJQ[?A?CB<}vywb,S uoDʓ1 B XBqr>fڜ]@9Apt6ݏhiP k1~ږ^Ms![FFC`o"&AbB sԻjO'bGB5li< .r% ݠPQ>j;At"i:i/IӤGeoTW&\0ݍsuy5Ӫ BQ37w46pXՆ 0U ^ DPQ2 a2 {Z9/+ T˗#gqhJ4XL\'Kb5C̅FR3 %(9!I{ɐ+? !K'a4z/x>7|,$X0o${ i$0g8,M Ӣ}1ma.bFm) t58z :Q8aȎ@6AI}ŗN ߎO!Yntk$*ٍ'bJ~3efWk({D6;h/PMLTgxOs%:Oׁ`pd7pAV9TVvrׯ\9l5EUзr(r71Nj.R'jQBʩODDڭk*oɘÐ8{c4L7hcUC5r3qm;:=L?ş94zn(ӄ?̍o,}&*+0THgծv@6^T2|[ L5l,勂cl+N(=T6d " @P?rErc28 >\aY"BzDžN?Ӡ Sdvj3] Kx&"]vmȫIkIةH64 "(q;xemNzbytqb:c hPg(補AGJ9^;ơbd[0h}cmvuY!lfCyŏ+(A@xmu&0)|=ݷh}6L=o,JS$ xS}J>@M~{9Jhmi$tfL++/ہP^N4p+ġ-N=)o :T8{mO_W,/mo>j|UFֻ8N\[vOAAͱ7Dytm&Ѝ f]2?(D׾/B[ Dx-r7 [6^to8 Ri6O :n D_/*w(,Uqd t=s tgoV\cULN_xA`v#=xS'ߦ"c| U.t`U13bӢ/2b"|mIkY0dB6.> p0uHf6Qu[\ipq"[MkY+.VM)bI9#7zn<{ūc@hhTZ$7A^@_<q: "vt4䅤ȩ>وqY1XI~Zf<%~~#U`sͭA %{WL#0xz֎Ұ2)x=՘K~< ^'^#Ҏ`c{rQ /9I}) 2މ«btn0yq|`Qp5ճk2[]EtBsOT/r`5i6ԼGtB`9s t5&y6O $[VS^V|-ߍ'cˤYц&uJ6DDlnr营C: f:۟рTRZ_F*c- h:d>BbD NzriK _rC=J&(|xgxVCEgʄU' Ga@~H PC`ir/@KG!kl.Ƴ&,A5/,I5&cL>ܬ?z/mIӲP dLqŅiӐ[K#+úsOm|瓟oc&3m ug!~@% E`MsEoO%'BlWocUrFg^ߠ5c+bpg1xQl}` LJA΁#$Gc,_`HOח܄tERBOҹ;މgecdmhog+goC ʰ112eJY81篶FZUY}s#G}q+=/3wazz:#@+hcichg`C+ddf`$j@+` gd/hcekcmd`ЊY:ٿ[9 xx` im9af8ULj-ؾƀ`69lr ~@m] XOA AxIq; hOy܍2N[ |Yu2*It^K9Jr~Yl=:1hbʟuҦtu\~7niO̓mp/WB< ҟR iLk&UGɗNV8 CRRZG뻎v+GkZkP7w/xy?D`/[;_zz$8Xh,ۀ6)̞> +|Y1ձnɒh{Q HB$X! CߤZ|8P0)p3(eXE'Oe`bb?Wqw=CX};THV ``a; 6(/ @l:7+:~(OZ})8E[u|p߷}v B>!lk}z4Xo+cHԯ{cD= m#ꥧ<vI1,i%y$.H֡CuSImRzj2MX*g{lX3BT-W/[M6.idL:"xޮho48. xީ*r'%U5 P/l⫤DAp4o}S6FqIG^џW0a_򋋫([HMM:spL:TIMn^<¾ĻR{! -sTLI h^𚚾]i]o,z8KfG- l)|h$~ՒSw8[$ts{oy6!zZ!}/gT0ֿ0kĦ,׏T?8e!`"-'S{"d.p&fS-wʠykre09NJ /׷~R{5vr}ܳIE㞞uZuX52Vha@CHi²v{k*4zLwM IHh N`Ҧūbg筫#R5--G6·/Fj5ޜ{O}8MOQOu-mtSo")~U_[#Q ]v D|yۢߪ_x%x}c{\Յб[_a~^JqWTFanOFࢹtIĆqz'wjx@86.xz=&JNT'JNR1#Ηz,z^waW "^ibea4=%es{du{=DKϹi^%aGbsMJ}YR2.SҖ= 5 ׺V]قANB/hǁ^{1qJ^̚-+.¢X:U*N=q1Hx,~5ggXhѱv6E#ʟ?k$|h_uUhSe9(cKF ' ӑSrƤJ4wvUq71-KgdbqHF&|9bIz6:JX8dI{ iEu_@J9Dr>FH0?8Hz|0nؒZL0kI~B2w1=!mj1;̾@B4a9`{rte4 X/8N7+ x,8;㟎8Mi o cΗvqgÈFto DqTXjDaa≒͛$27g݀^icgM(ŎDɢۮ1WHq!>tY4b VrjN3_ Ͷ+;tδRW)ew]?Z}g1{M'V Cs=b7iE6URX/ rY(::PBڈ/qElp9quu5HDl' MfZb7^O~-s`&D1 T$y~Xg(S@)0"q)乙*x@7~B'?g/l>._z:6_ky<+_XlUD_S-@if3 OB>/@U4(JIQ bBRpbYe$QB\Z|tL$\١ u8M7&N(i٫-aktl5*ǧcs (Of+?/fY@@<ґ\Iey#(Q+ it@16Zcj+b'7iiҾ\h>44Q~]ƾ֩jzqq.p\ѩ@YXw-~2BQ3}C|r@OvXX8>X dh_~Ru Mpv!%;P&gwglys5ĺX}ng! TZ VBG 8{y{[jE3̈ns7.jfܸ/80nԗ`L Ԗ X 4wC]82CIBdA3I Ao^88628씅aӦƵIe0ʧ+ >6a즙@.&;`! fCƏқ.Ru"нlլRLcN+OOվ>t.z*p>)]Lfg[Ӷv$(YAn˞Zjm} ;9tβ<`} dK={R,D!Ge4-,*1iml|*= 2@I ?Ĵ5G5k~ g v&q!n ABP"k^Wc z6ӊ*(Ge(]EN쏃]m=04+[{6I.](P}.;`pף:I,|DD0^{}e iD.cġ+|7'"&iǏ0PӖ$œJ` ,ɰK4}*XWl=Zܒ..!A+ǘ3i{","8ɍX6~!9I&TK D['Z9Gd;@\857A?X?U?Do_-'IzS`LStt8OqxFFdػ# =t [ã~25OnO.Ti'"+SSkk C7?8'4S/S/oӀ4l"O=s͠.g[:$C7}~n >Ɛ&\6gNi9a[qLz!bߩϪou{^>F4l0(nsV;8J%F1N''é̃^q“,X9L>2$,4nV_<"94gA.hZ4TL$'_\<]ZŢfD"$ќEEE݄%TjwDhxXnDN%w3A'[0g4'?wKF'+u(ppB{Jv*uwZb(#.cO %iWoo|sSGX2]2n_w_7+@ZMMN˔G'2b67#Efܚ*u#NF[kmD(kD~ qz'uzg'1n3+5e[6o:VbK"FX֡ks{--Q-OWk+̗oGBdWb,mL9>5FDll_G8M lma(Y31 3{GAS=__ ~{F⛑?_{Zѓ}s~ 8 |(Q/<ʦIM{\/@;SٯfxMQN?aob~" .߷ⱞ `:(WDaXD.NNgxACbIw(-I{*8 gS[V 2~Ca^/0Þ\E 24OHZ˦Q][2o2ǭhIhݻ&vw]=.uk~/Y[8~Lj&F +U V~f&F; ^3ڨ^fx0({kZEG#+_-TGa~N&GMYE;=y7F6e#J{]ɘoU?k?J|͈K%djE!^-5Y;:%b:z|QyTEu40z}H,K5vNWuunUw<2굕~s u: }yT/42>dg9*$N&HiI: W]QNu p<ȡ) ޲mMeUV&+cV/xrZ{"F7k3CPԔ5F2[%:Œ<A9O#mc=2{e:rU\Փt;YH{V8.񕳔8Rh{H"HH\HK@k0):g=pʿkl@5[},U"A/U&Ie(G#VƼ7u92?ݗXImvUh"aKu&k] 8j73"#`.% /lw?Nyf2?M26_!ٮUNz&HH+,eH F ډGw!'"8lag-&c`+V 3 (¾tI$@T현- $^Wtb/t{Jؤ> 1>@=G8<qAeyYzK3\/V9Qq#KuFBOMNՙs+Ȥ08RX*9I1pj}mD<]߫n`4U~[L%"g:aP{ȏ.RF 7xR/i݅ncނӊUgU9x$[TUǾ[حN㨄>Cz>]-Ghs^K׆1OCԸWmr]Bo>~0ZQX`!Y tU kS bkIdlC_+*zk0p7S"p( 0~`7PAFfA[mr-6Λ;<4[_,;I~D |}S ;{@רb? ol |r 2ܳdzޓNƴQͣQkwfc?pe=~B;#}|ڷJ:NB'j_6O'< W"O />$Ou K% B,&+ nym˗(7DO7i7a"ws}EkdL+N V 9:˨̪e0/KV"MufhQ (<32$us_.?ܴZzdg\Qw36ͼiT}#;(L.HL+#W$T syYL^u5l>3OϔZ >PҼJ/H􀊊P''_[T:whwg8 H`/HQ(^`< .. $`ޭV|`,A΀}``>MPŐh ?}@xɠ;|TSӢ7/1>Ey%ǐ77נ//jb^^ ywǭ7ZY6n7Eky6s6 7p)kŬG ^#oa''a":RCKm;Txxפ2#!W ;ufEꪧ2X޾mKO~%|pM+#vo { 4V ᾦ:;P`3el^6h ^^'jd)-xa:#'_Jqv.p]4?BENa=/ks㕫`0VE~5'2Ţ)m:0QBY9:G9!~.a;ɹ{o/%;GA#.k>yjVCfam|ѽ/" pC#Q1IA{8u!I_okrgs>pjlׁwvz !6j YR_]Uax$]-jT!&߲U WQpk!+@yl~w@yU};k( 9 ^%U5I!80Qܫ_z7w=!O*SG7SCkk K0m[Bk)uDUÙ{0m 6R;nu#jZȚp܁V%;}^UAyԏTIi`Q !FQruRG:9x,%I:_o@'B»x@NN%rb-Ʃ.(߲CTrfn_‹xs?!RVrfu5f~>pyB=ӀT"z&Uՠ wfU4҂`I+!yY®nJ+ɬ]|vceb]oXZMGj2($金W~ZmyB錭114.rGE+)Z ڙRF#yXGvfF~$XqX/(dp$a|[)udZ,bLŝ tkqRڶÊEw)Tt/ n?)@a*TGC![ 5;!4QV{~7[C$}jCsՊga]ܑc5C7(rN$`~ >ڌljS+X< /_<+V(@mShSW~f2@6)dCg 7(A8Lh] B!]] :$'"(єXp+9v+ebv@b:(JɅ lO\ќ#b| WdZd42ytԕO_JĦÅd5" +\葖1<"-W 2H%X;FT#d7Jӷ$U6Z|$bH WZ R*)JF:,4nmCrʰJF I{*(9I$6go^n20MGPTJ2(u77)ت2,jB v(hUyF&u?CH4lL (9grP'[;S CF.~rf@^B߱QטxN/f7$5Ix j( ꙰BUs2ĒhRdžgj&4bIbCse+g๜(CQ8{L@iߡ5+DڻLUVpagtH@js Bq!S9Q1Ѓ%sVu\qaIW1JzBWړzX {tA(fzJ9" ^jrlv$X\@ָ-X5%m0Y!R^Ӯ \H[C #62m&RPPa1e i.R7Gރ}!I^LYo(:4 MmK2~Cd61~$vZ@u7pg7,?pcRt끤k)8I6P E2v9rR$i)]\y:1$?=IceE#Sad{jK Kɽ=a&ѤvՋϊMaJ(g`u1lDΕU},6<30#cdSSJg *pc4Q]e(՟)=_[k]Z4i\ʚm-+B~kV 0M.Nw+{[|kWR@C +nd@Q{ P/"efef'2i="@@OGaѳwt X;8?Ȅ8YH?J-#{Ghghfc-0gKm Z1  01[5?rY~&G|۲cb{[vVv^;?ce9121c\F&q1cg` lt{_/;Nߊq1C?/cqcaZc\v`LhJ]r;wY;_~qu34M\@`c`?ŭm 4\,tL,Lz̬¦o`?U㻉M1CL,,+=A'_p ZG9=%'?xOHy>$R~`MN=Q'R~ +ipY~WiI R Q % #0H2BDI%a!ZX-Ş@nB*WVVv]v.^wtṫi| 툞vDLLsjL't˻==~1l5In7_7п~׉mMe3&W/ݴ/g_\}\F ٟO\[o{<&A\hy8R ն{i}ѯAf|j]t´B|?n'L-~} cK; XuU%'/p<"nEt吞~qڤ'Y%hSӪZ|9\kp;Wfh+ =5< oIv)׍,⪠zEISAh?drb8KPĐt3_dKO^SЯ@µcg>r葬61\j43Ĺ =#+= ׏׎<8\cXyVV -SpA*Ei׍lV:+з߁~ Fc*=Avws,UpjW#oB A不"^;;z&;*3YGXJ-;떝uNetݲSn)]씮[vJ-;떝uNetݲSn)]씮[vJ-;떝uNetݲSn)]씮[vJ-;떝uNetݲSn)]씮[vJ-;떝uNetݲSn)]씮[vJ-;떝uNetݲSn)]씮[vJ-;떝uNetݲSn)]씮[vJ-;떝uNetݲSn)]씮[vJ-;떝uNetݲSn)]씮[vJ-;떝uNetݲSn)]씮[vJ-;떝uN底AC7 !g'wis)tz}3驈}t:mVA_NnFh?tz}fv'=y1̲HOELk毒p-\LN,/\C~B)yA&_ ! ,XJ@qg00îJ{|I ;?|6Z~h tXyRW~a0w}_:8X9z8-#?+TS!n{v15Fx~Lwφ6Hgdz+#I͙^'Xm>ebc$A(>O?!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B!B/H!(2y̗2(W2ߗHk!,Lч3@ʨtKQ& !J&AТT$eLfAYS==˅b:;ջ1ѳM_@ˠ⠒&$E!ݖ4dZFo/~\>.;z7=^C-J@+ h&ǪNLv!-K-BِߌYgldy?UARq+CmH~4ҐL뢐q!LL߬3Fл9A[P# ڝ_\J=]AL6h+ټך/+̷|٦q! m($oތ3nzv BꀾuB]Z`49Cm^hy_gɼ36g lWaX\T18K)o 0~wӃ^(A<44 mYN68t .@1 ty_ i%4bYc݅uC͊M !Dv}1g ,~B3>Λz z9xL -ϲq9crm^v9c.!D* X؎¶X}c<pknB]7MסG;лA,@s/ЛCem1:r=1gYa,|_SoS.2َ¶Y?a{>ͷ07_җQoA߆>}CZ|мYt| ۧs̗,OY6qy"c[88|?&Tl;y|kC ~7BZ|jlca=ɶ*lOa?2&.B3ADz-lslU0nd}^ yߢ]~{'=^>_Xql S֍Bts3yb|^xz8;z?]`Jrgl_b;ۛw1 !>py"{Åً<\.^p!D" !y<\BE.Bd/py"{Åً<\.^p!D" !y<\BE.Bd/py"{Åً<\.^p!D" !y<\BE.Bd/py"{Åً<\.^p!D" !y<\BE.Bd/py"{Åً<\.^p!D" !y<\BE.Bd/py"{Åً<\.^p!D" !y<\BE.Bd/py"{Åً<\.^p!D"z{ooBoqÅszo@?~yߊ> E,XEԒ%=:bp!|V =4y\s zڠA? "KzL.{8ٟ6YͲmle-l`,ɘOq,0w9vH IH'm, YaBۡ: Tlp!Df2y8le[,dYg^hl>d{ KlSzէA/ L iHC|ҋ18:elYZAˠۺBTpFh 63Blϥ3|׼Gmoӷ3> 7Bz1ݮtxn/+ٟ6,e_l*)zBxuYg=|L|~) BbcT6{97ӣ8r~u)7ӁD1os !dc6 ʩ(j Bb{ )\kg7-ol~l3Mu#Lf: ˜9ͲSk`MfJEHe69 !Rɱ)ouy/|~qp/#zzg  P;BpL~3> Dʼtg+BDz,}}q!rzCtїWLQTA|z7F;݊'l+BLTm*+lgH/p N/b_ׂjRTz_ i4b0ۥ[2oT`jCB̞q Ǫ1Ƌs`H_Z%MPL!Ҏr#,3oyb*ƣ3^N~NߡӃST"MRLe!͖4, ɴcobx9ВXʨ4=;vBK&/~ץ+5rmo{[yHtORfMnX-k/FB!B!xdfcG|9PbUx p!Ns)I /B!J>B?FkO~>|ɇ8Ia_aK%]~s8_N&Ň?z Jx|&αd~I1ӝ:^8.>!4 y>xi.3KBG8.6AF9p_2;ӽ(%)|֝Ke׳Da~S79??_CFtLwҔ4gsB[?B4g!y^9aϛ__A5Hsӝ;=rBi4)\i4W/)͕ AJsB\i4W/)͕ AJsB\i4W/)͕ AJsB\i4W/)͕ AJsB\i4W/)͕ AJsB\i4W/)͕ AJsB\i4W/)͕ AJsB\i4W/)͕ AJsB\i4W/)͕ AI- FK诡 ˸n;!͹C0??t/Ҝu^I\teJsV.U++@ҝHsֿ5N"קyg,W4gՇ^cS.q~Jt/ׂ|xDL*|.oBR }3 RBgs)I ;?|6Z~3lGg[O0vhYIn@^^kn}9k|=Ss _XU4d~T {LztޏK(yצכbxbKU m0 iz y*t0?ף[U/N~$1yhP,?1w\˺o)HO.2זo˼)g]%Z|r$ION(o{a| BB = nu^6$I|Z5A P TF-|wnX6 &$IFͰZ@5T-ÈoGk-c$el]_C}69vs(.lhA^m2_g`@/Thnmt]/F%CkzcMEmy?S13VzzbK̷0G/( bR&x!4xcVʂbL2_`*jkɫf= ߢ=80V7׸ >zBw/9=b~<ɉy}ST:+ ]V[h.5w`C\3mRW;; 3\g! s MJ;m/,{70/ bl l[ȃ6B}k\>JZsC}n\/5+ZcVqD8 /7ZYs.%%ZmQ?8 /4kz>\lb^23߮伆}|qOR%WU v@#2M3o1y[1+~߻q]vlwu۾۬Aَo-Hdjnzzz~оEs-q̧p\#8Ob}eRveZ+grqc`?òg -x.[w>ll.D- cHu26/mo1 ye=m5:zRC%7s!Cqx~3Bfq<``/n`ooOS);86|껌`b9X9>\f%}D,3w36X1ET/6>?A[Y]];7;m'z/^D >Gp ԇ(> POh: 8cy>:-!]9.K>1or>"W 2lO^ioOJm16yR+wY+_U:%CO)Y /p|B_TgfrrkS:J_G8щDЋ9C\!|5|lܮ椗2o b8آ/8SFw瑹eiU8z Nr?&j6K|<9Z$v]N2wP6hw6pY[ߩ̐/A{I7Ҥ{[tp }!s[~:Bqx@Msv}&ty{><̲vʿgBK> Xyy|.[k,bBgpa #4!@ ]wpw߂WPۥx@\df^^{[r&Dٟ;j_d>7̍op>bU6 mZϺ rn۹\>O8Vs=vC A_G] uO]KϾخ4o`?_>\|) ,f=4!8'w3yA"3|yA ن9c8dnb=cUm8`#s>w I+/s/ \c~qG;56s?guXg>\_){5\;6x/ZoT#k|fNj/? | }7%2;{;uLe&3U7/6:uS~:'!=jX%>X`3M vۏؠO.+E,b"-wܗ"VWif1 cb7l+c81on.|fm3ߓDZ92I}amw<>9_.2hٌYӵfo2#@>/k5 ?l܇G| x\}uO:bmp1.`*f0Ov̻2^UW̽?r Mpr^ 8 4) =ͣ蓭+}tл1A7 xWoܱWK19A+~{ibͼb^y<lom+Wq}axsg;` ( ~<{}:4YN%Bб J?H3喜{Nkk(.6w0Vt|U#;ܩyii'{d%=~*e_\1=N"9W=:WM2ggǜw͸mb+PO"Nعu乲zK_uΉMΎ_{L!Tf|xϲ.͟(!︝!ߧ6?$b3&93 5{۫Koa$ロ<è}rqy^_@< oWF~Yk,r|׀ =VHjťng7>{H~2\c=ϸ  g1AFӗoN#fznezɞp|*zUr;X+w8^".uCb+63 噟[Qn J@wQ&f~x9sIu>ҭMyem^~~4 ?g؏"F9vovivp"upKYzٵi~{w='={bbg?2&﫛/vx=|?Ix߾3g3iAA{Q&W#/s.Wq'!q!^< ǻƔm w 9CC5{c ]ΞgU9Y=t6;kv+܁*gn9[;i~U&ի!Kޟ6xesuXr>otCS6wos}{PjdC㐪K?>a-P?\:t*>cc7<7bȳ7#O"1xR c ^ԉr6;ܾcݬm ]'bcx bԯr5J_;N쌥b̒*g:ľ01ṭC3}_{z#vߝx e&߀nj+NLu.kɈ8t'#)c ޻,cO71liη)_Xϑ}  ~{.ȯ8!⛋7mH_m 4N]d_#c-zP?j /GzH+ACH2?ޢ ;4bN\8<˼)z 8$D`I?w؎v)y'!ϙgpmpl;guQ޽{z|l'Jjy1ͱeciC.q@;w:aΝI`3̅Ԛ㝣<:Cۈ/"F\ ȟ s /؃ؠj۸[Jqg.9~پ6k%gnit< x1C)b=ۯ9g{% ._4̫A~Zr\1x_`>Bwe`CrUaY6ʾ&6Jv^dyӆT$9JG5wdtw/c{'s|cyzl_}x1VG9rVOüUx.QfCMH3nfhl,ly-bG>l$= h 'pN.WGcl3|cw9G1^o61䭻cQF"?+I';X`Y}~w= Ռrr~;}k ~>q˨}oO,3>m{V*7=(k_3E}x?Kt4n2y1g[k1:O?J<mCPo8|}Ii~X= Rs޻1^j{cLc|c^ȼsy U7qAx uks y5>]rxm/s-EXpD}o SNc|a}Bxh;V+;׵#ok|6VT+q; #3Vz# ~0v+ߡ']m φk{Pj/a{mt;{|Ii~9|3}:F.9d(wPi{ ""9$I#(;|e=eqnM7kcp_t[ٖub_:czcĘꃋݺHv>__G|&qH ț;=PX딳g{lEgWpkS-Hwց5XXB2r?=ȴ>o{R1.xkYGQ?Y7=\."O؇Q˺zj,9^>ɑ>!_r";1/g)GSӏXgul6e5(QV=96uR{'q^-2K.g=t ;;1!bne*w>3 ?Fo_c{1ou*_Q}q{+z[70-c mXCS9~oq. ,| zcszl7˝~.)~N2H;ݐt8n}]\*:𛓨tfz~2<|``sD\ 1Ve=G ݋slCΌ)eX2_ΥLJsgЃ&>y~g%+ݻ$c=]C&/tlN|oqTUUXg`yoO~>A]F\ :{K鋱61'b2uҹl'OrRuKldGXgyW;=wJֹĸ(wvKlv; Oxׅx8'JgLsVQ|N7ƘnB l:kn8Py  ?利:qL/|cg]&?٬n6 ӫzgs}@=ac.?2G{ӂsgU{\RF@eb{H8m7'NsOZG̾r|%6HXz[%MEcAqڐVb͕Y& 6a׷6$6'WeĚa_qx&lbqsk5 6dK|6k"#fo{ar1o. /;õZKƚ:ytq=tqWP?0S\W=x}Qi"j?> "?KB,y%maqa=ó{Ug!roOq %+g܅&E!e7Bޕ/n?ygr^U1={8o'֓xKA:!6>ϣ)h.W-"שυ3^szsaή셻ݓYJzv(r{b>nY HWZ/s'ڄh?pOvo[{vb{cqDyeU9mluaoGM>~Nj>',/c}[?wgoK9<}ٟ+%~M&VDe5 MUȃG!}) w!1#]"-!/xn۲wkGo1.\KbK480Op#L{ u𡳃cοuuߛғWg9U;A|nlgERߏ# #VG;gX=Z {skgz䟶~[i}#W$7gvn{B{M^@7]r  (5`_`w8|V1u|Aq\,>:m_Oanَoo9hF:TU|aLFm} 9b]!HmeW8:8%g>p@+;ٌ-Tgۓxul qޓAO`%QN=6>WpAy.bqq?ᰍ<-D^c_vA7P/~nii6KΉI漆@8>>Оq{lcSuU/Xrb6 lu1Aog8slMy]u||k=fnv+^qv|([4>㦓K}6'ocEvdz&>vcY~& ͭo62{17w1QBy{sUW'}2x-uvSYG\F|}'C3=cm??|+\ཏ>7R\p7vvㆳ#;ݮ3#}u1EQ/͏m l|{UXe&58zeHcֳl'82:QWJgqg^sWTE+ľRyA6yCs S1>l23i"6oD,zGC>U>|X|H7Ź{|ʬծvc,d{tvsbgʺ~?< _f|~8%_G=Q^lǕuֹ%~>qν(Nbv3 ܒiplv[PmWQ=݉YxnKcYr}<[ls:oyQ'z x.wbS#%|N~*?j_Ң|XzbCp[~}e]sk{+o4g3Oqṵœާ/1FXϩ iD.G'.;k2<u\ЫG4qi~{#( Lu4gɊgpw7ZW|_Dm{2z<ϗ/yϸ2Z?'}[x$}1:0"9sMΫX\)e.bLl#[kkø15=^8 Oww%*WYu[un~k^#K90J5N'몵\kYH맠WnvomZjgC,smy4;MQ^?E7;ۋ~09X>=,{_\U(7>29Ή47/ ˺>]y:|\IrW!^Xap|ޯً;{ۮ`gIa f7˘nl`;sy&}q߾~oGw^C\>o/אҔNGNÇ6 "Oa;MNc>ẪGg^䜔?XW:YJ<(CJ+ ^8Ql˦Z{Ɉr~ƲF?`yrDw~bN=χ~eFG>xq/8!G,JLKVhugw-.);nkoqփ];N"p-P_kǜm/k";{vw 8>RZ2.-6y9Π N 3,e{C2GL" sww#s5a9sFb/Ǿl+3_""S\`n+ŒcxmQOC:2 ʔqE7,BX>MYSeYn^J~79kvv<:gW>qkWݦ׊r#c߱ݹ&1Ou[ ֣>qwHX->85#pe^ϴ巬W<<ζ:ʙ׷m lb^BLYxuQ}isŹDfڷlvKqߗqgǏJ{ݣn\pK4!oAF#9~{OYb x>οo[}<|z~6$>>|p v=7Gvľ!Nx7s7A9Y}$`C_Nq7͙S)[)uB8֐GboA0E[ ,yoE#[agOľٌHhS#̨(^svUg/~ .gCE.|"n p4A }:Յxb Wo5p_z+`8Ev^P_7ŋk:7`9 8xOG3O^c8~gpWMm cй~,Эv> 6%19\8RYǤBݸم]לzċήpKc}֯]pN_6|쌯;P[|'{GM<Аc Pwߊqy :U[[PW轗 b[rUw?\;^+\ u>xrJ}9J3bsd4lbL@/`Q{ȗ*2륧eݮ<xQԽL)S:[ٲkOU8{ɗ/G#Ot!--޸[:p>|nwdO (o{<=ȏ)^ҙME\^qΉu{]@oe znX[#WsoHnqI163#,714lU@a bsɶ'3DwⳎݼۨkTk_-I^4q ޿5~m;#|,,7:˭Q_Woq~iԇ|^*:QgW:{ u& Cۜy١#m|}}(Q^mahwmTHc>2R=*vUx yqAqg oׅ8rE AՖpXG~8?wzBgVOq +n&{0&s F?:ǩj㫈+>=ȏV<ݪ ˥Wp>B &W곓b%'յ|}gS~J?uVqΚ>qMmmB~e7LH3% =P߉|k?'1c|b9Җk=N ;9_2}3r1!}ܷqgoĴZ@ t'>ӿc!>i##߼&W-B9{ 8OP\/ue5zBGd97(̸lϸC'Bc:$,Bހ37Ȍ#Z bߵӌ_Xbи , oBqgyn`}t(r֏1*Fߎ~K[X.sUPv O0/fkᷝF>~/]=Ɖ@/\ZSpr>iY>#?ʰ`;2˦r'ՠ>{){}+.cʺa컄g s\#Pۏ߈2W/L{lv!Ѿ^qvbm\ϔ|%Hs\{ ywׯwX} |lK`M+-c\ؗǶp{2Nf{T}>1C.]l<} ,1yl ZbW@2`9{, P`;.! ovP-rk+]WX/,1j~w^>Gw~sC[Aljijͬ㿆WUym+g9v ǯ}qC8)'9wA]ZwPo)[hGz$s7: }FL~.ƭ$/Qƺ qiqu6<}??TrN!-~>.pkC\Ϡ|گ#8ok>:sc,!ߋzXVw#K{õ}noux#ץHZ_ ݘv᚟8m=22ɀWk_ҵp03f4 ۣF+_q#|ӏe+IMb1ýyռO؏Xxm ma,R?:}+2lu>돿nr쯷P}cq~qcƑ} 9Sk>x7${*9k*rdu|aQ6ڴy {odG[P+Z3v }pMb=e.5?c=Sxy={ypv}NζD1.;l{bqs > x 1'gğt៭s ?]_rgMXqbM>x*w _hkk0h?c'C~N+{XM;1}ug6m>|q)ԝn7wӧ&&qzS;;֯8 !.jl+>iܰM! Uv呱i݄gEkµbX|?]%6&kpm_ƽ&'.>ṴK2=܇}xMTϕ؄1Cܣ#ksl׿Vgy_acG+Y yϿ{5\|Lp pq= ~tg$~;ק:pn9K;g 7P*s[8([?ڪSo ^rV23z$4}qC~ƜuU#/acg~ϗR,s6?)=V16dgܷ[ʷG+&'Ÿe6IE%]+>g{™-9>:8!{ŗc\Tg.›ΗoQ_cvdȖo`'ɶB'x3^H1vv?ܾQocX``XP~͏弉G=i+?e+g{ه9DaɶMvx@uz7<667 ^BY375 xJ̭õ 8fp=S̯PQ~ }1w:]1<_pxԇq -KӈU!6'E^b~Fz_A0 ~z'$يr"㸳+n/'=Qc Ӥ[ Cz~|xc_@il>58jp[Z spMKB_g\~^kb r}xvVK}>Z'^h+E:ʏ%>o㑩T_Cbo8- 9p?*<gZgӷQ 49EMc~|r7|bw4 b~i7*Qh{Ʋ[pQ҉F4\` + h&DȌ̓}̓\~W<ܿqz,ޫs-1 "3Odf{c6k6p,}Z?B'[cg6|tא}@_]ӤUp7Ң.!{G拎4JLXZzEƳ<4K<6Op_Wmz56IQ3zϡL=k~^·< 轓rD()E z7EFam;^ ޡs@o^]"RQ |ݙR;};kgV1]ߋMK]a2nLB1taӻJbl ?9tz|n*e󎟀߸dsҴjMg`NԬg}bD4uyǬw+нqD;b`#tDގ(wHe8#> ϑsmt-{Q~nD^5vd|o߄=.*5&0NXd}Uo#83y$q zONwMͽFᐳs7X}ؤc2bk#`o[lj('-`xy<3p<Ȏ '1=]Zf2!oпhk4Sv019\oBkx / 8*ܨz|k}Wg]qSSOzGs/?7E݁G7O!S6 *s~Yf+a|~ez< y{=1xmz؅u8Y=hDp`xZU\>7Ʌ|Rܧp<YkEqn x><#qʓ]t<\wj|S|7Kjc_A6C޶_([K|Neb /T,{n˹N GؗqAꟴb+8W `-^Wi:$$#_Fm_[xԪ4q.}.@6N^uo]MpHD'F{N_PW`ny_ {ϴlMsƝ9}ٳ%8g+mjNyV@/^ ,|Km^ykK_IG n͵rn?|On`QK| zr}]99\% c-T|Pb=!Ky26zVV$ɻc]]*tlo w:ݾ/пx!gX` {@ j]%2UavzXb eN<ʭ+bϙf挸IL@̤?tC} X/?+ۣ9he$2-CF&`ca Cq}n$ b)vrM5uy\5 6Ɖ&~jS(񇯠s,劽#~]s -;ABvW&[E^L+<]53=X鈯8ﵚ߄V?VQo4&qS9W7J}a)A%~gψ_)0w/2 ۛMgV*3Bo:f+|G~|Xb|~Zc&9Z`N"s%&0zН_0/ ;dt߿U溟@> _6 jYj<2)c}yA1#ya3{;hګ8SZUkՃZ}gOui ý7Rt~ By 17Kl:}nM'nY%BW{T1ߥ^bS|=$`DR.n6ƜH ~ dz\ڏ$yKiemA]kZam&:)emv>}5=̭)Ƚ6 mO|69}N@>/}wB~1 9\w Xukrl.x\c(PgjzV箐V NV=z(h B˸'n Kfa@RߡOlgQ@8` 2PnZoYaWu6q؍C] ĿHc8s.\*n5m̟aV@V@^f8Ѷ#ּ)X׈x;'N>k.WF+{;>an#. hqm'Ka-dbʁՉk+;Ě]c =F3~4c5/9tIx*E}Շz*<N~4&u^n?u;1EEqͳ)<<*ył۳׽ N̫:vXPm0 Ch{'bŐˎڸN-d %:#sJoN_8 9l~=Gk+gwIV7ڃ|y ~; iz^ƹ}`3ucNKIh_tH!G%亮ؿW> q[j VkJF:}Q2[c3Xˑ )A`quD2qWIĘ#-1\ɬ%꠶nyr똗(kڠ9#YjR)-r5ULe1k+J06E]v;g{紽݋3nh2Хx |MC<ԩc|jLN,jN*fmjsz.u4c}s3y 0>5; @ij?;v:qM`7kquCmkwW0gqF%N1 㤙pS` 5L'^uK2'wD>'(~)E=&l4ӌ5zd|#uYAOA`}B 'mƞ "R?(4c]_g .t5.Rg:EM -Qqܿoc~ta = ^eO7?$I>eDS\VD_j]Aɴ%>_6ʚ̗ccvQr/zeVڹk<|}\.[~nűkEBę%k!lk2ޗdm}FCycqh^[ć[5ϼwՈ.k_[J-*|0FEW.Z1Ú:5q5fҗzN^}˹*z:V#VS&ZBo8ޞyV8@>gf *}6 6~S=#F+JO[9v{?ȕpӵ=E" 6~-#6,6s(;<";3J~uzR?"nױ45CṂfMwŹ^{$w+m\\/j9|yտ}1O~w `wbn?ry&)?@rrPfϛڂZɑNC"{W[ݞ93^ƺ CME xV-kyKBwy2 ; 뒓P$VGA6dHJ4HtF\7o:D0k\XMJv+0mqϵ8!uF解&'TSm焺v޺k`݆ۄ)%M1,yk'֘KcoE^)ӼՍ;zYꙄ ?gD?)>CN5\;>a8|_ 5s\"ڏʥgzZ @ ү=^zNtT^t0o3ܨAep^s=1oo2G|<>(q./z Ggy\$&a{ T >.JRo=59\%M" M[A<ƘNůLzG o5mȣ]ojP=Gk6crWC?X06y_96&4#| Ck{1_6'3Ԍ%|vC{6f^ͳxr4l[ѯ/R_T| ?u:)2x6>73ϗ.yAC_WUy_UWOKn9;'1%)z]cQ<>k;w!a~$`9ID_yhroK%q[>߼wr 苷O*xraAcx2]d13mZqsNlr NI_&kY'\יqg(Dz.091%.'Xd)瀃'`)KRy ۄL/pߧp%i5}dz70<#7k]]s$lS&t l"!=ʟFoW6sK/4רc I%z>Uuv=sν[O(b4h1wv.O~Yc12k?Xץ4>wT36vkoo]2~0!W }<3]*k3]^be\91>$5ՎUʯ΢V̧2 (?Uhu OE愎dHMZ./a_嫋|ć+~g5tkٓYq+ ֻHWbczUp]^hopƍ8 :+A;y,O6Le2|?fWj[^@ -sȤLy]x9hOיΚs^v=E$S.NcgÃ&\[b_͓ȷn})Ajul1>!Jz8 ;hKȹxOYEw?fZk5z3Ns7q[ Dɾe[+ \=i0W跡ݶ~u̘یoNIzĵJ2XN~'(#`}B Vn'"WNգW5/[=qOeorcͽ818f@\!@#bgk1ԥlsY"Zߪah[v4kx~'4vL<wC%Eo*VSD^\Ǝ}_~m>ib>9G\iZ~-60&'O=kz>5H50Yz#/k[5K.(9o~Cus%fs>iq4,A8@,e20|}0 $qRU76B+_w Q'4D|bmu6` tۇ'dWlK~Nps INQ`\ ĸd۲˘vdk5RS̋ %ל}yn>Ӓs~lR%/2kK.V0F8r֓~#%#Ƈѳx3+zaԩhWQ3g_`ܞ7߯0Djxң2ɼI?zc?H<ʵE. \GX*+QΓͱ0c["ơL+Sn4=|eS{dfgɱ "\W'H76El<^ocAceIC|̫ Ɯ9Y.y'@k?)0V[J_yk6(פQ+y@}GUJw[?rk:R>}O9 >HoC<$f̹`=>m+{ywO@51kW^1X"1za, ͪ H~cisݩ+^3zA-[b}RNWBԭK5hL*>`α1sy=y̺P|u2'rArB0oE%!b*މ%OEyrۋ=u8yru׳A_ga[1T+7595JՊ໸yܿG|'άp'[OO2 Y,Y?(01+|3a;,8t徨0&fz݌ \rg-kf~A7:{rUF5bK`Iܛ}lvI Vz*I?.٘5ĵPj/׮"ښv\1B'Q_vzȫs^B$wj>cSOzow'6dGNś'+ꡓ/q~}\+aT^{751DmA˲ v~)F#"ة[b&NP,y-:*Y}{bO\nM+7d ~Z-+0O]cb;f2LJP~$jEXd#Ke8g[CThWr(f=W_MdmUKV!>މ|hסS֤=Mr0e 1~ko['vױ$361t|,?^oB Tlmf.{mpA_bƵ½uZ}KZMi׵1 z c~Kq=[ӣܸo[2#fL,pN/=-T.ԢJ ߅#m=bB>G!~zI52D[,ѢoX\rƮEK+g丰ݏ=GY+a<Z}= <{ w|wk{*DcW?=ݬBkyQ0d﨟0.la cgSJmR=ً9 <ЃښMɰW$/>QDpju#3>MyzkOc@Kb,)CS>eNGi714`$"?ٺ7ubo~cr:$;rK[&XO׊.bcmop~GL`t~!>-z:^4lˠXmS}q2C+Jh{XGuRc[lIw>?s >Y҃cA=EE=#-ycV n}SxtUB3cS)x`}+%k C}Iѥ}_y!~!bEeєI qs%5 }u ;YR;8I:-⤎SVӲ=~j:/&PIRȧl g&Y `>tȳM*=]/kk{9x:a_NH~^K+_8̙/ؚ")SanRR,@^[:>tV sEMN)=vV#W1^\gzH=M[`'snLD}(c ]ԭ͚O\ llY_Ɡ?D`CGv|MSD9]E ~Z*x">l}y"삥6[|>4 yQ|8#*1aCtZ_SӨN^Ef,b" Z4k5fmzGzv%z{|rUq>^VnH밲`t}bth伜@m4k 3أj&_jQ|3e7:awXEF[%/=L΃`{AC/o?15B .rc8xLOaLkNH8ȃk肎^q'~V{+6ﲾ~#jjRu[rZ-{]'T?~f5<-Y ZfoA|b xa2Ďe r(b}5#W[1fϓ1~at vB.d.ky} }`}}\<;;k^/~mЪGc~:wgzq!tyrj r#Fƺ45^:%ׇE9[j4u~Dۄ>H_c ?nsK?Db al-NAe?>=͚>й{0}^g78`DxpaWt]Z^N,P~RNjӜވ>Wk_@:A8X YXXϣygw>#Tn> =O'myMsaΰmH}1}@>/o8kS/{x=VОqjH NCԋjꝺ8'(׶^dqcZ}&-86`P#s7_Lxb۸cg3kEtj\]+2Ix<4CO}q|_q w7^SOc؛;SX_ayeT#ϗ}6v`+mUscX;a\.ux5=$(?[w=uؾ? ϝ)e<\ MS\=t(3Ys4$kQ~o+  9%s=r8a+!KgQ#I}gJյuժ:z:ra GޤMC?ˋw dIyg'a pmq֪WZCKPbI_SϪ O .1͋IҏKE|~ /(C{gicp͓O('m1'O_I?-La1uvA%CCގJf]u3g/M=>\ X{Q7jVUgaoiGN{Rב8hz]n?'Tz~W#_] ۤz{AyN1ȹfV\;PXϲK-zcJ!m/R/]mi{ 曱~b$:O2˕bcp` |۷Z5dމ}9%f BwO6s3 Gxt>ߙZ-s]nc{GgP8u[h zr764]%@d{oC'i,}M\w9/H[v } |aIGs{?Z֪>JBr{,;7$o`1LqV哺'/k{3ag̋^jg~zW:`+ < FQV={suj)ܺe伓iA?h( 9xaZ1[`i5?k5ކx[-֣2IoGԉ&Ky+6m,2M)zjyV譲։qAm~Qs59 t-ߝAs[B1}ʭs0Z#%0^6kၭcK]qɩD`g BLJ|߷鞋xу~is{/̋Wށw6rOl<~We;E<=1r,>A.Gh5NcXJ[q|x 3<9\-ޙlCڨ/ʭikcyx SRg}s5d$bG]tZ=V_.kw sSgHrR9p-ާJwqۤ\NNX r}G{Y%^,~Ɵ|nSX2}Ţ {84kX1Ly)1N`Nzk;:|ă Վi/yq1g>':PX=,xL'/K|WU\/{_Uv/(T3z>2]\(5U>M8m257\=V_Ci!<>v{))W'_1 X;m^|hBz^~ #xnHp~SMcNje|@`&~h9\=>s,BƘx~ !&Eɐw>I~:͈Vkw  VOv>A#m @>VCeTI^!M|ܯFma~>|1^X0aL8~Ս,'kB$D,]\;JamMq$>V8dw8WF[;sH[;Ojރ,?㾄^>0l[^~ 眣Oa2:D~S?)0Ś8n :C9|.W|쏴v?c3}woBƎ?̼ڞuE80,YDZ]GMIq Q7Z pGiԍ|">Ƙ5Gr Z^Wx9:-o5j2^~/ȿ}b~ ߆`Ut]|$=W=Ȃ;qJ#.R(1p~ݨVB:=-a!sGxY f[zƏ^uJb_,lisc ߼6_֮!|뽬>Vq oT0l@C?hs{HھQ=$멳Aye` E{A\x.8~,G'6Ck#Ɩ%o>y:^]s\]1'y5E 9>~kBjҹԀ3~3 aNjWg帹OT)6p`6H'c{"l6sp>[!nXj$QAF{aǰs9,ns1I, /S_b2Xz4U;שp>>`A#`calCY7!;dlPA@ULD3]M/&>W[$S5F-QK)˧Uzѯˍt뉈dbg V)yôKcGZޅٵm7 Nw d#pמĹp7>c|lk˗l3Ƕ6*X@'Txw:@d sA`A/pzCG]Hl}ԡ'A =]4}g"ƾW_?fm Dp??My~Eb}\\SmM,)|a,#ew/P~VNVK*g|[r +d ޘÒUW~{m[#R׼ U>DasƖ9aw[LF]g[3-fiF|wh <ތQ'qϋ9G!MoJm(}}vӬ86-IhB5y嚥@|OƲϛðawcmb7j`w16-| &J 0Es5K g؁ @AhG^輋1?$W1. ݕA41G6b(5[ ̩]͹&n 7qq]0Ӷ(X'[p o~ŚyV(ʥcZX/3;Ze h7b7W'Mܧ$=o\ 9J qrh/MƘs[&}ؓ# uN"h k2u ~؁ް5<:hQIdr[l??:?%5X}KV4Ч!qUV1U(u0q:A3qe̟#`-0)\'R?t&k;`_6C i>x9m60&s[:l>ߩ:&#}sy:sIWPK\C 5b{oNW^Cv%1;L?[}rv:dth*+9 ;zx#S*n3xk%SML N3#ۤ7=59sgMbEoۻ\>ԯ Y]yJe/y~za3|@`nD*}Ţku>)%}$;]'k:7Wd{^{+A@nxĺWF`?wL,>{Dys~ t)}pϡ zBI|~oܩV=Ӫ'+_~z hw"FU)N X'$hiR|1ܖa?MbޘqTr%}5[a}.1*}9P`cAEyzU;i7y6d|!]d]^/ZIzgGڬ|j[ j*>Y5Ի.~+Ol=y0R)R|Wm\á.' iuo>xvk5f1pwM`u¹G\%>> _%k9{~ |R͞hυjRgE鲽R\?!2Tcbg`Dz+#ab ;7%ި[5~# qOMzAnL}h.t`O_ff%CmYۛ.5~S/I:9CcO ̳5lh+N +uY]r1/K:Y4 (B>k-3I5|yܾiEasDcr Wz06v`=?1^M'ܽ y{_WxSt֜\>Kڢ'3wcB#jV[՘qX1.Gَs<Āc7nc^"``j]ݏtG&r.?)Y}ڛEYk(1> 1C>ً3f=JObFS]KbC݃c])qץ~+6 c E^7=\hwӧ}E#ExDu8]~;\eϪx }`4-=80 [G8Jjl`34]`׼Kf/+zx?I.QƓ]VVqWu ʗ3OZ]eY]!'by@rk~P֒ W{CwGt!ؔ9_W(j8Uw/~w :[Yh ~$tYxhl8!L2y0d6ﬞ0#vwf@/e_5L tj<%?l?W]SߣXՠU 0+6?ԑ\[5[,=|SbMxK hѪFx}CO?+p5shUٵ z@9tW%w,7}!˥)냄[$Vy_`^!qB gBl\,@ήYkY\pd8ξNoX`O LY#Z-{#Za~ lYuWq8{oB.̚l{H?t+`vv%+}X2pn ƒWb[2zGfuPwqm`$l1w]ۂ"#MuDbWs ?F{DDl ls979l/qWI|wzaGo=A?8>Ȼr{JS5JUG9l|}P iex])'6dY48 zߺ^Z@/tC+01'mfOwq@*C"<]=}p'z |=@*tc~05s4!c[8/W>0kƽm*c"*(!kI]%f 61Gvkw|Rp\aWs$5S5 S2.=k$%Q428K]ЅJj k B.9wr\ۜ?3/71tXeb_碸N?ӈk@7/g+{?Cxtl'.z\k X.{ ݸt< { vvǁUK&.cF8zRg4src|Ɉ8ok0w8iLw -¦h+auLf#ox1WubӒGls Ok< &mm@ B'lY;ĠX✭-~gu\Ȣlxbn{isLc]:xِ={`M~a9db 1}3Wu0s$Ԫ"OO􂽘9nUcjUV ]9dnr>x}El }=xq-uZ`qH3{5vۏ"I JWnf]]wҋu65і V=:2f Z4׼ *ףUU30 #=^wB贅 RK1 3O{S1Cc>R{ɩ3e֧A&CX-:M?czͼ3ղUWix gG{U ,h>i ϔ1=-/\?h[~4Gf0%)b{tU[ܾo2BX >ijlxCt16ek$mT o w l}r..*<0{ q:e 3`~ . ;%;ZGi^/h6V5Gb"U3)Gq߶G3\#|bM n1:OAF-~E; Txj<0`_@?쭋} "~BOBVsB\=*7ϔ~gƀqWI\ x}o#Y\N]bLr}&c½ȐqdC*_eKLazyrU 8@7qܛc%c>lOķC<]EEo@M'vb:ΗQG@?hWz )Pn*xDājjYObf/h8}8oөΘ `&Ko_?V?PYGI.ZHę^Ïawoip]_x03UG;W6hLQn?p󰅏Ro}1@`nd8oNu?M[觏DZaUz;p.⍍F:"{95dy ;[Z W3w|_k&VC4?wg ںƿe՛༶n:YymePV\Oa7{AfqC &}Sr9}97#_֎sNf&2I$m`%faW.؁雴 `C2LeIuu+c!+7cۻ4$q +'6$f;QQ1 ~BRŮ_Dso,ɷg,0iɔxdܭac Ύ/f/V{C%^p{Ŏ#?)n=qSeC>u|j8#utDz(wGNV/iUPꌏ¶`Ol c^L,w؞5?^oϓăb3~[scfAb9sZqo%묑Df.:0Ql*;],1ij-D/a={#+|݇Lc걎=8k!/T_|e=4q_[*5 bK?wJwYI9|)tjI/s@] oAWu[0.uloVU76WX%oƌ\T|^ak@jUJl"u3{\ʔ\Id֍(֗p''-Izh:ڥljg\;dwJ^0"qA3i:'Y9Z֍W#peCiU@IO&5;ɫ'&F0G9n kG2pd /M:{˙+WHELKea[>kؾf53/Snh{O1N%8@>wjГ1u`@;$e(>c#nQW`MjԒ>tOS%A_'Q3:dxVvwtp` 5JLTaNA|V u>=eG~c;y2'R(v!s/|O(ۇ{'zO ڗY'0[8|!LٽOAm{3_KN-Zl*my[wEr )7rVbIFTN+tlkh/`̻X]+=q߻A +e߂.#veo ]$1Ji6|ZՐ^S=X3dU7TiC~!{}W7ZyZ}x[_k'©6ɾ5ÿ>ӈquq|cM BǏAYMAl$R@^rX@q97wryPyjѧn@|ue~]그#v!޲N=#KiU~nE8C{TR!أI<Ε sgS[PՈib4Kt(R_׀w0$d[>MTyo1}CD|]$%gDhT`K`%| j#N/ei3,짍+IuT)Ku3MJ>A+j˴&@GȯVRtr%(ãi“kMC luZKL*T3@_|H5Ю8D_D}+N.IR~dc#_:)6 6ϖ GaOY m|]`xiM-R!Etztq\V\YgB  ì(Ev+5Ģ5gK"AB@#Gm$|/C3y#skا4MrZ5#UFb6xt kdR{L=vUnιGl+%:k4\H(㚏?3KRyr?[&n$G^d_MAG1 fUZ_ܓZJ5Jy h' eJu`&agg5b<8wցg ]RʗkP8MdZv{%("}D}{e&dr~t]= cH=x"=Q)10x1'^wQM/=}@r1p r~55(߿n BL'Ac`ƃ2B;9ҟ5q $%H%Ŏρ{Y`ׇ`Jk}!{z >`DK1%tc8|Y*K$)U_9^M/x^(G6Qhb~$%GWG\Ȍ9ۜ=ilIJo2~? W{O}$%)IIJR$%)IIJR$%)IIJR$%)IIuP/Uogϴ7i>R;#Y?ļ/ՙ)"Sx%} }kq;U>W1M}&2Z9J=bs|"s|oʉ v0006866666662 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p(8HX`~8XV~ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@666_HmH nH sH tH D`D Normal*$CJ_HaJmH sH tHZ@Z F Heading 1$<@&5CJ KH OJQJ\^JaJ V V  Heading 2  & F@&OJQJCJ$5PJ ^JaJ$\V@ V  Heading 3  & F@&OJQJCJ5PJ ^JaJ\JJ . Heading 4$<@&5CJ\aJDA`D Default Paragraph FontVi@V  Table Normal :V 44 la (k (No List ./. WW8Num4z0^J./. WW8Num5z0^J./. WW8Num6z0^J./!. WW8Num7z0^J./1. WW8Num9z0^J4/A4 WW8Num11z0OJQJ0/Q0 WW8Num12z0^J4/a4 WW8Num13z0OJQJ4/q4 WW8Num14z0OJQJ4/4 WW8Num15z0OJQJ0/0 WW8Num16z0^J0/0 WW8Num17z0^J0/0 WW8Num18z0^J4/4 WW8Num18z1OJQJ4/4 WW8Num18z2OJQJ4/4 WW8Num18z3OJQJ4/4 WW8Num20z0OJQJ4/4 WW8Num21z0OJQJ4/4 WW8Num22z0OJQJ0/!0 WW8Num23z0^J4/14 WW8Num24z0OJQJ4/A4 WW8Num25z0OJQJ0/Q0 WW8Num26z0^J0/a0 WW8Num28z0^J0/q0 WW8Num29z0^J0/0 WW8Num30z0^J0/0 WW8Num31z0^J4/4 WW8Num32z0OJQJ8/8 WW8Num32z1 OJQJ^JJ/J Absatz-Standardschriftart./. WW8Num3z0^J./. WW8Num8z0^J0/0 WW8Num10z0^J4/4 WW8Num17z1OJQJ4/4 WW8Num17z2OJQJ4/!4 WW8Num17z3OJQJ4/14 WW8Num19z0OJQJ0/A0 WW8Num27z0^J4/Q4 WW8Num31z1OJQJP/aP WW-Absatz-StandardschriftartR/qR WW-Absatz-Standardschriftart1./. WW8Num2z0^J4/4 WW8Num16z1OJQJ4/4 WW8Num16z2OJQJ4/4 WW8Num16z3OJQJT/T WW-Absatz-Standardschriftart112/2 WW8Num3z1OJQJ2/2 WW8Num3z2OJQJ2/2 WW8Num3z3OJQJ2/2 WW8Num4z1OJQJ2/2 WW8Num4z2OJQJ2/!2 WW8Num4z3OJQJ2/12 WW8Num5z1OJQJ2/A2 WW8Num5z2OJQJ2/Q2 WW8Num5z3OJQJ2/a2 WW8Num6z1OJQJ2/q2 WW8Num6z2OJQJ2/2 WW8Num6z3OJQJ2/2 WW8Num8z1OJQJ2/2 WW8Num8z2OJQJ2/2 WW8Num8z3OJQJ4/4 WW8Num10z1OJQJ4/4 WW8Num10z2OJQJ4/4 WW8Num10z3OJQJ8/8 WW8Num11z1 OJQJ^J4/4 WW8Num11z2OJQJ4/4 WW8Num12z1OJQJ4/!4 WW8Num12z2OJQJ4/14 WW8Num12z3OJQJ8/A8 WW8Num13z1 OJQJ^J4/Q4 WW8Num13z2OJQJ8/a8 WW8Num14z1 OJQJ^J4/q4 WW8Num14z2OJQJ8/8 WW8Num15z1 OJQJ^J4/4 WW8Num15z2OJQJ4/4 WW8Num17z4OJQJ8/8 WW8Num20z1 OJQJ^J4/4 WW8Num20z2OJQJ8/8 WW8Num21z1 OJQJ^J4/4 WW8Num21z2OJQJ8/8 WW8Num22z1 OJQJ^J4/4 WW8Num22z2OJQJ4/4 WW8Num23z1OJQJ4/!4 WW8Num23z2OJQJ4/14 WW8Num23z3OJQJ8/A8 WW8Num24z1 OJQJ^J4/Q4 WW8Num24z2OJQJ8/a8 WW8Num25z1 OJQJ^J4/q4 WW8Num25z2OJQJ4/4 WW8Num28z1OJQJ4/4 WW8Num28z2OJQJ4/4 WW8Num28z3OJQJ4/4 WW8Num29z1OJQJ4/4 WW8Num29z2OJQJ4/4 WW8Num29z3OJQJ4/4 WW8Num30z1OJQJ4/4 WW8Num30z2OJQJ4/4 WW8Num30z3OJQJ4/4 WW8Num31z2OJQJ4/!4 WW8Num31z3OJQJ4/14 WW8Num32z2OJQJDA AD Default Paragraph Font6U`Q6 Hyperlink >*B*ph(W a( Strong5FV qF FollowedHyperlink >*B* ph2/2 Bullets OJPJQJ.X`. Emphasis6]./. RTF_Num 2 1./. RTF_Num 2 2./. RTF_Num 2 3./. RTF_Num 2 4./. RTF_Num 2 5./. RTF_Num 2 6./. RTF_Num 2 7./. RTF_Num 2 8,/!, Definition&/1& CITE6]4/A4 CODECJOJPJQJaJFV QF FollowedHyperlink >*B* phB/aB Keyboard5CJOJPJQJ\aJ0/q0 Sample OJPJQJ@/@ TypewriterCJOJPJQJaJ./. Variable6]:/: HTML Markup <B*ph*/* Comment<./. RTF_Num 3 1./. RTF_Num 3 2./. RTF_Num 3 3./. RTF_Num 3 4./ . RTF_Num 3 5./ . RTF_Num 3 6./! . RTF_Num 3 7./1 . RTF_Num 3 8./A . RTF_Num 4 1./Q . RTF_Num 4 2./a . RTF_Num 4 3./q . RTF_Num 4 4./ . RTF_Num 4 5./ . RTF_Num 4 6./ . RTF_Num 4 7./ . RTF_Num 4 8NO N Heading x$OJQJCJPJ ^JaJ6B 6 Body Text x$/ $ List8"8 CaptionCJ5aJ\* * Index $00 H4 dd$5<" < Table Contents $F! 2 F Table Heading $a$ $5\BR B Definition Term NB N Definition List^h]`<< H1 $ & FCJ05KHaJ0\88 H2 $ & FCJ$5aJ$\<< H3$ & F@&CJ5aJ\<< H5$ & F@&CJ5aJ\<< H6$ & F@&CJ5aJ\88 Address 6]<< Blockquote^h]h`vv Preformatted0 # ~= z9!v%OJQJCJPJaJ]  z-Bottom of Form"$$d*$1$7$Na$'<CJOJPJQJ_HaJmH sH tH~\ ~ z-Top of Form"$&d*$1$7$Pa$'<CJOJPJQJ_HaJmH sH tHJ^@ J b Normal (Web)dd*$[$\$tH * * F highlightN" N w*articledetailsdd*$[$\$tH *1 * w* maintitleVoB V Default 7$8$H$!B*CJ_HaJmH phsH tH 4 @R 4  0Footer !.)@a .  Page Number>Or > /Lauthordd*$[$\$tH <c < *[HTML Definition6]: : .paradd*$[$\$tH B' B `V0Comment ReferenceCJaJ8 8 `V0 Comment TextKHJ/ J `V0Comment Text CharCJKHaJtHH H `V Balloon TextCJOJQJ^JaJR/ R `VBalloon Text CharCJOJQJ^JaJtHLj L iDfComment Subject5CJKH\aJV/ V iDfComment Subject Char5CJKH\aJtH4 4 Header H$:/! :  Header Char CJaJtH:/1 : 0 Footer Char CJaJtHZOB Z y"vbulletindent11dP*$^PJtH PK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭VGRU1a$N% ʣꂣKЛjVkUDRKQj/dR*SxMPsʧJ5$4vq^WCʽ D{>̳`3REB=꽻Ut Qy@֐\.X7<:+& 0h @>nƭBVqu ѡ{5kP?O&Cנ Aw0kPo۵(h[5($=CVs]mY2zw`nKDC]j%KXK 'P@$I=Y%C%gx'$!V(ekڤք'Qt!x7xbJ7 o߼W_y|nʒ;Fido/_1z/L?>o_;9:33`=—S,FĔ觑@)R8elmEv|!ո/,Ә%qh|'1:`ij.̳u'k CZ^WcK0'E8S߱sˮdΙ`K}A"NșM1I/AeހQתGF@A~eh-QR9C 5 ~d"9 0exp<^!͸~J7䒜t L䈝c\)Ic8E&]Sf~@Aw?'r3Ȱ&2@7k}̬naWJ}N1XGVh`L%Z`=`VKb*X=z%"sI<&n| .qc:?7/N<Z*`]u-]e|aѸ¾|mH{m3CԚ .ÕnAr)[;-ݑ$$`:Ʊ>NVl%kv:Ns _OuCX=mO4m's߸d|0n;pt2e}:zOrgI( 'B='8\L`"Ǚ 4F+8JI$rՑVLvVxNN";fVYx-,JfV<+k>hP!aLfh:HHX WQXt,:JU{,Z BpB)sֻڙӇiE4(=U\.O. +x"aMB[F7x"ytѫиK-zz>F>75eo5C9Z%c7ܼ%6M2ˊ 9B" N "1(IzZ~>Yr]H+9pd\4n(Kg\V$=]B,lוDA=eX)Ly5ot e㈮bW3gp : j$/g*QjZTa!e9#i5*j5ö fE`514g{7vnO(^ ,j~V9;kvv"adV݊oTAn7jah+y^@ARhW.GMuO "/e5[s󿬅`Z'WfPt~f}kA'0z|>ܙ|Uw{@՘tAm'`4T֠2j ۣhvWwA9 ZNU+Awvhv36V`^PK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!g theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK]  3 KET&7*+M-0>5R689=(@BAnCE`GIK3MOSUWY[H^`bOf^hkmoUrwy{|}[+P0HGƬ~~\^_acdfgijlmnptuwxyz{|~:ak-+ ,7,L,0(@IfKbP[{`ell[sP}zDŽ׉^|~]`behkoqrsv}CCDqqreވ4{~ ڋYcf9|)\ޓny|!),ir| 'gќ.|66} Ơ#i15ALOϤ٤ܤ]hk{aXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX /1!!@ @H 0(  B(    ^0e0e.@`T`T`T`T"? B S  ?m: _Hlt266386346 _Hlt266373682 _Hlt350871343qߟn@@@q~j.JNP >FG:;jkTU]^HIl""""""" # #### #+#,#6#:#@#A#K#N#$$B$'o(q(Y)Z)^)_)))))(*)*****++,T,`,b,--L-N-^-_--------- . . ....//)/00001y1z11111U2V222H3J3333333/434R4S4u4v4444455S5T5a5c5555.7D7E7O7P7u7w77777777778E8F899~999>>RRRR6ZZZU[[ \ \O]P]W]X]n]o]]]]]^^[^RbSbTbUbWbbbbbbbWcXccccd#d|ggggggggg;iNiOirisi"n8n9nJnKnLnNnnnnnPpQpSpTpppppqq#q$qqqrr rrrG|K||||}}}}V~W~hrt4؀܀ Ѕх -fIJTUst݈y:|Ï<>PQnoܐݐikovzSWX\sy =AhМ/|ԝܝФ֤|CK*,-/02356>A\ ,)*A\)*A\(ŀ     H7 *,Y&stL$6 r?F#^fq}dXz5nJtj.RQ"Q~(ޒ}-p9x&|ik2H` {Er}@N7FTjB{LZ3.LήاeT"Mޒ<~Q|QP(]<>`Dr~O.fzE[omI| f ^`OJQJo( 8^8`OJQJo(^`OJQJ^Jo(o  p^ `OJQJo(  @ ^ `OJQJo( x^x`OJQJo(H^H`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(P^`P@@^@`0^`0``^``^`^`^``^``00^0`P^`P@@^@`0^`0``^``^`^`^``^``00^0`^`. ^`OJQJ^J^`OJQJ^`OJQJ^`OJQJ^`OJQJ^`OJQJ^`OJQJ^`OJQJHH^H`OJQJ^`. ^`OJQJ^J^`OJQJ 88^8`OJQJ^J% ^`OJQJ^J%^`OJQJ pp^p`OJQJ^J%   ^ `OJQJ^J%@ @ ^@ `OJQJ   ^ `OJQJ^J% ^`OJQJ^J%h ^`hH.h ^`hH.h pLp^p`LhH.h @ @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PLP^P`LhH.h ^`hH.h ^`hH.h pL^p`LhH.h @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PL^P`LhH. @^@`o(hH. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.h 8^8`hH.h ^`hH.h  L^ `LhH.h  ^ `hH.h x^x`hH.h HL^H`LhH.h ^`hH.h ^`hH.h L^`LhH.^`o(. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.8^8`o(. ^`hH.  L^ `LhH.  ^ `hH. x^x`hH. HL^H`LhH. ^`hH. ^`hH. L^`LhH.h^`OJQJo(hHh^`OJQJo(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJQJo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJo(hHohP^P`OJQJo(hH P^`Po(hH. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.h^`OJQJo(hHhp^p`OJQJo(hHoh@ ^@ `OJQJo(hHh^`OJQJo(hHh^`OJQJo(hHoh^`OJQJo(hHh^`OJQJo(hHhP^P`OJQJo(hHoh ^ `OJQJo(hHh ^`hH.h ^`hH.h pLp^p`LhH.h @ @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PLP^P`LhH.h ^`hH.h  ^ `hH.h  L^ `LhH.h x^x`hH.h H^H`hH.h L^`LhH.h ^`hH.h ^`hH.h L^`LhH. h^h`o(hH. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.^`o(.  ^ `hH.  L^ `LhH. x^x`hH. H^H`hH. L^`LhH. ^`hH. ^`hH. L^`LhH.^`CJo(. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.8^8`o(. ^`hH.  L^ `LhH.  ^ `hH. x^x`hH. HL^H`LhH. ^`hH. ^`hH. L^`LhH.^`o(.  ^ `hH.  L^ `LhH. x^x`hH. H^H`hH. L^`LhH. ^`hH. ^`hH. L^`LhH.h ^`hH.h ^`hH.h pLp^p`LhH.h @ @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PLP^P`LhH.0^`0CJaJo(hH. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.h^`OJQJo(hHh^`OJQJo(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJQJo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJo(hHohP^P`OJQJo(hH^`CJOJQJo(^`CJOJQJo(opp^p`CJOJQJo(@ @ ^@ `CJOJQJo(^`CJOJQJo(^`CJOJQJo(^`CJOJQJo(^`CJOJQJo(PP^P`CJOJQJo(h^`56hH.h ^`hH.h pLp^p`LhH.h @ @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PLP^P`LhH.^`OJQJo(hHpp^p`OJQJ^Jo(hHo@ @ ^@ `OJQJo(hH^`OJQJo(hH^`OJQJ^Jo(hHo^`OJQJo(hH^`OJQJo(hHPP^P`OJQJ^Jo(hHo  ^ `OJQJo(hH ^`CJaJo(. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.^`o(. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH. ~O.fH7 <>`eT"M],Yr}- {E.LB{L}~(Q"Qtj#st5n|ik2I|<~Q7F[o(WW8Num2WW8Num3WW8Num12WW8Num13WW8Num14WW8Num15WW8Num20WW8Num21WW8Num22WW8Num24WW8Num25WW8Num27WW8Num31WW8Num32(                                             6O                           ֺ        B0                 P@D                 0                                  R!()6v,a>u(c|**Me~o-",P~6S4a5woSoS_ h1I$ a] > ~02]T fE,gq^ O/Jq  K]mhe R!(_O 4W .%= 8_~#9o|d^nO/:3C3Zpmhy4FGhv,"S?SO*[U@4= *ina]co:Ih3Zs7gST4@y f}}w379QJm'KZ&=59E5!i#!-9$bg1"I23=Mp"i 1F~#r B $9&G%|07T%01Tw]%|0.%@`\9&cnj (N| 0J'*Be-c|*--+MyF ,==IaO-c|*Be-e$O-p;Z-w5 /s~0||0a Ih18_z2I23x>{*3c|*m4W ~4c|*GJ5B vE537GU_8hA8C`5>9&dl9p;6d{_x>Ngy$?LkPD?"S?$?-?GU_8ST4@i 1FG@V^:Bc|*NszC59:3C4CCMe4C_ A\D6d<G E7T%9OC XW];R+X_O s*Yi#!`>ZmJvNf<[s@`\!=v^Z-{_z2C`j (S4a!|n{?v`ar tpaUe<-9$bRCVb`>Z*;cGJ5Rd&d9e8#IMes*Y ec|*fE,g:w]Gg-+mg-?Hho|FGhu@4@vO/7/LX.GV~JBNs-M%%;zMhS."9+CF+k~ (-4g}MNa_y2b,b)3i) o6?An*3i %=<umg("]"UtCQ{rv?P!=oFE5Tf6}ILz*[f9vQ W CH=bH# p&yYE y>*,@d !5`5a55@(T@j@@@UnknownG.Cx Times New Roman5Symbol3. *Cx Arial7. [ @Verdana?ArialNarrow_TimesNewRomanPSMTMS MinchoEyPHelvetica Neue7@Cambria7.@CalibriOHelvetica-CondensedO.  k9Lucida Sans UnicodeG=  jMS Mincho-3 fgILatin725BT-RomanI. ??Arial Unicode MS;Wingdings?= *Cx Courier New] OpenSymbolTimes New RomanU  PLucida GrandeSegoe UIC.,{ @Calibri LightA$BCambria Math"hjS'jS'J'g, X<. X<!4ҭխ 2qP$PM!xx ,KHuman Immunodeficiency Virus and Acquired Immune Deficiency Syndrome (AIDS)Raymond.Lengel Doug Lawrence(                           ! " # $ % & ' Oh+'00 HT t   LHuman Immunodeficiency Virus and Acquired Immune Deficiency Syndrome (AIDS)Raymond.Lengel Normal.dotmDoug Lawrence2Microsoft Office Word@@HС~@wz@wz ,՜.+,D՜.+,x4 hp|  <Xҭ LHuman Immunodeficiency Virus and Acquired Immune Deficiency Syndrome (AIDS) Title|% 8@ _PID_HLINKSA4%9lhttps://www.uptodate.com/contents/management-of-healthcare-personnel-exposed-to-hiv?source=search_result&search=post%20exposure%20prophylaxis%20aids&selectedTitle=1~150lJishttp://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Horberg%20MA%5BAuthor%5D&cauthor=true&cauthor_uid=24235263lHfshttp://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Zingman%20BS%5BAuthor%5D&cauthor=true&cauthor_uid=24235263=cshttp://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Emmanuel%20P%5BAuthor%5D&cauthor=true&cauthor_uid=24235263.T`rhttp://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Ghanem%20KG%5BAuthor%5D&cauthor=true&cauthor_uid=24235263mR]shttp://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Gallant%20JE%5BAuthor%5D&cauthor=true&cauthor_uid=24235263%Zqhttp://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Aberg%20JA%5BAuthor%5D&cauthor=true&cauthor_uid=24235263i=WKhttp://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdfTUhttp://www.aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv-guidelines/0/eQ'http://www.homeaccess.com/HIV_Test.asp_]Nhttp://www.oraquick.com/<#KGhttp://www.cdc.gov/hiv/pdf/HIVtestingAlgorithmRecommendation-Final.pdf|Hhttps://www.uptodate.com/contents/screening-and-diagnostic-testing-for-hiv-infection?source=search_result&search=HIV%20antibody%20test&selectedTitle=1~150 OENhttp://aids.gov/hiv-aids-basics/prevention/hiv-testing/hiv-testing-frequency/A B2http://www.cdc.gov/hiv/pdf/PrEPguidelines2014.pdfM2?thttp://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Wolitski%20RJ%5BAuthor%5D&cauthor=true&cauthor_uid=24804859=P<rhttp://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Sansom%20SL%5BAuthor%5D&cauthor=true&cauthor_uid=24804859h9phttp://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Lasry%20A%5BAuthor%5D&cauthor=true&cauthor_uid=24804859hZ6shttp://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Markham%20CM%5BAuthor%5D&cauthor=true&cauthor_uid=24810219^-3phttp://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Ross%20MW%5BAuthor%5D&cauthor=true&cauthor_uid=24810219I,0phttp://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Tran%20LT%5BAuthor%5D&cauthor=true&cauthor_uid=24810219nJ-ohttp://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Bui%20TC%5BAuthor%5D&cauthor=true&cauthor_uid=24810219E~*lhttp://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Nutan%5BAuthor%5D&cauthor=true&cauthor_uid=241748830'qhttp://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Gupta%20SK%5BAuthor%5D&cauthor=true&cauthor_uid=24174883^$shttp://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Kashuba%20AD%5BAuthor%5D&cauthor=true&cauthor_uid=24664786O !thttp://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Cottrell%20ML%5BAuthor%5D&cauthor=true&cauthor_uid=24664786pwhttp://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Cayley%20WE%20Jr%5BAuthor%5D&cauthor=true&cauthor_uid=15508535| Chttp://www.nhlbi.nih.gov/health/health-topics/topics/bt/risks.htmlnNphttp://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Heimer%20R%5BAuthor%5D&cauthor=true&cauthor_uid=1403641>Wqhttp://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Kaplan%20EH%5BAuthor%5D&cauthor=true&cauthor_uid=1403641&qhttp://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Quinn%20TC%5BAuthor%5D&cauthor=true&cauthor_uid=24111891[rqhttp://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Kacker%20S%5BAuthor%5D&cauthor=true&cauthor_uid=241118914U rhttp://www-ncbi-nlm-nih-gov.online.uchc.edu/pubmed?term=Tobian%20AA%5BAuthor%5D&cauthor=true&cauthor_uid=24111891 r Ghttp://www.cdc.gov/hiv/prevention/research/malecircumcision/index.html-https://www.uptodate.com/contents/the-natural-history-and-clinical-features-of-hiv-infection-in-adults-and-adolescents?source=search_result&search=HIV%20disease&selectedTitle=1~150-<,http://www.ncbi.nlm.nih.gov/pubmed/23917901A 2http://www.cdc.gov/hiv/pdf/PrEPguidelines2014.pdf  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHJKLMNOPRSTUVWXYZ[\]^_`abcdkRoot Entry FPmData S1Table$WordDocument1SummaryInformation(IDocumentSummaryInformation8Q&CompObjr  F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q